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Abstract
Organophosphates (OPs) are the most common pesticides used in agriculture. 
Although they can be broken down in nature, OPs pose a severe health hazard to human 
due to their inhibitory effect on acetylcholinesterase, a major enzyme in nervous 
transmission. Therefore, detoxification of water and soil contaminated by OPs is 
important. One way of achieving this is by bioremediation of sites with OP-degrading 
enzymes. One such enzyme is methyl parathion hydrolase (MPH) isolated from 
Pseudomonas sp. WBC-3.
MPH is a highly efficient enzyme that is capable of hydrolysing methyl 
parathion at near diffusion-limited rate. While MPH can hydrolyse a wide range of OPs, 
the substrate specificity of the enzyme was not well characterised. In order to study 
MPH, the enzyme was expressed and purified. In the process of MPH protein 
purification, proteolytic degradation was observed. Various methods, including protein 
engineering and optimising the purification, were employed to investigate and 
overcome the degradation. A protocol that allowed rapid purification of MPH was 
developed so that the proteolysis can be minimised. Due to initial suspicion of 
autoproteolysis, nickel affinity chromatography was also used in further investigations 
and autoproteolysis was eventually ruled out.
Stability is one of the most important characteristics that define an enzyme’s 
practical use in the industry. For MPH to be an effective bioremediator, it needs to be 
thermally and chemically stable. Unfortunately, MPH does not have exceptional 
thermostability and could benefit from extra thermostability. To achieve this, MPH was 
subjected to directed evolution for enhanced thermostability. In the course of 
characterising the mutants isolated, it was discovered that MPH expressed in E. coli had 
lower than expected metal content. It was also found that Zn2 supplementation prior to 
activity and stability assay drastically increased the activity and stability of WT MPH. 
Since the evolution was performed without metal supplementation and the isolated 
mutant did not have enhanced stability with Zn2" supplementation, we hypothesised that 
the mutant isolated was stabilised “metal independently”.
Another desired characteristic for a bioremediator is the ability to hydrolyse 
various OPs efficiently. The substrate profile characterisation of WT MPH revealed that
vii
while MPH is highly efficient towards methyl parathion, its activity towards other OPs 
varies. To alter and broaden the substrate specificity o f MPH, structure-guided site 
saturation mutagenesis (SSM) on active site lining residues was performed to obtain 
mutants with enhanced activity towards ethyl paraoxon. Mutants with modest 
improvements were isolated and two rounds o f DNA shuffling were performed to 
compound the mutations. The best mutant towards ethyl paraxon exhibited 98-fold 
increase in kca/K m Several other mutants exhibited interesting and respectable changes 
in their substrate profiles. One mutant with selective activity towards chlorpyrifos class 
substrates was found. These results highlighted the ‘plasticity’ o f MPH active site that 
allow efficient hydrolysis o f other OPs with only minor changes.
In short, progress had been made in purifying MPH and in evolving it to be 
more stable -  although further work is required in this area. Considerable progress had 
been made in identifying mutations that alter the substrate specificity o f MPH.
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1. Introduction
1.1. Preamble
This thesis is concerned with a phosphotriesterase (PTE) known as methyl 
parathion hydrolase (MPH) that was identified in China. The enzyme, and its gene, was 
isolated from the bacterium Pseudomonas sp. WBC-3 and was found to be able to fully 
mineralise methyl parathion (MPS). Other bacteria were later found to express MPH: 
some with identical sequences and activities while some had similar sequences and 
activities. These proteins have a number of properties that distinguish them from other 
organophosphate (OP) degrading enzymes and that may make them useful in the 
bioremediation of pesticide-contaminated water and other applications. However, MPH 
is not well understood and some of its characteristics are not ideal for practical 
applications. Therefore, protein-engineering studies directed towards improving its 
stability and understanding its kinetic properties, as well as altering its substrate 
specificity, have been undertaken.
A brief description of OP pesticides will be given along with an overview of 
MPH publications. A brief review of protein-engineering methods used to modify and 
improve enzyme will also be given. In the final section of the introduction, an outline of 
the specific objectives of this study will be given.
1.2. Organophosphate pesticides
Organophosphate (OP) is a term used to describe esters, amides or thiol 
derivatives of phosphoric acid and other sulphur-containing analogues. OPs form a 
large family of -50,000 chemical agents with biological properties'. OPs can be further 
classified based on the extent of esterification (Figure 1.1). There are formal naming 
conventions for these compounds, but they are usually referred to by their common 
names in the literature and in the present work. Standard reference text can be consulted 
for a detailed coverage of phosphorus chemistry and only a brief description of relevant 
compounds will be given here. The chemical structures of OP pesticides and nerve 
gases have been compiled and those referred to in this thesis are given in Appendix D.
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X X X
OR —  P-----OR' OR —  P-----OR' OR —  P---- OH
OR" OH OH
Phosphotriesters Phosphodisesters Phosphomonoesters
X X X
R----- P------OR' R----- P------OR' R----- P------OH
OR" OH OH
Phosphonodiesters Phosphonomonoesters Phosphonic acid
Figure 1.1: Some structures of different classes of organophosphates.
X can be O or S; R. R‘. R” can be alkyl, ethyl or phenyl groups.
Many biological molecules contain phosphate and addition, subtraction or 
modification of the phosphate group is often involved in the regulation of various 
metabolic processes2. DNA and RNA, the genetic material in organisms, contain 
phosphodiester backbone that connects individual nucleotides to form long DNA and 
RNA chains. Phospholipid, the main component of cellular membranes, has a 
phosphodiester hydrophilic head that gives rise to the amphibatic character of cellular 
membranes. Glucose-6-phosphate, a monophosphoester from the phosphorylation of 
glucose, has prominent roles in the cells, as it is the substrate for glycolysis and the 
pentose phosphate pathway. Phosphate esters are usually stable and are broken down 
enzymatically when required in cellular metabolism. The stability of phosphate esters 
makes them of considerable interest in the mechanisms of enzymatic modification and 
hydrolysis2. While phosphomonoesters and phosphodiesters are abundant naturally, 
phosphotriesters do not occur naturally2. OP pesticides are triesters -  these are unusual.
OP pesticides were first synthesised in the 19th century as a chemical curiosity. 
In the early 20th century, German chemist Gerhard Schrader noticed the insecticidal 
properties of these compounds and began research into the development of more 
superior insecticides and subsequently military nerve agents3. OP pesticides and nerve 
agents are similar; they differ in their toxicity. Nerve agents are more toxic to humans 
while the less toxic OPs are used as insecticides4. However, OP pesticides actions are 
non-specific and can be lethal to human if exposed to in large quantities.
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The structures of a few common pesticides are given in the figure below to 
explain the abbreviation convention used in this thesis. Some of these pesticides are 
substrates of MPH and the abbreviations used to denote the compounds are given in 
Figure 1.2. The structures of some nerve agents are also given in Figure 1.3. The OP 
pesticides used in the work for this dissertation were mainly parathion and chlorpyrifos 
derivatives. The parathion derivatives have a /?-nitrophenolate (pNP) leaving group 
whereas chlorpyrifos derivatives have a 2,5,6-trichloro-2-pyridinol (TCPy) leaving 
group. In all the pesticide abbreviations used in this thesis, a three-letter format was 
adopted. The abbreviation for methyl parathion, for example, is MPS, where M 
indicates it has a dimethyl substitute; P indicates it has a /?-nitrophenolate leaving group 
and S indicates that it is a thiophosphate.
Parathion derivative
Methyl parathion (MPS): R = 1C; X = S 
Methyl paraxon (MPO): R = 1C; X = O 
Ethyl parathion (EPS): R = 2C; X = S 
Ethyl paraoxon (EPO): R = 2C; X = O
Chlorpyrifos derivative
Methyl chlorpyrifos (MCS): R = 1C; X = S 
Methyl chlorpyrifos oxon (MCO): R = 1C; X = O 
Ethyl chlorpyrifos (ECS): R = 2C; X = S 
Ethyl chlorpyrifos oxon (ECO): R = 2C; X = O
Figure 1.2: The general structures o f parathion and chlorpyrifos derivatives and the abbreviations.
Figure 1.3: Structures o f some nerve agents.
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Both OP pesticides and nerve agents act on acetylcholinesterase (AChE). AChE 
is a serine hydrolase that catalyses the breakdown of acetylcholine (ACh) at cholinergic 
synapses and the catalytic mechanism is shown in Figure 1.4a56. OP pesticides and 
nerve agents function by covalently modifying the catalytic serine of AChE (Figure 
1.4b). As can be seen in the figure, the serine displaces an alcohol that is generally a 
good leaving group like p-nitrophenolate (pNP). The specificity of these agents is 
determined by a number of factors -  the alkyl chains being the most important. OP 
pesticides are usually triesters with two short chain alcohol such as diethyl and dimethyl 
substituents. The result of the inhibition of AChE by OPs, is the covalent modification 
of the nucleophile, forming an extremely stable and slow hydrolysing adduct that 
mimics the intermediate in ACh hydrolysis5,6. Dealkylation of the adduct to a 
phosphodiester, also known as aging, leads to irreversible AChE inhibition and causes 
hyper stimulation of nerve cells and death. The symptoms of OPs poisoning can be 
found in a review by Bajgar7.
Currently, treatment for OP poisoning relies on chemical antidotes such as 
cholinolytics, oximes, atropine and anticonvulsants to minimise toxic manifestations.8 
Classical studies done by Wilson and his colleagues showed that strong nucleophiles 
such as oximes can reactivate phosphorylated AChE.9,10 Examples of commercially 
available oximes can be found in Figure 1.5a. Oximes reactivate the phosphorylated 
AChE by attacking the phosphate centre of the adduct to regenerate the free catalytic 
serine (Figure 1.5b).11,12 Oximes such as pralidoxime (2-PAM) and HI-6 are often used 
with atropine, a muscarinic acetylcholine receptor antagonist, as antidotes in acute OP 
poisoning therapy.13 However, they have to be administered quickly after exposure as 
they are impotent against aged phosphorylated AChE. Furthermore, the effectiveness of 
oxime reactivation differs among OP compounds.14 OP-degrading enzymes like MPH 
and OPDA can be used to remove excess OPs from the bloodstream, allowing 
reactivation to occur without re-inhibition.
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b)
His440
His440 His440
Figure 1.4: The mechanism of acetylcholinesterase and its inhibition by organophosphate.
The reaction mechanism of AChE with its natural substrate, ACh is shown in (a). His440 acts as a 
general base, abstracting the proton from Ser200. Transesterification of ACh at Ser200 of AChE via an 
unstable tetrahedral intermediate liberates choline. His440 then again acts as general base, abstracting a 
proton from a water molecule, leading to the hydrolysis of the acetylated enzyme and regenerates the 
active enzyme. However, as shown in (b), when exposed to OPs, the compound binds to the active site 
and phosphorylates Ser200. The resulting adduct is a stable structure that resembles the transition state in 
ACh hydrolysis that hydrolyses extremely slowly5 6. Aging of the adduct through dealkylation leads to 
irreversible inhibition of AChE. R is the leaving group of the OP.
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a)
pralidoxime (2-PAM)
O
asoxime (HI-6)
trimedoxime
methoxime
Figure l.5:Examp\es of AChE reactivators for OP poisoning and its reactivation mechanism.
a) Examples of commercially available oxime antidotes. The oxime groups are highlighted in red. (b) 
Oximes are strong nucleophiles and can reactivate phosphorylated AChE through nucleophilic attack on 
the organophosphate moiety. The oxime is phosphorylated, liberating the Ser200.
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1.3. Organophosphate-degrading enzymes
1.3.1. Enzymes other than MPH
Organophosphate-degrading enzymes were thought to have evolved in recent 
times, as OPs were not present in the environment until after the Second World War.15 
OPs are xenobiotics and are not naturally found in the biosphere. Hence, the enzymes 
that degrade these compounds have either evolved over a span of less than 100 years, or 
they are enzymes that have an alternative primary function and fortuitously break down 
OPs. Enzymes with both evolutionary origins appear to have been identified.16,17
In 1946, Abraham Mazur found an enzyme in human and rabbit tissues that was 
capable of hydrolysing diisopropyl fluorophosphate (DFP), a dialkyl fluorophosphate, 
and other OP compounds. He found that rabbit and human liver extract contains high 
amounts of enzymes and noted that liver plays a significant role in DFP 
detoxification.18 In 1950s, Aldrige studied the hydrolysis of various carboxylesters and 
paraoxon using sera from human and various mammals and proposed that serum 
esterases can be classified into A and B-esterases. He found that the A-esterases 
(subsequently named paraoxonase) were capable of hydrolysing organophosphates and 
aromatic carboxyl esters and the B-esterases (serine carboxylesterases and 
acetylcholinesterases) were inhibited by paraoxon.16,19,20 The name was eventually 
shortened to PON and various homologs were identified. The paraoxonase family 
consists of three members- PON1, PON2 and PON3 that were named in the order of 
their discovery. These different homologs share about 65% sequence similarities at the 
amino acid level and have different cellular localisations.21 PON1 has been the most 
studied paraoxonase and was found to require two calcium ions for activity and 
stability.22 The structure of a PON1 mutant variant was solved and was found to be a 
six bladed ß-propeller as shown in Figure 1.6.“ PON 1 is unstable and aggregates in the 
absence of detergents, as it is a lipoprotein-anchored enzyme.24
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Figure 1.6: Structure of PON 1 mutant variant (PDB ID: 1V04).
Figure shows top view o f  ß-propeller fold. The catalytic calcium is shown in blue and the structural 
calcium is shown in green.
In addition to a variety of OPs, PON1 can degrade aromatic esters as well as 
aliphatic and aromatic lactones. The latter compounds are probably its physiological 
targets as OPs are not naturally occurring and its ability to degrade these compounds 
was found to be relatively modest. Several reviews can be consulted for more 
information on this enzyme.2125
In 1982, Hoskins and Roush identified a new enzyme that, like PON1, was 
capable of degrading DFP and OPs and the enzyme was named diisopropyl 
fluorophosphatase (DFPase).26 The enzyme was isolated from squid axons and the 
crystal structure was eventually solved.27 28 It was found that DFPase is a calcium- 
dependent hydrolase and is structurally related to PON1 (Figure 1.7). Both PON1 and 
DFPase exhibit the six bladed ß-propeller fold.
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Figure 1.7: Structure of DFPase (PDB ID: 2GVV).
Figure shows top view of ß-propelier fold. The catalytic calcium is shown in blue and the structural 
calcium is shown in green.
Another class of promiscuous OP-degrading enzymes that received attention is 
organophosphorus acid anhydrolase (OPAA). While DFPase and OPAAs share the 
capability of hydrolysing DFP and can be grouped together as OPAAs based on the 
activities they catalyse, it was eventually shown that DFPase does not share the same 
protein folding as the other OPAA members. To avoid confusion, these two enzymes 
would be classified differently in this discussion, based on the classification used by 
Singh15 and Bigley et al?q in their respective reviews. OPAA was isolated from 
Alteromonas udina and Alteromonas haloplanktis. 30,31 Similar to DFPase, OPAA was 
found to be highly efficient against DFP and various G-type nerve agents.31 While both 
DFPase and OPAA are highly efficient against DFP, OPAA crystal structure reveals 
that OPAA and DFPase are structurally unrelated. OPAA is found to be related to 
aminopeptidase P (AMPP) as both enzymes show a “pita bread” fold (Figure 1.8).32 33 
AMPP catalyses the cleavage of amino-terminal X-Pro peptide bonds. OPAA belongs 
to this dipeptidase family and does not share sequence or structural similarity with other 
OP-degrading enzymes, suggesting that the OP degrading capability of OPAA might 
have evolved from a different progenitor. 15 Jao and his colleagues demonstrated that 
AMPP is capable of hydrolysing a wide range of OP triesters34, suggesting the 
possibility of other enzymes in the superfamily to also have OP-degrading activity.
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(a)
(b)
Figure 1.8: Monomeric structures of (a) OPAA (PDB ID: 3L7G) and (b) AMPP (PDB ID: 1WL9).
The manganese ions for both enzymes are shown as spheres.
Insects are the main targets of OPs and it is not surprising that resistance has 
emerged in them. Mutations that confer this resistance have been found in a family of 
esterase genes. Newcomb and colleagues found a single amino acid substitution in 
blowfly carboxylesterase that converts it to an organophosphorus hydrolase.36 This 
mutation is thought to introduce a general base, which is capable of breaking down the 
covalent product formed by the OP, into the active site. Although the OP-degrading 
activity of the mutant is low, the naturally occurring mutant illustrates evolution in 
action. It should be noted that these insect esterases belong to the a/ß hydrolase fold and 
function without metals.36 In this respect, they are structurally different from the other 
OP-degrading enzymes (Figure 1.9).
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Figure 1.9: Structure of (*Esterease7 (PDB ID: 4FNG).
MPH was not the first OP-degrading enzyme that was isolated from bacteria 
found in soil contaminated with pesticides. Various OP-degrading bacteria were 
isolated and the genes and the enzymes responsible for the OP-degrading capability 
were isolated from them. In 1973, Sethunathan and Yoshida reported the first OP- 
degrading bacteria isolated from the environment. The bacterium, Flavobacterium sp. 
ATCC 27551, was found in a Philippines paddy field that had been treated with 
diazinon for years37. Phosphotriesterases (PTEs), the enzymes eventually isolated and 
characterised, are a group of enzymes that can degrade OP compounds, and they can be 
found in various organisms. Singh, in his review, stated that there are currently three 
different types of well-characterised bacterial PTEs: opd type hydrolase, OPAA and 
MPH15.
Three PTEs from the opd type hydrolase, OPH from Flavobacterium sp. and 
Pseudomonas diminuta and OPDA from Agrobacterium radiobacter, share about 90% 
sequence similarity and similar activity profiles.38 Although no physiological substrates 
are known for OPH and OPDA, structural and sequence similarities suggest that they 
have evolved from the lactonases that function in quorum sensing.17 These PTEs were 
found to have a very high activity towards OPs and degrade some substrates like 
paraoxon at diffusion-limited rates.38 They are metal dependent and function with a 
variety of divalent metals -  Zn2 being reported as the preferred metal for OPH while 
OPDA has been observed to have Fe24/Zn2 centre.39 PTEs are also active with 
binuclear Co2+, Ni24, Cd2+or Mn2 centres.40
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Structural studies have been carried out with OPH and OPDA. As expected, 
both have very similar structures and are placed in the amidohydrolase fold 
superfamily.41’42 Both enzymes are homodimers with a TIM barrel fold, consisting of a 
distorted a/ß barrel formed by eight parallel ß-sheets and surrounded by 14 a-helices 
on the outer surface, as is typical of amidohydrolases superfamily enzymes (Figures 
1.10 and 1.1 1).38,43 Reviews on the members of this fold have been published and 
discussed in detail.41,44 The metal binding sites of OPH and OPDA are essentially the 
same and are located at the C-terminal end of the ß-strands of the TIM-barrel43 and 
features a binuclear metal centres -  the metals being designated a  and ß. His55, His57 
and Asp301 coordinate the more buried a-metal, while His201 and His301 coordinate 
the more solvent exposed ß-metal. A bridging hydroxide and a bridging carbamylated 
Lysl69 coordinate both metals (Figure 1.12). The a-metal is pentacoordinated, 
assuming a trigonal bipyrimidal geometry, while the ß-metal has a distorted octahedral 
geometry with two terminally bound water when the metal ion is Co:+, Cd2 and 
Mn2+.43,45,46 However, when the ß-metal is Zn2f, the metal ion is pentacoordinated with 
one of the terminal water molecules moved away from Zn" into a non-coordinating 
position. The metal assumes a trigonal bipyrimidal coordination geometry.45,46
(a) (b)
Figure 1.10: Structures of (a) OPDA (PDB ID: 2R1N) and (b) OPH (PDB ID: 1PSC).
(a) and (b) shows the top view o f  OPDA and OPH respectively. Orange and pink spheres represent the 
Fe2 and Co2* in OPDA respectively while wheat spheres represent the Cd2 metals in OPH. The OPDA 
and OPH structures are very similar.
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Figure 1.11: Structure of Klebsiella aerogenes urease, an amidohydrolase superfamily enzyme 
(PDB ID: 2KAU).
Figure shows only the TIM-barrel domain of urease. The green spheres represent the catalytic Ni2" 
metals.
K169
OH-
H201
H20
H57
D301
H230 H55
Figure 1.12: Metal coordination centre of OPDA and OPH active site.
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1.3.2. Methyl parathion hydrolase (MPH)
1.3.2.1. History and general information
MPH was discovered due to a search for OP-degrading microbes in soil 
contaminated with pesticides. Two enzymes with identical protein sequences and near-
identical DNA sequences were isolated from Plesiomonas sp. strain M6 (M6-MPH) and 
Pseudomonas sp. WBC-3 (WBC3-MPH).47’48 These enzymes exhibit a very high 
activity towards methyl parathion. Subsequently, many other MPH variants were 
identified and were found to have high levels of sequence identity to one another.49 54 
Pseudomonas sp. WBC-3, from which WBC3-MPH was isolated, was found to fully 
mineralised methyl parathion as the sole nitrogen and carbon source. The aligned 
sequences for some of the known MPH variants are shown in Appendix E. These 
sequences all show low levels of similarity to other proteins that are members of the 
metallo-ß-lactamase (MBL) superfamily. When these amino acid sequences are aligned, 
the conserved putative metal binding residues can be observed. The conserved metal 
binding motif in MPH is HXHXDH; where X is any amino acid, H is histidine and D is 
aspartate.
The MBL superfamily was first identified by Neuwald and colleagues while 
demonstrating the capability of a bioinformatics program to construct multiple 
alignment models for protein superfamily identification/6 Daiyasu and colleagues then 
expanded the zinc superfamily by introducing further classification based on the 
conservation of metal-binding residues and biological functions.56 Thus the 
classification proposed by Daiyasu et al. does not always reflect phylogenetic 
relationship. The MPH variants did not show any sequence similarity to the opd type 
hydrolases such as OPH and OPDA. Subsequent structural analysis, described below, 
confirmed that MPH is not related to OPH and OPDA. No natural substrate is known 
for MPH but its structure belongs to the metallo-ß-lactamase fold that encompasses 
esterases that degrade a variety of substrates including ß-lactams and lactones.56’57
Like OPH and OPDA, MPH variants are binuclear metallo-hydrolases. MPH 
variants are natively zinc-containing enzyme, but preliminary characterisation by Chu 
et al showed activity enhancement with Cd2 and Fe2+7 as well as activity inhibition 
with Hg2", Zn2+, Al3 and Bi3 .58 However, subsequent work done by Dong et a l59 and
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our group confirmed that WBC3-MPH has two Zn2 metals and the Zn2 metals have 
catalytic and structural roles in MPH as discussed in Chapter 4. In addition to methyl 
parathion (MPS), MPH variants are able to hydrolyse other phosphorothioates (P=S 
moiety) and oxonates (P=0 moiety) such as parathion (EPS), paraoxon (EPO), 
chlropyrifos (ECS) and fenitrothionf3,60 WBC3-MPH is able to hydrolyse MPS at near 
diffusion-limited rate, with kcat/Km ratio of more than 106 M'1 s'1.58,59,61 However, the 
published literature does not have a detailed kinetic characterisation of MPH with many 
substrates, and only limited information is available. To address this, a detailed kinetic 
characterisation WBC3-MPH with different OP substrates can be found in Chapter 5 
of this thesis. The literature does however, draw attention to the fact that MPH has a 
pronounced preference for pesticides with dimethyl substituents and only has low levels 
of activity with pesticides that have diethyl substituent. This will also be discussed in 
Chapter 5. It was also found in this work that WBC3-MPH has a preference for 
phosphorothioate substrates like MPS and EPS as opposed to oxonates like MPO and 
EPO.
1.3.2.2. MPH structure and metallo-ß-lactamase superfamily
Dong and his colleagues solved the structure of WBC3-MPH in 2005.5962 The 
structure shows a homodimer with subunits that are related by a two-fold symmetry 
(Figure 1.13). Each subunit is a ß-lactamase-hke domain, with an cxß/ßu sandwich 
consisting of flanking a-helices and two internal mixed ß-sheets. The active site is 
located between the two ß-sheets; with the metal binding residues emanating from 
loops in between the ß-sheets. The dimerisation of MPH is facilitated by domain 
swapping of N-terminal domains of the two subunits. The N-terminal arm of each 
monomer extends into the adjacent two-fold related subunit, suggesting that the dimer 
is not a crystallographic artefact. Structurally, WBC3-MPH is similar to B3 MBLs such 
as LI from Stenotrophomonas maltophilia and AIM-1 from Pseudomonas aeruginosa, 
and MBL superfamily enzymes such as human glyoxalase II and E. coli zinc 
phosphodiesterase (ZiPD). Figure 1.14 shows examples of MBL superfamily enzymes 
and the conservation of the cxßßa fold among the superfamily members.
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Figure 1.13: Overall structure of MPH (PDB ID: 1P9E).
(A) illustrates the homodimeric structure of MPH. The N-terminal arm of each monomeric unit interacts 
with the other monomer to form the dimerisation interface. The monomeric units are shown in cyan and 
green. Zinc (Zn2+) metals are shown in grey and the cadmium metal (Cd:+) is shown in wheat. (B) 
illustrates the top view of the monomeric MPH. The metals are located in between the parallel ß-sheets. 
The ß-sheets are flanked by solvent exposed a-helices.
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Figure 1.14: Overall structure of MBL superfamily enzymes.
(A) illustrates the structure of MPH (PDB ID: 1P9E). (B) illustrates the structure of AIM-1 lactamase 
(PDB ID: 4AWY). (C) shows the structure of human glyoxalase 11 (PDB ID: 1QH5). (D) shows the 
structural superimposition of the 3 enzymes. The superimposition reveals the conservation of the aßßcx 
fold among the superfamily members.
As noted above, the active site of WBC3-MPH has a binuclear metal centre and 
is situated between the two central ß-sheets. The metals have been identified 
spectroscopically to be zinc but the crystallographic data revealed that they have two 
different metals.59 Dong et al. reported each MPH subunit has a hybrid Cd2+/Zn2 
centre. Since, MPH could only be crystallised in the presence of Cd2f, it was concluded 
that Cd2 displaced the more solvent exposed ß-Zn2 during crystallisation.59 However, 
upon closer inspection of the coordinates obtained from the protein databank, the 
structure reveals a Zn2 binuclear centre in one subunit and a hybrid Cd2+/Zn2 centre in 
another subunit. As shown in Figure 1.15, a water molecule and Asp255 bridge the two 
metals. Aspl51, His 152 and His302 coordinate the a-metal while Hisl47, Hisl49, 
His234 and a terminally bound water coordinate the ß-metal. The more buried metal (a- 
metal) has a trigonal bipyrimidal coordination, while the more solvent exposed metal
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(ß-metal) is coordinated with an octahedral geometry. The putative substrate-binding 
pocket is hydrophobic and is formed by Leu65, Leu67, Phel 19, Trpl79, Phel96, L258 
and Leu273. Phel 19, Trpl79 and Phel96 were suggested as possible substrate-binding 
residues. The side chain of these residues may form ^-stacking interactions with the 
aromatic p-nitrophenolate leaving group of MPS.59
(A)
(B)
H234
H149
H152 HI47
Figure 1.15: Metal coordination centre of MPH active site.
(A) shows the location of the metal centre in MPH. The metal centre is located between the ß-sheets and 
the metal coordinating residues emanating from the loops in between ß-sheets. The Zn2" is shown in grey, 
Cd2" in wheat and water in red spheres. (B) shows the schematic of the MPH metal centre.
It is worth noting that, despite the lack of sequence and structural homologies 
between MPH and opd type hydrolases, there are similarities between the binuclear 
metal centre in WBC3-MPH and those found in OPH and OPDA. The a-metals are 
coordinated by an aspartate that also forms a hydrogen bond with the bridging
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hydroxide in the active site. In addition, several histidine residues coordinate the metals 
in OPDA and OPH, as is the case for MPH. The metals are also bridged by a 
carboxylated lysine and a hydroxide. In MPH, OPH and OPDA, hydrophobic residues 
line the active site pockets.
1.3.2.3. MPH mechanism
Since the MPH and OPH share a number of common features in the active site 
metal centre, as well as the ability to hydrolyse OPs at near diffusion limited rates, it is 
generally assumed that the two enzymes also share mechanistic similarity. On this 
basis, Dong et al. proposed a catalytic mechanism that is based on the mechanism 
proposed by Benning et al. for OPH with paraoxon.45,59 Detailed mechanism for OPH, 
OPAA, PON1 and DFPase can be found in a review by Bigley and Raushel.29 It should 
be noted that the choice of nucleophile has been a subject of speculation. Work done by 
Jackson et al. provided some evidence to the alternate view that a terminally bound 
water to the a-metal is the nucleophile, and that the bridging hydroxide acts as a base to 
activate it for attack in OPDA.63,64 The two possible mechanisms for MPH are 
summarised in Figure 1.16.
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Figure 1.16: Proposed mechanisms for OPH, OPDA and MPH.
Two mechanisms have been proposed for the catalytic hydrolysis of organophosphates (OP) by OPH. 
OPDA and MPH. Mechanism (A) utilises the bridging hydroxide as the nucleophile while mechanism 
(B) utilises a terminally bound hydroxide as the nucleophile.
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1.3.2.4. Genetic organisation of MPH
The genes coding for the various MPHs are all designated mpd, and they were 
all isolated in China, with the exception of Burkholderia cepacia mpd that was isolated 
in Thailand.47,48,51-53 Most of the mpd genes isolated are found in the bacterial genome, 
with the exception of mpd isolated from Pseudomonas sp. WBC-3. This mpd gene is 
located in a 70 kb plasmid65 and the gene product, WBC3-MPH, is 98% and 100% 
identical to two other MPH variants, where the mpd genes are located in the 
genome.48,49 This observation suggests that the widespread distribution of mpd genes is 
possibly due to horizontal gene transfer aided by mobile genetic elements. Liu and co-
workers investigated the MPS and p-nitrophenol hydrolysing capabilities of 
Pseudomonas sp. WBC-3 and found that the plasmid-cured bacteria could not 
catabolise MPS and p-nitrophenol, confirming the location of the mpd gene. They also 
identified the plasmid harbouring mpd to be a class I transposon, as the mpd gene is 
flanked by two copies of insertional sequence (Figure 1.17a).65 Wei et al. demonstrated 
the transposibility of the plasmid, supporting the hypothesis that horizontal genetic 
transfer was responsible for the distribution of mpd genes.66 In the search for evidence 
that horizontal gene transfer had taken place, Zhang et al. found that the mpd gene 
clusters from the genome of seven bacterial strains isolated from MPS contaminated 
soil were conserved.67,68 These bacteria belong to the genera of Pseudaminobacter sp., 
Achromobacter sp., Brucella sp. and Ochrobactrum sp. Computer analysis revealed that 
the region contains five open reading frames (ORFs); two on one strand and three on 
the complementary strand. The cluster contains mpd, a tnp and three other ORFs that 
highly resemble permease component of ABC-type transport system (Figure 1.17b). 
The distribution of highly similar mpd genes in both bacterial genomic DNA and 
plasmid DNA is similar to that observed for opd and opdA, the genes coding for OPH 
and OPDA respectively.69 71 The gene clusters of Flavobacterium sp. opd and 
Agrobacterium radiobacter opdA were analysed and transposon elements were 
found.72,73 The genetic organisation of opd, opdA and mpd are shown in Figure 1.17.
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Figure 1.17: Genetic organisation of known organophophorus-degrading genes.
The arrowheads indicate the location and the direction of transcription. (A) Gene clusters of mpd located 
in a catabolic plasmid isolated from Pseudomonas sp. WBC-3. The mpd gene is flanked by two IS6100 
elements, each containing a gene encoding transposase (tnp) that is flanked by inverted repeats.65 (B) 
Gene clusters of mpd found in the genome of Ochrobactrum sp. The cluster includes mpd, inverted 
repeats flanking a transposase encoding gene {tnpA) and three ORFs of unknown function.67 (C) Gene 
clusters of opd found in a plasmid isolated from Flavobacterium sp. The cluster includes a complete 
islAB operon, opd, tnpA and inpR that codes for transposase and resolvase. orf243 that codes for 
metabolite utilization and 2 other orfs of unknown function.77 (D) Gene clusters of opdA found in the 
genome of Agrobacterium radiobacter P230. The cluster includes tnpA, opdA and two orfs of unknown 
function.72
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1.4. Protein engineering
Enzymes have been studied for decades, and rather glowing descriptions of their 
properties have been given in many basic biochemistry texts. However, these 
descriptions often present a rather incomplete picture and leave the reader wondering 
why these marvellous catalysts are not used more frequently in the industry. For this 
reason, it is worth spending a little time looking at how enzymes evolve in nature, and 
how this process place limitations on their usefulness in practical applications.
Enzymes have evolved over millions of years with mutation and genetic 
recombination, providing sizeable gene pools from which exceptional characteristics 
are selected for propagation. This process is repeated over many generations so that 
highly optimised enzymes would be produced -  enzymes ideally suited for cellular 
functions. However, it should be noted that natural evolution occurs at the level of the 
organism and that, unless an enzyme gives the organism a selective advantage, it will 
only evolve to the point where it satisfies the need of the cell. Thus, it may fall short of 
being suitable for industrial applications. In short, an enzyme evolves to the point where 
it satisfies the need of the cell and no more. For example, a highly regulated enzyme in 
a pathway may only function when required -  under a specific set of conditions, and 
these conditions may not be appropriate for practical applications outside the cell. 
Increased activity can be generated in several ways. Rather than increasing the catalytic 
efficiency of the enzyme, increasing the amount of enzyme produced in the cell will 
give the desired outcome. Alternatively, increasing the stability will effectively increase 
the activity displayed by the cell. Suppose that an enzyme is not crucial for the survival 
of an organism and that relatively low levels of activity are required for survival. Over 
the course of evolutionary time, the properties may alter -  the expression may drop, 
solubility might decrease, but as long as the needs of the organism are satisfied, then the 
properties of the enzyme can drift in directions that may be detrimental for industrial 
applications. In short, enzymes are often not suitable or optimal for industrial 
applications due to limitations such as instability in reaction conditions required in 
large-scale applications. Furthermore, despite the fact that there are an enormous 
number of enzymes, there are many reactions for which an enzyme cannot be identified.
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The idea of improving or engineering an enzyme is not a novel idea, but the 
technology to alter an enzyme has only been available for a relatively short period of 
time. The advent of molecular biology and DNA recombinant technology offer avenues 
to modify proteins in a specific way. Initially these developments led to studies that 
were aimed at understanding protein structure function. Residues were mutated site 
specifically and changes in activity were monitored. Eventually, the idea of modifying 
protein in a useful way emerged, and the term “protein engineering” was coined.74,75 
Early studies were directed at improving the stability of enzymes used in laundry 
detergent, but as the tools improved, the objectives became more ambitious. However, 
it was not until mid 90s that the tools necessary for artificial evolution became 
available. It should be clear, from this brief history of protein engineering, that the field 
is relatively new, and that it should not be surprising that detailed protocols for 
improving specific aspects of an enzyme function are not available. There are three 
general approaches to engineering proteins: the rational approach, the semi rational 
approach and the evolutionary approach.
1.4.1. Rational and semi-rational approaches
The rational approach relies upon computational calculations such as molecular 
dynamics76 that enable predictions of molecular behaviour to be made. In principle, 
these techniques can be applied without the structure known, but are usually applied to 
a protein structure that has been obtained experimentally. These studies are usually 
restricted to peptides or small proteins and require significant amount of computing 
power. These techniques have not been applied in the present study and will not be 
described further.
The term “semi-rational” is meant to imply the use of approaches that draw 
upon the significant amount of structural and sequence data that has been accumulated 
for proteins. Analysis of sequence and structural databases is generally referred to as 
“bioinformatics” -  this type of study can involve very sophisticated statistical analysis 
of very large libraries that is beyond the scope of present work. Hogewed and Hesper 
first coined the term “bioinformatics” in 1970s, referring to the study of informatic 
processes in biotic systems.77 Many of the bioinformatics approaches have been 
incorporated into softwares and web servers that are readily available and can be of
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some value to inexperienced users. Some o f these programs have been used in this 
study and references are made in the next chapter.
1.4.2. Directed evolution
Directed (molecular) evolution is the term used to describe evolutionary 
approaches to protein engineering -  it mimics natural evolution although it is applied to 
a single molecule, and it can be quite rapid compared to natural evolution. One o f the 
earliest examples o f directed evolution can be traced to the in vitro evolution o f self- 
replicating nucleic acid by M ills  et al. in the late 1960s.78 But it was not until the 
invention o f polymerase chain reaction (PCR) decades later that the concept o f directed 
evolution gained traction, and directed evolution is widely used today to improve 
proteins. Directed evolution usually involves two processes: generating diversity 
(through mutagenesis and/or DNA recombination) and screening/selection. One 
complete cycle is usually called one round o f evolution. The mutants chosen at each 
round usually display the greatest improvements towards the chosen characteristics and 
are used as parents for the next round o f evolution. These processes are repeated until 
desirable properties or convergence is obtained (Figure 1.18).
Homologous 
diversity generation 
•ePCR
•DNA shuffling
Identifying variants with 
desired improvements
•Screening
•Selection
Improved mutants
Mutants with 
characteristics 
optimized for 
application
Figure 1.18: The general process of directed evolution.
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1.4.2.1. Generating diversity
The polymerase chain reaction (PCR) was invented in 1985 while error-prone 
PCR (ePCR) was first used about five years later.79 81 ePCR is an easy to use technique 
to introduce diversity for library generation -  the amplified full-length gene (or part 
thereof) of an enzyme is subject to random mutagenesis. The general principle of ePCR 
is shown in Figure 1.19. The experimental details of introducing mutations into genes 
will be discussed in Chapter 2. In addition to random mutagenesis, DNA shuffling {in 
vitro sexual recombination) can be used to generate diversity. This technique involves 
fragmentation of DNA and reassembly of the fragments. This creates new genes with 
various combinations of mutations, thus accelerating the evolutionary process. The two 
main techniques in recombining genes are Stemmer’s DNA shuffling and Zhao’s 
staggered extension process (StEP)83. Stemmer first used shuffling to increase the 
diversity of a gene library, but this method requires large quantities of DNA and is 
difficult to implement. For this reason, StEP was used in this work -  the experimental 
details are given in Chapter 2. To further increase the efficiency of introducing 
homologous diversity, an elegant one-step approach that integrates ePCR and StEP, 
which consist of many cycles of denaturation and extremely short extension times, was 
developed in our group. Figures 1.20 and 1.21 show the two main methods of DNA 
shuffling.
The ideal mutation rate for directed evolution experiments is debatable. 
Choosing an error rate for evolution is a matter of balancing a number of 
considerations, namely the possible combinations of a library for a given mutation rate, 
the proportion of inactivated mutants due to accumulation of mutations and the 
efficiency of introducing homologous diversity. Most single mutations are deleterious 
to the enzyme’s apparent function and high mutation rate would render most of the 
mutants generated inactive. However, if the desired character is far from the enzymes 
physiological character, higher mutation rates may be required to bring about activity 
enhancement. It should be noted that although mutant libraries with high mutation rates 
can be generated, these libraries would quickly become too large to screen. By keeping 
the average mutation rates between one and three amino acids per gene, one can be 
confident of being able to screen a reasonable fraction of the theoretical library size that 
consists of a reasonable number of active mutants. This requires several evolution
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rounds before the desired level of change is identified, and it assumes that mutations are 
additive and they can act independently of one another.
Taq
polymerase
Mn2+
Figure 1.19: Error-prone PCR.
Mutations are introduced to the gene by including Mn:+ to a PCR mixture. The inclusion of Mn:< reduces 
the DNA replication fidelity of Taq polymerase by promoting base pair mismatches.
Reassembly
Figure 1.20: DNA shuffling by fragmentation and reassembly.
Homologous genes containing different mutations are first fragmented with DNase I. The fragmented 
DNA is then reassembled by primerless PCR.
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Figure 1.21: DNA shuffling by staggered extension process (StEP).
Homologous genes containing different mutations are amplified using very short cycles of denaturation 
and extension. This allows partially extended PCR product to switch template and pick up mutations on a 
different template molecule. The PCR cycles are repeated until the full-length gene product is formed.
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1.4.2.2. Screening and selection
The techniques for generating mutant libraries can be transferred from one 
system to another, although some “tweaking’“ of the experimental parameters may be 
necessary. In addition, the methods used to screen libraries or select mutants are very 
enzyme dependent, and both are often very challenging processes, frequently being the 
limiting steps in directed evolution. In selection method, the target enzyme is often tied 
to the survival of the cell so that the mutants carrying the desired function can be 
readily identified, as is the case of antibiotic resistance. Selection methods are generally 
less laborious and allow for larger libraries to be evaluated. However, due to the fact 
that the enzyme activity has to be linked to the host’s survival, it is not always possible 
to employ selection as the evaluation method.
A screen, involving the direct measurement of the enzymatic activity of a 
protein of interest, is more versatile than selection. The throughput for a screen is 
usually lower than that for selection. This can be done spectrophotometrically if the 
product, substrate or co-factors are fluorescent or absorb in the visible or UV range. 
Coupling with another reagent or enzymatic reaction may be required for reactions that 
do not show spectrophotometric changes. For example, liberation of thiols can be 
monitored from the formation of 2-nitro-5-sulfanylbenzoic acid upon reacting the thiol 
with 5,5’-dithiobis(2-nitrobenzoic acid) (DTNB). 2-nitro-5-sulfanylbenzoic acid is a 
yellow compound and can be observed using a spectrophotometer.84 The formation of 
an alcohol can be monitored by coupling the alcohol formation to the depletion of 
NAD catalysed by alcohol dehydrogenese. There are several techniques for observing 
spectrophotometric changes during screening. For an enzymatic reaction with coloured 
product, selection of bacterial colonies can be done directly on agar plate or via top agar 
plate assay based on the size of the haloes formed as a result of substrate hydrolysis. 
For changes that cannot be observed visually, colonies can be cultured in 96-well 
microtitre plates and assayed using a plate reader. This method has been used 
throughout the present work.
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1.4.2.3. Applications of directed evolution
Traditionally, one thinks of reaction rate acceleration when one thinks of an 
enzyme. In this regard, directed evolution has produced enzymes with increased kcal. In 
some instances, this has involved lifting the activity of an enzyme towards a 
promiscuous substrate. However, in addition to the kca, of an enzyme, there are many 
other enzyme properties that are important for practical applications. For example, the 
Km of an enzyme is crucial for its ability to catalyse a reaction at a given substrate 
concentration. The stability, solubility and ease of expression are clearly important 
factors for industrial application because they will dramatically affect the cost and 
convenience of an operation. Again, directed evolution has been successful in 
improving these enzyme characteristics.85 89 Similarly, directed evolution has been used 
to enhance the activity of an enzyme in an organic solvent, as organic solvent is 
required in some processes. One such example is the lipase-catalysed transesterification 
in biodiesel production. Lipase catalyses the transesterification reaction instead of the 
hydrolysis reaction in high methanol environment. Increasing the stability of lipase in 
high methanol would reduce the cost of using lipase by reducing alcohol-induced 
denaturation.90 There are also other applications such as altering or improving the 
enantioselectivity of an enzyme. May and co-workers demonstrated that directed 
evolution can be used to invert the enantioselectivity of an enzyme91 while Liebeton 
and colleagues improved the enatioselectivity of a bacterial lipase dramatically using a 
chiral model substrate.92
1.4.2.4. Advantages of directed evolution
The main advantage of directed evolution over rational approaches is that it does 
not require prior knowledge of enzyme structure and mechanism. It can also provide 
multiple and independent solutions to a problem and can lead to the discovery of 
beneficial mutations that are unlikely to have been revealed by simple inspection of an 
enzyme structure or by the use of computational approaches. This is supported by the 
discovery of beneficial non-active site mutations in various directed evolution 
experiments to alter enzyme substrate specificity and to increase catalytic activity.93,94 
However, it is also possible that theoretical methods can arrive at possible beneficial 
mutations that do not arise during the course of artificial evolution. However, such 
mutations can be made site specifically and shuffled with mutated genes that have been 
obtained from directed evolution experiments. It is not a matter of choosing between
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theoretical methods and directed evolution, but rather of incorporating both approaches 
so that the benefits of both approaches can be reaped while searching for improved 
mutants.
1.4.2.5. Directed evolution of phosphotriesterases
OPH, OPDA and more recently MPH have all been the subjects of directed 
evolution experiments to improve their activity and to alter their substrate specificity. 
Cell surface display methods have been applied to phosphotriesterases as one of the 
bioremediator deployment methods and have met with some success.95 99 Liu and co-
workers demonstrated that by displaying OPH and MPH-green fluorescent protein 
(GFP) fusion on the surface of E. coli, the substrate specificity of the whole-cell 
bioremediator can be broadened, as well as being used as a biosensor for OP 
detection.97 In directed evolution, cell surface methods have been applied to OPH to 
obtain improved activity towards methyl parathion100 and chlorpyrifos101 -  activity 
enhancements of 25 and 725 folds towards methyl parathion and chlorpyrifos 
respectively, were achieved. Directed evolution has also been utilised to improve the 
activity of OPH towards that of OPDA for coumaphos-o-analogue, methyl paraoxon, 
methyl parathion and demeton. In the process, a comparison between natural and 
directed evolution of OPH into OPDA was made.38 In another directed evolution of 
OPH, Griffiths and Tawfik isolated a mutant with 63-fold increase in kcat by utilising in 
vitro compartmentalisation (IVC) that allowed the screening of very large libraries. A 
library of 3.4 x 107 OPH mutants was screened by immobilising the mutant genes to 
microbeads. The microbead-bound mutant genes were translated in vitro in water-in-oil 
emulsion droplets and a paroxon analogue containing was added into the emulsion. The 
hydrolysis product formed was then bound to the microbeads and subsequently; a 
fluorescent-labelled anti-product antibody was added to bind the microbead-bound 
product and the beads were sorted using flow cytometry.
In our group, a screening method based on cell growth has been developed for 
directed evolution of OPDA in E co//.84 This was achieved by constructing a short 
degradation pathway in E. coli through co-expression of both OPDA and GpdQ. E. coli 
is unable to grow on medium with paraoxon as the sole phosphorus due to its inability 
to metabolise phosphodiester. By co-expressing GpdQ, the phosphodiester is 
metabolised to phosphomonoester that can then be converted in vivo to inorganic 
phosphate, effectively coupling the cell growth to its ability to scavenge inorganic
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phosphate. OPDA variants with improved expression were successfully isolated when 
this selection method was employed in directed evolution.80 A recent study by Ghanen 
et al. suggested that cell growth rate using this system is dependent on the expression 
level of the variant and the rates of hydrolysis of the organophosphate and the 
phosphodiester products by OPDA and GpdQ respectively.102
MPH is the newer phosphotriesterase isolated. Only a few known reports of 
MPH evolution are found in the literature. Two reports for evolving MPH to have 
higher activity towards poor substrates were found. Xie and co-workers subjected MPH 
from Pseudomonas stutzen strain ZK-5 to one round of error-prone PCR and found a 
mutant with five-fold increase in kca, for chlorpyrifos hydrolysing efficiency.1(b Yeong 
and colleagues designed a high throughput screening (HTS) system that utilises a 
phenolic-responsive transcription activator for directed evolution of OP-degrading 
enzymes.104 The system is composed of a cytoplasmically expressed OP-degrading 
enzyme, a phenolic-responsive transcription activator DmpR, and a green fluorescent 
protein (GFP) placed under the control of Pdmp promoter. The hydrolysis of OPs often 
produces phenolic compounds such as p-nitrophenol. DmpR forms a transcription 
activation complex by binding the phenolic compounds produced and activates the Pdmp 
promoter, leading to the expression of GFP. The cells can then be sorted using 
fluorescence-activated cell sorting (FACS), allowing large mutant libraries to be 
screened. In this approach, the hydrolysing capability of the enzyme is coupled to the 
fluorescence intensity of host cell. Using this screening method for directed evolution, 
Yeong et al. found an MPH mutant with 100-fold improvement in kca,/Km for p- 
nitrophenyl diphenylphosphate hydrolysing efficiency.104
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1.5. Applications of OP-degrading enzymes
With the rapid isolation and discovery of OP-degrading microorganisms and the 
genes responsible for the ability, there has been much interest in tapping the potential of 
these organisms and genes for industrial applications. One such application is the 
bioremediation of OP-contamination. Accumulation of OP pesticides in the 
environment due to excessive use and accidental spillage poses health risk to humans 
and animals. It was estimated that OP pesticides account for -38% of total pesticide 
used globally.1Cb One example of high pesticide usage is the Tick Eradication Program 
ran by the US government to prevent re-introduction of cattle fever through ticks on 
cattle imported from Mexico. The program employs 42 vats, each containing about 
15000 litres o f coumaphos at concentration of about 1600 mgL'1.106 Conventional 
decontamination of OP waste involves chemicals such as NaOH and NaBÜ3 that are 
corrosive and will in turn generate substantial residual waste.107 Use o f these chemicals 
will also change the salinity and pH of the soil and may not be very suitable for 
foodstuff.
Bioremediation presents a cheap and environmental friendly alternative for 
removing OP compounds from the environment. Currently, there are two main methods 
of deploying bioremediation -  live cell and purified enzyme, with both methods having 
their own advantages and disadvantages. Mulbry and coworkers demonstrated one 
successful example of using live cells for bioremediation. They developed a biofilter 
containing a consortium of microorganisms that can mineralise coumaphos.108 The 
biofilter, capable o f treating 15,000 litres of OP-containing dip waste in a single batch, 
was subsequently used in a bioreactor.106 Other forms of live cell approach include cell 
surface display o f OP degrading enzyme", localisation of OP degrading enzyme to 
periplasm98109 and bioengineer o f E. coli to fully mineralise OP compounds by 
establishing a short OP degradation pathway84.
However, the use of live cells in bioremediation has inherent practical issues 
such as the release o f microorganisms into the environment and nutritional 
requirements to keep the cells alive for a reasonable period of time. As a result, there is 
a growing interest in using purified enzyme for bioremediation. A commercial product 
containing OPDA formulation was marketed under the brand name Landguard™ for 
decontamination of sheep-dip waste.110 However, large-scale usage of OP-degrading
34
CHAPTER 1
enzymes in bioremediation is still limited due to their short shelf lives, activity of 
environmental proteases and trapping of enzyme to other substrates in the soil.15 To 
overcome this, numerous molecular evolutions were undertaken to produce more stable 
enzymes.111 114 Enzyme immobilisation was also used to increase enzyme stability, as 
well as to facilitate enzyme recovery and reuse. These approaches drove down the 
overall cost of using purified enzyme for bioremediation. In conventional enzyme 
immobilisation, the enzyme was often immobilised to silica115, agarose116 and other gel- 
based carriers117. Recent advances in nanotechnology open new avenues in enzyme 
immobilisation. Nanoparticles offer several advantages including minimum diffusional 
limitation, maximum surface area per unit mass and high enzyme load.118 The 
usefulness of this approach has been established by various works done on 
immobilising OP-degrading enzyme to nanoparticles.119,120 Daumann and co-workers 
demonstrated that glycerophosphodiesterase from Enterobacter aerogenes (GpdQ) 
immobilised to magnetite nanoparticles suffered no activity loss after 120 days and was 
active after multiple usage cycles.
Other than usage for bioremediation, OP-degrading enzymes have also been 
used as biosensors for OP contamination and therapies for OP poisoning. 
Potentiometrie121 approach to measure local pH change, amperometric122 measurement 
of electroactive product and optical123 measurement of chromogenic product were the 
main approaches used in OP biosensor development. These biosensors have broad 
linear range and low detection limit. For example, the amperometric biosensor 
developed by Mulchandani et al. has a linear range up to 140 pM and a lower detection 
limit of 20 nM for methyl parathion. OP poisoning, caused by unintentional exposure, 
occupational exposure or suicide attempts, has resulted in approximately three million 
cases of poisoning and 220,000 deaths worldwide annually.124 As mentioned earlier, 
current treatment of OP poisoning relies on chemical antidotes such as oximes and 
atropine, and the effectiveness of these antidotes differs from one OP to another OP 
compound. Enzymatic therapies were therefore explored to develop efficient therapy 
for patients with severe OP exposure. OP-degrading enzyme like MPH can be used to 
clear excess OPs from bloodstream, allowing AChE reactivation to take place. Limited 
success was achieved by using OPH, OPDA and PON1 to treat OP poisoning in animal 
models.12' 129 Bacterial PTEs are good candidates for use in clinical therapy due to their 
capability of hydrolysing several OPs at near diffusion limit. However, to effectively 
utilise bacterial PTEs in human therapy, immunological reaction due to foreign protein
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injection and activity of proteases in blood plasma have to be addressed.1* On this front, 
OP-degrading enzymes can be immobilised in a carrier to protect the enzyme against 
protease activity as well as avoiding immunological reactions.124 Liposome130, 
erythrocyte encapsulations'31 and hollow fibre reactor12* were used in developing 
carriers for OP poisoning therapy.
1.6. Objectives and overview of this thesis
OP pesticides are toxic materials that can find their ways into the environment 
and pose health risks to humans and other higher organisms. There are numerous 
reviews covering the dangers of OP compounds and the interested reader can consult 
these for more information. In short, pesticides are found at low levels in the 
environment and as such present a danger to wildlife and members of the agricultural 
community. OPs pesticides are also used in some communities as poison for 
committing suicide. OP chemical weapons are also classified as weapons of mass 
destruction due to the devastating toxicity they have on humans.
It should be clear from the discussion above that phosphotriesterases are 
enzymes of great interest, in large part due to their practical application. However, to be 
able to fully manipulate the enzyme, the enzyme’s characteristics and behaviours have 
to be known. The initial aim of this thesis was to express and biochemically 
characterise MPH. The gene for the protein had been synthesised so that the protein 
could be expressed in a functional form. However, during the course of MPH 
purification, it was found that the protein was degraded and the purified product was 
not stable for very long. The purification of MPH was optimised and the cause of the 
degradation was investigated in Chapter 3.
The first aspect of MPH that was subjected to directed evolution was its 
thermostability (Chapter 4). While MPH is not particularly unstable, better 
thermostability is beneficial to an enzyme that is to be considered for deployment in 
bioremediation and OP poisoning therapies. During the course of the work, it was found 
that activity and thermostability of the enzyme increased with Zn2 supplementation, 
leading to the investigation of Zn2 content in purified enzyme, as well as the effect of 
Zn2 on MPH stability. These results are discussed in Chapter 4.
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The long-term aim of this work is to evolve the protein to have broader substrate 
specificity or to produce mutants that have altered substrate specificity. In order to 
achieve this, better understanding of how MPH functions, particularly the key residues 
in substrate binding, have to be identified. While there are numerous reports on OPDA 
and OPH with enhanced activity and altered substrate specificity through directed 
evolution, directed evolution reports on MPH are scarce. The substrate specificity and 
substrate binding mechanism are not well understood. The substrate profile of MPH on 
various OP pesticides was investigated and directed evolution experiments aimed at 
altering the substrate specificity, as well as enhancing the activity against a poor 
substrate, were conducted. The substrate profiles of the mutants isolated from the 
evolution were characterised and the results are discussed in Chapter 5.
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2. Materials and Methods
2.1. Preamble
This chapter describes the techniques used in the experimental work performed 
for this dissertation. It includes the details of commonly used techniques of molecular 
biology as well as protein expression and purification. The experimental details of 
enzyme kinetic and the analysis of the data are also given. A reference to softwares 
used at various stages in this research is also made. Detailed information regarding 
materials, protocols and equipment used in the research are given in appendices -  as 
noted in the relevant sections below.
In general, all chemicals and reagents used were of analytical grade. For 
molecular biology and cell culturing work, glassware, microcentrifuge tubes, 
micropipette tips, growth media, buffers and solutions were sterilised by autoclaving 
using ASB270BT autoclave (Astell Scientific). Milli-Q Reagent Water System 
produced the distilled water used in this study.
2.2. Bacterial strains and their growth
The two strains used for this study are described, below along with the 
procedures used to culture them and prepare them for transformation. Appendix A lists 
the recipes for culture media and buffers used in this work -  much of this material was 
obtained from the laboratory manual for cloning by Sambrook and Russell1.
2.2.1. Strains
E. coli DH5a is a commonly used laboratory K12 strain. It has a high 
transformation efficiency, simple preparation and is easily stored. It has a recA 
genotype, which eliminates the possibility of recombination between chromosomal and 
plasmid genes. This strain has an endA genotype, implying that EndA, a non-specific 
endonuclease, is not expressed thus eliminating problems associated with plasmid 
preparation.
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BL21 (DE3) recA is used for high-level protein expression and is required to 
express genes cloned into T7-based expression vectors (pET vectors). BL21 is a 
lysogen of bacteriophage XDE3, which contains the IacUV5 promoter and the gene for 
T7 RNA polymerase. Upon introduction of IPTG, the expression of T7 RNA 
polymerase, that is located downstream of the \acUV5 promoter, will be induced. The 
T7 RNA polymerase then transcribes the target gene located downstream of T7 
promoter in the plasmid.2 The strain used in this work is a recA derivative for the 
reasons described above. BL21 strains also lack the Ion and ompT genes that code for 
proteases to reduce proteolytic degradation during expression.3
2.2.2. Growth media
The growth media used for most culturing in this work was Lysogeny Broth 
(LB). Unless stated otherwise, a culture is either an LB broth or LB agar. Recipes for 
the preparation of all media used are listed in Appendix A. Each media was 
supplemented with antibiotics in accordance to the antibiotic resistance that the various 
plasmids used confer.
2.2.3. Culture growth
All broth cultures used were inoculated from single colonies isolated from LB 
plates supplemented with suitable antibiotics. Broth cultures larger than 20 mL were 
subcultured from an overnight starter culture that was 1% of the final culture volume. 
Cultures smaller than 5 mL were grown in 10 mL tubes or 15 mL tubes, whereas larger 
cultures were grown in baffled flasks. Unless stated otherwise, most cultures were 
grown at 37°C with orbital shaking.
2.2.4. Preparation o f  electrocompetent cells
The procedure for electrocompetent cell preparation was adopted and modified 
from the laboratory manual by Sambrook and Russell1. A single colony was inoculated 
in 10 mL of YENB (Appendix A) broth and was grown overnight at 37°C. 8 mL of the 
overnight culture was subcultured in 800 mL of fresh YENB and was grown until 
O D 6o o  reaches 0.35 -  0.4. The culture was then rapidly cooled to 4°C and left to stand 
for 1 hour. From here onwards, the culture was kept at 4°C as much as possible and all
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buffers and solutions used were pre-chilled to 4°C. The culture was centrifuged at 5,000 
rpm in a VWR R9A rotor, at 4°C, for 10 mins. The supernatant was discarded and the 
pellet was resuspended gently in 300 mL of dLLO for washing. The cells were 
centrifuged and washed again with 300 mL of 10% glycerol. The cells were then 
centrifuged and the pellet resuspended in 1 mL of 10% glycerol. The cells were 
aliquoted into 50 pL aliquots and snap frozen in ethanol dry ice bath. The cells were 
kept frozen at -80°C until they were used. All competent cells prepared were plated on 
LBA and LBK plates for contamination check, as well as transformed with 1 ng of 
pJWL1030folA_cl 1 plasmid for competency check.
2.3. Plasmid DNA and their manipulations
The plasmids used in this work along with the methods used to manipulate them 
are described in this section. The methods include isolation, digestion and ligation of 
DNA fragments into plasmid. Techniques involving PCR are described in the next 
section.
2.3.1. Description of plasmids 
pETMCSI
This vector is a modified vector that was derived from T7 pET vectors originally 
created by Studier.4 The construction of pETMCSI can be found in the work done by 
Neylon and co-workers.5 The relevant modification was the introduction of an Nde\ 
restriction site into the multiple-cloning site, downstream of the RBS. Unlike some pET 
vectors from Novagen, this vector lacks the lac\ repressor gene, thus allowing leaky 
expression to occur. This was most likely due to the presence of lactose in the media, as 
tryptone, a common component in culture media was prepared from enzymatic digest of 
casein.6 pETMCSI confers ampicillin resistance to the host. This vector was a gift from 
Professor Nick Dixon of the University of Wollongong.
pCY76
pCY76 vector was constructed to overexpress non-toxic genes constitutively in 
E. coli1 The translation initiation region, RBS and the MCS component were isolated 
from pND706,8 while the backbone of the plasmid was formed from pMTL22P4. 
pCY76 is a high copy plasmid that confers ampicillin resistance to the host.
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pJWL1030
pJWL1030 was a modified vector constructed from pCY76 and pJJKmf.111 The 
constitutive expression cassette was isolated from pCY76, whose construction was 
described above, and ligated to the backbone of pJJKmf". A leaky lac promoter allows 
constitutive expression of target gene cloned into pJWL1030. Similar to Studier’s T7- 
based pET vectors, it has a strong RBS and translation initiation region to improve 
protein expression. pJWLKBO confers kanamycin resistance to the host.
pET47b
This vector is a T7-based expression vector that is commercially available from
Novagen. It is an IPTG-inducible vector, which uses kanamycin as a selectable marker.
1 '■)
The vector also contains an N-terminal his-tag for purification and detection purposes.
2.3.2. Plasmid isolation
Plasmid isolation was done using QIAprep Spin Miniprep kit from Qiagen. The 
manufacturer’s protocol was followed. In brief, 1 - 1 0  mL of overnight culture was 
pelleted and the supernatant removed before resuspending in Buffer PI. Then, Buffer 
P2 was added to lyse the cells, followed by Buffer N3 to neutralise the solution. The 
mixture was pelleted and the supernatant was loaded to the spin column to bind DNA. 
The column was then washed with PB buffer, PE buffer containing ethanol and finally 
eluted in distilled water.
2.3.3. DNA purification
Two types of DNA purification methods were used in this work, namely DNA 
gel extraction and DNA PCR purification. Whether DNA gel extraction or PCR 
purification was done would depend on the DNA and overall workflow. DNA gel 
extraction was done using Wizard* SV Gel and PCR Clean-Up System from Promega. 
PCR purification was done with either the same kit used for gel extraction or QIAquick 
PCR Purification Kit from Qiagen. All DNA purification methods were performed 
according to manufacturers’ protocol.
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2.3.4. DNA visualisation
All DNA samples were visualised by subjecting the samples to 1% agarose gel 
electrophoresis. The agarose gel was supplemented with 5 pg/L of ethidium bromide or 
lx RedSafe™ DNA Stain during preparation. 1.0 g of agarose was melted in 100 mL of 
SB buffer (Appendix A) and poured onto 125 mm x 80 mm flat glass plate so that the 
gel was formed by surface tension. Prior to loading, DNA sample was mixed with 
bromophenol blue loading dye (Appendix A) at a DNA: Loading Dye ratio of 6:1. The 
electrophoresis was performed at 150 V and 300 mA in SB buffer. SB buffer system is 
preferred over TAE and TBE buffer system due to its cost effectiveness, higher 
resolution at higher voltage and a cooler system during electrophoresis.13 After 
electrophoresis, gels were viewed under weak UV (365 nm), strong UV (254 nm) or 
blue LED array box for fluorescence. Images of gel were taken using UVI Pro 
electronic system.
2.3.5. DNA quantification
DNA concentration was determined using NanoDrop* ND-1000 
spectrophotometer by observing the absorption at 260 nm. A260/A280 and A260/A230 
ratios of the DNA samples were also noted to detect the presence of protein and 
carbohydrate contaminants respectively.
2.3.6. Restriction digests
Most of the restriction endonucleases used in this work were purchased from 
New England Biolabs (NEB). 1 0 - 2 0  Units (U) of each restriction enzyme was added 
to 2 -  3 pg of DNA in lx manufacturer’s recommended buffer and lx bovine serum 
albumin. The mixture was incubated at 37°C for 3 hours before being incubated at 65°C 
for 20 minutes to heat inactivate the enzymes. Digested vector plasmid was then treated 
with alkaline phosphatase as described in section 2.3.7. Digested PCR product was 
purified without phosphatase treatment.
2.3.7. Alkaline phosphatase treatment
Digested plasmid DNA was dephosphorylated with calf intestinal alkaline 
phosphatase (CIP) from NEB to prevent self-ligation of the vector. 10 U of CIP was
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added to digested plasmid and was incubated at 37°C for 1 hour. After CIP treatment, 
the DNA sample was purified via gel extraction as described in section 2.3.3.
2.3.8. DNA ligation
Ligation of DNA fragments was performed generally with the molar ratio of 
insert: vector of 3:1. The molar ratio was altered and optimized when the colony count 
was not satisfactory. Thermo Scientific, Fermentas and NEB supplied the T4 Ligase 
used in this work. 1.5 -  7.5 U of T4 ligase was added to the vector-insert mixture and 
the mixture was incubated overnight at 12-16°C. The ligation mixture was purified 
using PCR purification as described in section 2.3.3 after overnight incubation to lower 
the ionic strength of the ligation mixture that would otherwise lower the transformation 
efficiency.
2.3.9. Bacterial transformation
Electroporation was preferred over heat shock transformation due to its higher 
transformation efficiency.14 When the cells are subjected to high intensity electrical 
field briefly, pores are formed at the cell membrane due to an increase in cell 
permeability that causes reversible electrical breakdown of the cell membrane.15 This 
increase in permeability facilitates the entry of exogenous DNA molecules into the cell.
1 -  5 jiL of DNA samples were added gently to 50 gL of thawed 
electrocompetent cells (competent cell preparation described in section 2.2.4) and were 
mixed thoroughly by gentle flicking or pipetting. The mixtures were then transferred to 
pre-chilled 0.2 mm electroporation cuvettes. Electroporation was done on a Bio-Rad 
Micropulser™ using the built in Ec2 preset (V = 2.5 kV, x = s* 5 ms). The electroporated 
cells were immediately resuspended in 1 mL of YENB broth and were incubated in 
37°C for 1 hour to allow the cells to recover. 50 gL of cells, with or without dilution, 
were then plated on LB plates supplemented with antibiotics and grown overnight at 
37°C. Electroporation cuvettes were rinsed and washed with distilled water, soaked in 
70% ethanol, and then dried for reuse.
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2.4. Polymerase chain reaction (PCR)
This section includes basic PCR operations. It includes procedures for general 
amplification and DNA sequencing. PCR protocols for mutation introduction will be 
described in the section dealing with directed evolution (section 2.5).
2.4.1. Primer design
Oligo Calc Properties Calculator, a web based computational software, was used 
to estimate the primer melting temperature (Tm) and primer GC content 
(http://www.basic.northwestern.edu/biotools/01igoCalc.html).16 All the primers used in 
this work are listed in Appendix C. All the primers used were ordered from 
Gene Works or Integrated DNA Technologies (IDT).
2.4.2. Basic PCR
When accurate amplification was required, e.g., building new plasmid construct 
and long range PCR, high fidelity DNA polymerases such as Pfu (Thermo Scientific; 
Agilent Technologies) and Phusion (Finnzyme; NEB) were used as per manufacturers’ 
instructions. For routine amplification, Taq polymerase (Roche) and BioTaq™ (Bioline) 
were used. Thermocyclers used were GeneAmp* PCR System 9700 (Applied 
Biosystems), iCycler* (Bio-Rad), C l000™ Thermocycler (Bio-Rad), MJ Mini Personal 
Thermal Cycler (Bio-rad) and Veriti* Thermal Cycler (Applied Biosystems). The 
reaction mixture contained 5 -  30 ng of template DNA, 1 pM of each forward and 
reverse primer, 1.5 mM MgCh for Taq polymerase, BioTaq™ and Phusion or 2 mM 
MgSC>4 for Pfu polymerase, 0.2 mM of each dNTP and 1.25 U -  2.5 U of DNA 
polymerase. The cycling conditions were:
Initial denaturation 94°C (or 98°C for Phusion) 2-5 mins
30 -  35 cycles
Annealing Average Tm o f 2 primers - 5°C 10-30s
Extension 72°C 1 min/kb DNA amplified for Taq, 2
mins/kb for Pfu, 1 5 - 4 5  s/kb for 
Phusion. 1 5 - 3 0  s/kb for BioTaq™
Denaturation______________ 94°C (or 98°C for Phusion)______________________10-30s______________
Final annealing Average Tm o f  2 primers - 5°C 2 mins
Final extension 72°C 5 mins
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2.4.3. Colony PCR
Colony PCR was performed to provide a rapid and easy check for cells 
harbouring plasmid with the intended insert before proceeding to downstream 
applications, typically done after transforming a new plasmid construct or a new 
mutagenic library. A detailed protocol for colony PCR was described by Woodman.17 
In brief, a master mix for the reaction containing 1 pM of each forward and reverse 
primer, 1.5 mM MgCh, 0.2 mM of each dNTP and 1.25 U of Taq Polymerase 
(Roche/Bioline) was prepared. Single colonies were used as templates instead of 
plasmid DNA. A long initial (5 minutes) denaturation step is important to ensure lysis 
of the cell and release of the plasmid DNA. The cycling conditions were as described in 
2.4.1.
2.4.4. DNA sequencing
DNA sequencing was done in the ACRF Biomolecular Resource Facility (BRF) 
at The John Curtin School of Medical Research (JCSMR) in the Australian National 
University. Samples were prepared according to the facility’s guidelines given on their 
website18. Each PCR reaction consisted of 150 -  350 ng plasmid DNA, 3.2 pmol 
primer, 1 pL of BigDye® Terminator and 1 x Sequencing Buffer. Distilled water was 
added into the mixture to a final volume of 20 pL. The cycling conditions were:
In itia l d e n a tu ra tio n 9 4 °C 5 m in s
3 0  -  5 0  c y c le s
D e n a tu ra tio n 9 6 °C 1 0 s
A n n e a lin g 5 0 °C 5 s
E x te n s io n 6 0 °C 4 m in s
The DNA was cleaned up with ethanol precipitation prior to sequencing. A 
clean up mix consisted of 62.5 pL 95% ethanol, 3 pL 3 M sodium acetate pH 4.6 and 
14.5 pL distilled water that was added to the PCR product and mixed thoroughly before 
being left to stand at room temperature for 15 mins. The sample was then centrifuged at 
max speed for 30 mins and the supernatant discarded. If the sequencing sample was 
prepared in a microtitre plate, the supernatant was discarded by tipping inverted plate, 
and the inverted plate was centrifuged at 300 rpm for 1 min. The pellet was washed 
with 200 pL of freshly prepared 70% ethanol and was centrifuged for 10 mins. The 
supernatant was then removed, and the sample was air-dried before being sent to BRF
56
CHAPTER 2
for sequencing. DNA sequencing chromatograms were viewed using Sequencher 4.10.1 
(Gene Codes Corp).
2.5. Directed evolution and protein engineering
Chapter 1 gave a brief introduction to directed evolution. Most of the 
experimental techniques used for directed evolution and mutagenesis experiments are 
discussed in this chapter. Details specific to a particular set of experiments are given in 
the relevant chapters.
There are two main steps in protein evolution -  mutagenic library generation 
and screening. Mutagenic library generation involves the introduction of genetic 
diversity via ePCR, StEP, StEP-ePCR, and SSM are described in sections below. The 
resulting PCR product from these mutagenic PCR methods was digested with 
appropriate restriction enzymes and cloned into desired vector as described in sections 
2.3 and 2.4. The library produced was then subjected to primary and secondary screen 
for a desired improvement. A tertiary screening was carried out when necessary to 
verily the improvement seen.
2.5.1. Error-prone PCR (ePCR)
ePCR was used to introduce random mutations into a gene due to its simplicity. 
There are numerous approaches in lowering the fidelity of Taq polymerase; we chose to 
use unbalanced concentrations of MgCf and MnCf. The protocol was adapted from a 
protocol by Cadwell et al.19 and Arnold et al.20. ePCR has higher MgCf> (5 mM) than 
standard PCR (1.5 mM) to stabilise non-complementary pairs due to mutation 
incorporation while MnCE was added to reduce the specificity and therefore fidelity of 
the DNA polymerase. Increased amount of Taq polymerase (5 U) was used to 
encourage nucleotide extension beyond the positions of base mismatch.19
In this work, the ePCR reaction consisted of 30 ng of plasmid template, 1 pM of 
each forward and reverse primer, 5 mM of MgCE, 0.2 mM of each dNTP, PCR buffer 
without MgCE at a final concentration of lx and 5 U of Taq Polymerase 
(Roche/Bioline). The reaction also contained 0.05 mM to 0.3 mM of MnCf depending 
on the desired mutation rate. The typical strategy employed in this work was to prepare 
multiple ePCR reactions with various MnCl2 concentrations, and to pool the ePCR
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products to obtain a library with wide range of mutation rates. The cycling condition 
was identical to standard PCR and was described in section 2.4.2.
2.5.2. Staggered extension process (StEP)
StEP is an in vitro recombination process and was first described by Zhao et 
a/.2] 22 The procedure is much simpler than classical DNA shuffling by utilising shorter 
extension time during PCR cycle to allow incomplete extension and template swapping. 
In this thesis, StEP was introduced to shuffle mutations generated by site saturation 
libraries of various key residues surrounding MPH active site for the work done in 
Chapter 5. Both high fidelity polymerase (Phusion) and Taq polymerase were used in 
an attempt to increase the shuffling rate of the library.
The StEP reaction consisted of 30 ng of template, 1 pM of each forward and 
reverse primer, 0.2 mM of each dNTP, 1.5 mM MgCE for Taq polymerase or 1.5 mM 
MgCE for Phusion and 2.5 U of Taq Polymerase (Roche) or 1 U of Phusion. The 
cycling conditions were as below:
In itia l d en a tu ra tio n 9 4 ° C  (o r  9 8 ° C  fo r  P h u s io n ) 5 m in s
1 2 0  c y c le s
D en a tu ra tio n 9 4 ° C  (o r  9 8 ° C  fo r  P h u s io n ) 1 0 s
A n n e a lin g 5 5 ° C 1 0 s
E x te n s io n 7 2 ° C 2  s
F in a l a n n e a lin g 5 5 °C 2  m in s
F in a l e x te n s io n 7 2 °C 5 m in s
The extension rates for Taq polymerase and Phusion are 1 min/kb and 15-45 
s/kb respectively. Taq polymerase was used in later shuffling procedures to increase the 
shuffling frequency as the extension rate is slower. An extension time of 2 s was used to 
strike a balance between template swapping and the yield of the reaction.
2.5.3. StEP-ePCR
StEP-ePCR is a one-step procedure that combines both shuffling and error- 
prone PCR in a single reaction. The protocol was conceived after template switching 
was observed at very low frequency in ePCR.2, The PCR reaction recipe and cycling 
condition was identical to ePCR with the exception of much shorter extension time (5 s) 
and more reaction cycles (60x). In this work, StEP-ePCR was typically introduced from 
the second round of evolution onwards, to introduce new mutations in addition to 
shuffling the mutations obtained during the first round.
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2.5.4. Site-specific mutagenesis
Two types of site-specific mutagenesis were performed in this work, site 
directed mutagenesis (SDM) and site saturation mutagenesis (SSM). The protocols 
described below are interchangeable for SDM and SSM with the exception - SDM uses 
primers that contain a specific mutation for the targeted site while SSM uses primers 
that contain degenerate sequences at the targeted site.
Site-specific mutagenesis was carried out using protocols adapted from the lab 
manual by Arnold and Georgiou.243  The methods used were sequence overlap 
extension (SOE)26, mutagenic plasmid amplification adapted from Stratagene’s 
Quikchange and megaprimed ligase-free site specific mutagenesis.27 28
2.5.4.I. Method adapted from Stratagene’s Quikchange method (QCM)
Stratagene’s Quikchange method (QCM) allows introduction of point mutations 
without going through routine cloning procedures by amplifying the whole plasmid. A 
simplified diagram of the method was illustrated in Figure 2.1a. A high fidelity 
polymerase was essential as amplifying long stretches of DNA would be prone to 
replication errors.
The PCR reaction mixture consisted of 10 -  20 ng of plasmid template, 1 pM of 
each forward and reverse primer, 0.2 mM of each dNTP, 1.5 mM MgCf and 2 U of 
Phusion. The cycling conditions were as follows:
In itia l d en a tu ra tio n 9 8 ° C 3 0  s
2 0  c y c le s
D en a tu ra tio n 9 8 ° C 3 0  s
A n n e a lin g 6 0 ° C 6 0 s
E x te n s io n 7 2 ° C 3 0  s /k b  D N A
F in a l a n n e a lin g 5 5 ° C 2  m in s
F in a l e x te n s io n 7 2 ° C 5 m in s
The PCR product was then treated with Dpn\ to remove the wild type plasmid 
template that has methylated DNA and purified with PCR purification as described in 
section 2.3.3. 5 pL of the purified PCR product was then transformed to replicate and 
repair the DNA nick resulted from the PCR.
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2.5.4.2. Sequence overlap extension (SOE)
Sequence overlap extension is a more laborious site-specific mutagenesis 
procedure. Three PCR reactions, as well as routine cloning procedures such as 
restriction digestion and ligation are required. Two separate PCR reactions are required 
to generate the template for a third PCR reaction to assemble the DNA with the desired 
mutation (Figure 2.1b).
A forward flanking primer (denoted A) and a reverse mutagenic primer (denoted 
C) were used to generate the first fragment (denoted AC). A reverse flanking primer 
(denoted D) and a forward mutagenic primer (denoted B) were used to generate the 
second fragment (denoted BD). 10 pL of unpurified AC and BD were then used as 
templates for the third PCR to assemble the fragments that contained the mutation. All 
the PCR steps were performed based on protocols described in section 2.4.2. The PCR 
reactions can be performed with any high fidelity polymerase such as Phusion and Pfu. 
The full length PCR product was then subjected to routine cloning procedure.
2.5.4.3. Megaprimed ligase-free site-specific mutagenesis
The megaprimed ligase-free site-specific mutagenesis method is similar to 
Stratagene’s QCM, but the method generates a megaprimer first before amplifying the 
whole plasmid and requires only one mutagenic primer for single site mutagenesis. 
Tseng et al.2s and Sanchis et al.27 independently reported the method, at around the 
same time, as a better site-specific mutagenesis method than Stratagene’s Quikchange 
method. The method does not require cloning procedures and is more versatile as it can 
be used to introduce multiple mutations in one round. A simplified diagram of the 
method was illustrated in Figure 2.1c below. In a much earlier work, Miyazaki and 
Takenouchi reported the megaprimer PCR of whole plasmid (MEGAWHOP) method 
that can be used for generating error-prone, DNA shuffling and site saturation libraries, 
if the megaprimer was generated based on one of those respective procedures. While 
the MEGAWHOP procedure is more general and can accommodate a wide range of 
library creation methods, it requires two PCR reactions. Tseng et al and Sanchis et al. 
both reported a single-tube protocol that simplifies the procedure.
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The PCR reaction mixture contained 30 ng of template DNA, lx HF buffer, 1.5 
mM MgCF, 0.1 [iM of each mutagenic primer and flanking primer, 1 U of Phusion and 
0.2 mM of each dNTP. The cycling condition were as below:
In itia l d en a tu ra tio n 9 8 ° C 5 m in s
18 c y c le s
D en a tu ra tio n 9 8 ° C 1 m in
A n n e a lin g 5 5 °C 1 m in
E x te n s io n 7 2 ° C 3 0  s /k b  D N A
2 5  c y c le s
D en a tu ra tio n 9 8 ° C 1 m in
A n n e a lin g  an d  e x te n s io n 6 8 ° C 4 5  s /k b  D N A
F in a l e x te n s io n 6 8 ° C 10  m in s
The PCR product was then treated with 20 U of Dpn\ twice at 37°C for 1 hour 
each time to remove the template plasmid. The PCR product was then subsequently 
PCR purified and transformed.
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(a) Stratagene’s Quikchange
A pair of mutagenic complementary 
primers were used to amplify the whole 
plasmid, with the WT plasmid template 
removed by Dpn I digestion
(b) Sequence Overlap Extension
A *
5 ’ ----------------
3’
A
<r
Two PCR reactions are required for SOE. 
2 PCR reactions with primers A+C and B 
+D, with primers B and C being the 
mutagenic primers
PCR products from the 1st step were used 
as templates for the overlap extension 
PCR with flanking primers A+D
Completed mutagenic PCR product was 
cloned as usual
(c) Megaprimed ligase-free site specific mutagenesis
Requires the generation of a 
megaprimer by a mutagenic primer and 
a flanking primer
\
The megaprimer was then used to 
amplify the whole plasmid and the 
template was removed by Dpn I 
digestion
Figure 2.1: Site-specific mutagenesis strategies.
Simplified figures showing different methods used to generate site-specific mutants, (a) Stratagene's 
Quikchange. (b) Sequence Overlap Extension (SOE). (c) Megaprimer ligase-free site-specific 
mutagenesis.
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2.5.5. Analysis o f mutant library
Whenever a mutant library was generated, a few basic analyses such as library 
size, average mutation frequency and presence of the plasmid harbouring the mutated 
gene of interest were done to assess the quality of the library.
The library size was quantified by estimating the colony-forming unit (cfu) on 
agar plates supplemented with antibiotics. Usually, several dilutions of the transformed 
E. coli were plated on agar plates. The library size per transformation was then 
estimated from the mean of cfu of the agar plates with different cell dilutions. Dilutions 
that gave too many colonies (>800 cfu) were discounted from the estimation as they 
might skew the library size estimation.
The average mutation frequency was estimated by looking at the number of 
mutations in ten randomly selected colonies. The mutation frequency was expressed as 
the mean and standard deviation of the number mutations found. Colony PCR was also 
performed as described in section 2.4.3 to ascertain the presence of plasmid harbouring 
the mutant gene.
2.5.6. Library screening -  direct activity measurement
The primary screen master plate was prepared either by picking single-colonies 
that were then inoculated into sterile 96-well microtitre plates or by culture dilution 
method developed by Dr Bradley Stevenson during his time in this laboratory23. The 
former was employed when the library to be screened was small (< 1000) and the latter 
was employed when the library to be screened was larger than 1000 colonies. Dr 
Stevenson introduced the culture dilution method largely due to the laborious nature of 
picking single colonies manually, especially for larger libraries.
In the usual single-colony method, the colonies were picked by hand, and 
inoculated into 96-well round bottom microtitre plates containing 100 -  200 jxL of LB 
broth supplemented with desired antibiotics. With the culture dilution method, the cell 
density of the transformed E. coli was first estimated as described in section 2.5.5 while 
the remainder was either stored in either 4°C or -80°C. Once the cell density was 
estimated, the transformed E. coli culture was thawed and diluted in LB broth to ~3 -  4
63
CHAPTER 2
cells per 100 -  200 pL and was dispensed into sterile microtitre plates with 100 -  200 
pL culture per well. The plates were incubated in orbital shaking incubator at 37°C for 
24 hours.
Depending on the substrate screened, the cultures were treated differently before 
lysis to maintain the linear range of the assay. The amount of culture used and lysis 
procedure would be described in the latter chapters of this thesis. Unless otherwise 
stated, the proteins were assayed in 96-well flat bottom plates with 119 pM methyl 
parathion (MPS), ethyl parathion (EPS) or ethyl paraxon (EPO) in 50 mM Tris-HCl or 
HEPES, pH 7.6, 100 mM NaCl, 0.1% Tween 20. The activity was monitored by the 
release of /?-nitrophenolate at 405 nm using a Spectramax M2e microplate reader at 
30°C. This assay procedure was adapted and modified from various references30 32. In 
the later stage of the work, the proteins were assayed with 119 pM OP substrates in 50 
mM HEPES, pH 7.6, 100 mM NaCl and the rationale would be explained in Chapter 4. 
0.1 mM ZnCE was included in the assay buffer for all activity measurements done in 
Chapter 5. The activities were compared to those of wild type, and in some cases, the 
best mutant from previous round, and mutants with the best enhancements or with the 
desired substrate specificity were selected.
The selected mutants were streaked on LB plates supplemented with antibiotics 
to obtain single colonies. One colony was picked from each agar plate for primary 
screen master plates prepared with single colony picking method, whereas up to six 
colonies were picked from each agar plate for primary screen master plates prepared 
with culture dilution method. Mutants selected from the secondary screen were streaked 
and single colonies were grown in 3 mL LB broth supplemented with antibiotics for 
plasmid isolation and DNA sequencing. Unique mutants were then selected and 
subjected to the next round of evolution.
With the culture dilution method, the method assumes that a mutant clone with 
enhanced activity can be detected even in the presence of other non-performing 
mutants. The method also assumes that the cells are evenly distributed in the culture 
dilution and the cell division is at minimal during the process of dilution and 
dispensation of the culture.
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The Poisson distribution given by Equation 2.1 describes the probability of 
finding viable cells in any well:
e *1 f ir
=  ^  ( 2. 1)
Where P(r) is the probability of a well having r number of cells, when the mean 
number of cells per well is f.i. Based on the number of sterile wells in the microtitre 
plate (i.e. r = 0), the actual mean number of cells per well can be calculated.
(a)
0.25 n
Actual number of cells in a well
(b)
a 0.7 -
2 0.6 -
A 0.4 -
I 0.3 -
Actual number of cells in a well
Figure 2.2: Poisson distribution of cells in liquid culture.
(a) shows the distribution of cells in wells of microtitre plate culture with a mean of dilution of three cells 
per well and (b) shows the cumulative distribution of cell distribution of the same dilution.
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As illustrated in Figure 2.2b, for a mean of three cells per well, ~90% of wells 
have five or fewer cells and ~9% of wells have six or more cells after dilution. As a 
compromise to isolate all variants present in a well, up to six colonies were picked from 
the streaking of each chosen well for secondary screen.
2.6. Protein manipulations
This section will focus on the general methods used for protein studies such as 
protein concentration quantification and protein visualisation. Description of procedures 
that are experiment-specific such as protein expression for certain experiments and 
protein purification would be described in Chapters 3.
2.6.1. Recombinant protein overexpression
Proteins were expressed by ‘leaky expression’, 1PTG induction or constitutive 
expression, depending on the plasmid vectors as described in section 2.2. BL21 (DE3) 
RecA was used for expression gene in pET based vectors and DH5cx was used for lac 
promoter based vectors. For large-scale expression, a single colony was inoculated into 
10 mL of LB broth supplemented with antibiotics and grown overnight at 37°C as 
starter culture. The next day, the 10 mL starter culture was subcultured to a fresh 1 L 
LB broth supplemented with antibiotics (starter culture volume: final culture volume 
ratio of 1:100). Three different growth conditions were used after the subculture to 1 L 
fresh media:
• pETMCSl is an IPTG inducible vector. The cells were grown at 37°C for 4-5 
hours to an ODöoo of 0.6 -  0.8. IPTG was added to a final concentration of 0.1
-  0.5 mM and the cells were then incubated by orbital shaking at 18-25°C for 
either overnight or 16 hours.
• pJWL1030 and pCY76 express constitutively. The 1 L culture was further 
grown overnight at 37°C.
• pET47b is an IPTG inducible vector used in Chapter 3 to investigate MPH 
proteolysis. The cells were grown at 37°C for 4 -  5 hours to an O D 6oo of 0.6
-  0.8. IPTG and ZnCL were added to final concentrations of 0.5 mM and 0.1 
mM respectively, and the cells were then incubated by orbital shaking at 
37°C for either overnight or 16 hours.
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For small-scale expression that was used for expression confirmation, crude 
lysate assay and mutant activity validation, the final culture volume was scaled down to 
typically 5 - 2 0  mL. The starter culture was also scaled down accordingly, based on the 
starter culture volume: final culture volume ratio of 1:100, and was grown similarly as 
described above.
2.6.2. Cell lysis
For large-scale culture to be used in protein purification, the cultured cells were 
harvested by centrifugation at 5,000 rpm in a VWR R9A rotor for 15 minutes and were 
either used immediately or stored at -80°C until required. The centrifugation and all 
subsequent steps were done at 4°C. The cells were resuspended in 10 mL of column 
binding buffer per gram of wet pellet until it reached homogeneity. The column binding 
buffer was supplemented by either 1 mM PMSF or AEBSF to minimise proteolysis. 
The column binding buffer used for each column are specified in Chapter 3. The 
resuspended cells were lysed by passage through a French Pressure Cell Press (12,000 
psi cell pressure, two repeats) and centrifuged in a VWR R20A2 rotor at 12,000 rpm for 
45 minutes to pellet cell debris. The clarified lysate was then applied to a purification 
column using a peristaltic pump and was purified. The columns used for each 
purification protocol are described in Chapter 3. Unless stated, all purifications were 
done using an AKTA™ FPLC System.
For small-scale cultures, cell lysis was done with Bugbuster® protein extraction 
reagent (Novagen) or rLysozyme™ (Novagen) according to the suppliers’ protocols. 
The cells were harvested with an Eppendorf 5415D bench top centrifuge at maximum 
speed for five minutes. In the case of using Bugbuster™, the cells were resuspended in 5 
mL 50 mM HEPES or Tris-HCl, 100 mM NaCl, lx BugBuster®, pH 7.6 per gram of 
wet cell paste. The mixture was kept at room temperature for 15 -  30 minutes prior to 
centrifugation. For rLysozyme™ lysis, the harvested cells were frozen completely at - 
20°C or -80°C. The cells were then completely thawed and resuspended in 7 mL of 50 
mM HEPES or Tris, 100 mM NaCl, pH 7.6 per gram of well cell paste. rLysozyme™ 
was then added to the resuspended cells at a ratio of 7.5 kU rLysozyme™ per mL of 
resuspended cells. The cell suspension was then incubated on a shaking platform for 10
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-  20 minutes at room temperature. The mixture was then centrifuged for 20 minutes at 
max speed to remove insoluble cell debris.
2.6.3. Protein visualisation
Proteins were visualised using Laemmli SDS-PAGE.”  The SDS-PAGE used 
composed of a 5% (w/v) stacking gel at pH 6.8 and a 15% (w/v) resolving gel at pH 8.8. 
The two component gels were prepared as below:
15% (w /v ) R eso lv in g  gel 5%  (w /v )  Stack ing  gel
A c ry l/B is  37 .5 : 1 ,4 0 %  (w /v ) 3 0 0 0  pL 375  pL
0.5  M T ris, pH 6 .8 - 833 pL
1.5 M T ris, pH 8.8 2 0 0 0  pL -
10% (w /v )  S D S 80 pL 3 3 .3  pL
dH 20 2 8 5 0  pL 2 0 6 9  pL
T E M E D 10 pL 3 pL
10% (w /v )  A P S 6 0  pL 2 0  pL
Total v o lu m e 8 0 0 0  pL 3 3 3 3 .3  pL
Low range SDS-PAGE molecular weight standard (Bio-Rad) and Dual Color 
Precision Plus Protein™ Prestained Standards (Bio-Rad) were used for all protein 
visualisation described in this thesis. Low range SDS-PAGE marker contains six 
different proteins with molecular weights ranging between 14.4 kDa and 97.4 kDa, 
while Dual Color Precision Plus contains ten different proteins of molecular weights 
ranging from 10 kDa to 250 kDa. The stock for low range SDS-PAGE marker was 
diluted 20-fold with ß-mercaptoethanol and stock sample buffer (Appendix A) mixture 
as recommended by the supplier’s protocol. Diluted protein standards were heated for 
five minutes at 95°C and stored at -20°C until use. Dual Color Precision Plus marker 
was used without dilution and heat treatment.
Protein samples were mixed with SDS-reducing sample buffer (Appendix A) at 
a ratio of 1:1 and heat treated at 95°C for five minutes prior to loading onto the SDS- 
PAGE gel. The 5 mm well width (10-lane combs) and 3.5 mm well width can 
accommodate a maximum of 20 pL and 15 p.L of protein sample respectively. The 
electrophoresis was ran in SDS running buffer (Appendix A) at variable voltage with a 
constant current of 30 mA per gel. A typical SDS-PAGE run required 35 -  45 minutes 
to allow the dye front to migrate to the end of the gel.
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2.6.4. Protein quantification
Protein concentrations were determined by NanoDrop® by measuring the 
absorbance at 280 nm. 1.5 -  2 pL of protein sample was used for each measurement. 
Each protein sample was measured at least thrice and the mean and standard deviation 
of the measurements were calculated. Only a mean with less than 10% standard 
deviation would be accepted. The protein concentration was calculated from the A280 
values obtained based on the Beer-Lambert equation34 that is given in Equation 2.2:
A  = e/c (2.2)
Where A is the absorbance, e is the molar absorption coefficient (M 'cm 1), / is the cell 
path length (cm) and c is the molar concentration (M). Protein extinction coefficient 
was estimated by ProtParam tool (http://web.expasy.org/protparam/).
2.6.5. Protein molecular weight determination
Size exclusion chromatography and Fourier transform ion cyclotron resonance 
mass spectrometry (FTICR-MS) were the two main methods used for molecular weight 
determination.
To determine protein molecular weight with size exclusion chromatography, the 
column was calibrated with commercial protein standards with known molecular 
weights. Superdex 200 size exclusion column was calibrated with four protein standards 
and blue dextran from Gel Filtration Markers Kit for Protein Molecular Weights 12,000 
-  200,000 Da (Sigma) according to the supplier’s protocols and the calibration curve 
obtained is shown in Figure 2.3. To determine the molecular weight of MPH, MPH 
enzyme purified from purification workflows that will be described in Chapter 3 was 
used. The purified MPH fractions were collected and concentrated down to 1 mL and 
loaded onto the Superdex 200 size exclusion column. The elution volume for MPH 
obtained was then fitted into the linear equation obtained from the calibration curve to 
calculate the molecular weight. Size exclusion chromatography could also have been 
used to estimate the oligomeric state of the enzyme since the chromatography was non-
denaturing.
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ß-amylase
Albumin
Carbonic
anhydrase
y = -1.9097x + 4.8511 
RJ =  0.9908 Cytochrome C
Figure 2.3: Calibration curve obtained with protein standards on Superdex 200.
The molecular weights of ß-amylase, albumin, carbonic anhydrase and cytochrome c are 200 kDa, 66 
kDa, 29 kDa and 12.4 kDa respectively. Blue dextran (2.000 Da) was used to obtain the void volume. Ve 
is the elution volume and V0 is the void volume of the column.
To determine the molecular weight with FTICR-MS, purified MPH sample was 
dialysed exhaustively (two 3-hour dialysis, one overnight dialysis) against water at 4°C 
to remove any salt from the purification or storage buffer. A final protein concentration 
of 20 pM in at least 100 pL is required for the measurement. The FTICR-MS 
measurement and analysis were performed by Professor Thomas Huber.
2.6.6. MPH sample preparation for zinc content measurement.
Zinc composition of MPH was measured by inductively coupled plasma -  
optical emission spectroscopy (ICP-OES). In Chapter 4, the zinc content of MPH, 
purified as it is, and MPH incubated with excess zinc are measured. The incubation of 
the MPH samples with zinc prior to excess metal removal will be described in section 
4.3.2.4, In this section, the preparation i.e. the treatment of purified MPH enzyme with 
zinc is described. To remove the excess zinc after incubation, a 5 mL HiTrap Desalting 
column (GE Healthcare) was used. The column was washed with 10 mL chelating 
buffer consisted of 5 mM each of EDTA, 1,10-phenanthroline, 2,6-pyridine 
dicarboxylate, 8-hydroxyquinoline-5-sulfonic acid and ß-mercaptoethanol in 20 mM 
HEPES, pH 7 to remove any metal in the column. The chelators were then removed by 
washing the column with Chelex® 100-treated 50 mM HEPES, 100 mM NaCl, pH 7.6 
buffer. The Chelex-treated buffer was prepared in 1 M nitric acid rinsed glassware. 10 g 
of Chelex 100 was added to 1 L of buffer and was stirred overnight to prepare the metal 
free buffer. After HiTrap Desalting column was washed with Chelex-treated buffer, 1.5
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mL of protein sample was injected into the column with a syringe. 2 mL of buffer was 
then injected into the column and the flow through was collected. Based on the 
manufacturer’s protocol, the flow through corresponds to 95% yield recovery with a 
sample dilution factor of 1.3x. The concentration of the flow through was estimated 
with a Nanodrop® as described in section 2.6.4 and the protein was diluted to 1 pM 
with metal free buffer. The protein was then further diluted 10-fold with nitric acid to 
obtain a final nitric acid concentration of 4% (w/v). The zinc content measurement and 
analysis were then performed by Ms. Nur Hafizah Azizan.
2.7. Spectrophotometric assay
2.7.1. Standard MPH activity assay
The standard MPH activity assay was similar to the methods for screening 
libraries described in section 2.5.6. A standard assay mixture consisted of 119 pM of 
OP substrates in 50 mM Tris-HCl or HEPES, 100 m.M NaCl, pH 7.6. All assays 
described in Chapter 5 were done with the supplementation of 0.1 mM ZnC^. Activity 
assay was done with either 200 pL reaction mixture per well in 96-well microtitire 
plates or 1000 pL reaction mixture in micro-cuvettes. The 200 pL reactions were done 
using Spectramax M2e microplate and the 1000 pL reactions were done using Cary IE 
UV-Vis spectrophotometer (Varian). The rate of hydrolysis of MPS, MPO, EPS, EPO, 
p-nitrophenyl acetate (pNPA), /?-nitrophenyl phosphate (pNPP) and bis-(p-nitrophenyl) 
phosphate (bpNPP) were monitored through the release of p-nitrophenol (pNP) at 405 
nm while hydrolysis of MCO and MCS were monitored through the release of 3,5,6- 
trichloro-2-pyridinol (TCPy) at 310 nm. All measurements were done in either 
duplicates or triplicates.
2.7.2. Enzyme kinetics
To determine the kinetic parameters for the MPH variants that have been 
obtained in Chapter 5, purified MPH enzymes were assayed in 50 mM HEPES, 100 
mM NaCl, 0.1 mM ZnC^, pH 7.6 with various concentrations of different substrates. 
The substrates assayed were methyl parathion (MPS) (7.6 -  189.9 pM), methyl 
paraoxon (MPO) (15.2 -379.8 pM), ethyl parathion (EPS) (15.2 -  60.8 pM), ethyl 
paraoxon (EPO) (15.2 -  379.8 pM), methyl chlorpyrifos oxon (MCO) (30.4 -  379.8 
pM) and ethyl chlorpyrifos oxon (ECO) (30.4 -  379.8 pM). The rate of hydrolysis of
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MPS, MPO, EPS and EPO were monitored through the release of pNP at 405 nm (£405 = 
14696.56 IVT'crn'1) while hydrolysis of MCO and MCS were monitored through the 
release of TCPy at 310 nm (£310 = 5800.67 IVT'crn'1) with Cary IE UV-Vis 
spectrophotometer. All kinetic measurements were done in triplicates at 30°C. Standard 
curves of pNP and TCPy (Figure 2.4) were constructed to determine the extinction 
coefficients of pNP and TCPy by using the Beer-Lambert equation (Equation 2.2) 
since the absorption spectrum of a given compound is affected by pH and temperature. 
The pNP £405 value was obtained by taking the average of £405 values calculated from 10 
-  80 pM of pNP while the TCPy £310 value was obtained by taking the average of £405 
values calculated from 10 -  320 pM of TCPy. The measurements were done in 
triplicates.
(a)
y = 0.014x + 0.0176 
R2 = 0.9994
p-nitrophenol (pM)
(b)
y = 0.0055x + 0.0162 
R2 = 0.99958
3,5,6-trichloro-2-pyridinol (pM)
Figure 2.4: The standard curves used to calculate the extinction coefficient values.
(a) is the standard curve built using /Miitrophenol (pNP) and (b) is the standard curve built using 3,5,6- 
trichloro-2-pyridinol (TCPy) and their respective R2 values.
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The kinetics parameters were determined by fitting the data to the modified 
Michaelis-Menten equation, using curve-fitting software KaleidaGraph. Equation 2.3 
gives the Michaelis-Menten equation.
Vo
iT  + S (2.3)
Where v0 is the iniial velocity, Vmax is the maximum velocity; Km is the 
Michaelis-Menten constant and S is the substrate concentration. And since Vmax is the 
product of kCai and enzyme concentration, E (Equation 2.4), the Michaelis-Menten 
equation can be rewritten as Equation 2.5.
V max =  k carE  (2.4)
K m + S  (2.5)
2.8. Computer software programs
DNA sequences were analysed using Sequencher 4.10.1. Multiple DNA and 
protein sequence alignments were done with Clustal-Omega36 
(http://www.ebi.ac.uk/Tools/msaydustalo/). ConSurf Server was used for estimating the 
evolutionary conservation of amino acid positions in a protein based on the 
phylogenetic relationship between homologous sequences (http://consurf.tau.ac.il/).36 
Protein structures were obtained from Protein Data Bank 
(http://www.rcsb.org/pdb/home/home.do). MacPyMOL was used to visualise the 
protein structures and generated the protein structural figures used in this thesis. 
SWISS-MODEL37 39 (http://swissmodel.expasy.org/) was used to generate structures of 
MPH mutants that will be found in Chapters 4 and 5 by using WT MPH as template. 
AutoDock Vina40,41 and Swiss-Dock41,42 were used to perform molecular docking of 
MPS to MPH, which is described in Chapter 5. The structure of MPS used for docking 
experiments was obtained from ZINC database (http://zinc.docking.org/).
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3. Protein Purification: Dealing with Proteolytic
Degradation
3.1. Preamble
In the initial attempts to purify MPH, it became apparent that proteolysis would 
be a problem. Hence, much of the work in developing a purification protocol was 
concerned with avoiding or minimising degradation due to proteolysis.
Proteases are enzymes that cleave proteins and play a central role in cellular 
homeostasis. However, their presence in protein expression hosts can cause unwanted 
protein degradation during protein expression and purification. This degradation will 
result in reduced yield, poorer protein quality and introduce complications to 
downstream analyses of proteins such as kinetic characterisation and protein 
crystallography, due to heterogeneity in the protein sample. In Escherichia coli, one of 
the most common protein expression hosts, many proteases were identified in both 
cytoplasmic and periplasmic compartments. A list of proteases identified in E. coli can 
be found in the E. coli Protease Database
(http://www.cf.ac.uk/biosi/staffinfo/ehrmann/tools/proteases.index.html), and numerous 
reviews found in the literature.1 3 It is estimated that more than 3% of enzymatic 
activity in E. coli at any given time is proteolytic.1 The number of proteases that are 
present in various compartments of E. coli underlines the challenge a protein chemist 
faces when expressing proteins in E. coli. While there are strategies available to 
minimise proteolysis, the diverse substrate specificity and sheer number of proteases 
present in E. coli often complicate the troubleshooting process when protein 
degradation is observed.
In this chapter, a detailed discussion of MPH proteolytic degradation and 
attempts to overcome it is given.
3.2. Protein expression and purification
Otherwise stated, WBC3-MPH was expressed in E. coli BL21(DE3fetvl' for the 
work described in this section. 1 L cell cultures grown in LB supplemented with
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suitable antibiotics were used for the each purification. The expression conditions were 
described in Chapter 2 (section 2.6.1), and the exact conditions used will be noted at 
each of the purification workflow described in this section.
The first 34 amino acid residues of the intact MPH sequence that constitute the 
signal peptide were removed and the resulting sequence coding the mature MPH was 
designated MIT (MPH-l-Truncation) in the plasmid construct. The MPH signal 
peptide was predicted to be a Sec-type signal peptide by PRED-TAT4 web server and 
was consistent with the signal peptide found in MPH from Pleisiomonas sp. M6\ 
PSORTb 3.06 web server predicted that MPH is localised to the periplasm when 
expressed with the signal peptide. However, the signal peptide was removed to increase 
the yield of protein, as the posttranslational cleavage of the signal peptide was the 
bottleneck of obtaining soluble enzyme. That is, the yield of protein export to the 
periplasm was low, and the uncleaved protein in the cytoplasm formed inclusion bodies, 
as observed by Fu et al5 and in this work as shown in Figure 3.1. A reasonable yield of 
soluble protein was obtained by expressing the mature protein in the cytoplasm. 
However, along with the soluble protein, there was still a large quantity of insoluble 
protein in the cytoplasm, especially when the protein was expressed with an inducible 
promoter (pET vectors) at 37°C. Decreasing the expression temperature to 18°C or 
using a constitutive vector (pCY76 or pJWL1030) increased the fraction of soluble 
protein obtained. For the sake of simplicity, unless stated otherwise, MPH refers to the 
enzyme expressed in the cytoplasm with the sequence coding for signal peptide 
removed.
M SL P
Figure 3.1: The soluble and insoluble fractions of MPH expressed without prior removal of signal 
sequence.
The difference in the MPH mass shown by soluble and insoluble fractions, as indicated by the arrows, 
suggests that the MPH present in the insoluble fraction has the intact signal peptide. Molecular weights of 
proteins in the molecular marker, M. from top to bottom, are 97.4, 66.2, 45.0, 31.0, and 21.5 kDa. SL 
denotes the soluble lysate after clarification from the total lysate and P denotes the insoluble fraction.
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pETMCSI MIT WT was constructed by amplifying the sequence coding for 
mature MPH (MIT) with F-SSM-Flank_Ase and R-SSM-Flank-MIT-Eco primers 
(Appendix C) containing AseI and EcoR1 respectively. The PCR product was digested 
and ligated into JVdel and EcoK\ sites of pETMCSI vector. Nde\ was not introduced 
when amplifying MIT due to the presence of Nde\ site in the MIT sequence. Nde\ and 
Ase I produce the same overhang after digestion and therefore can be used for ligation. 
The digestion and ligation steps were performed as described in sections 2.3.6 -  2.3.8.
3.2.1. Purification workflow I -  cationic exchange column and gel 
filtration
The purification workflow described here was adopted and modified from Sun 
and colleagues’ work in crystallising MPH.7 The purification procedure involved a 
cationic exchange column and a gel filtration column. In Sun and co-workers’ protocol, 
MPH was expressed in the native host, Pseudomonas sp. WBC-3, and purified with 
CM-Sepharose Fast Flow column. For purification workflow I, MPH was expressed in 
E. coli BL21(DE3)^'harbouring pETMCSI MIT WT with 0.1 mM IPTG induction 
at 18°C for 16 hours. The cells were harvested and resuspended in 20 mM KH2PO4 or 
HEPES, pH 7 and were lysed with French Pressure Cell Press prior to purification 
(section 2.6.2). The clarified lysate was applied to a 20 mL SP Sepharose or a 5 mL 
HiTrap SP Fast Flow column and the bound MPH was eluted using a linear gradient of 
0 to 1 M NaCl in 20 mM KH2PO4 or HEPES, pH 7 over 10 column volumes. The 
eluted fractions with the highest MPH activity were pooled, concentrated and buffer 
exchanged to 50 mM Tris-HCl or HEPES, 100 mM NaCl, pH 7. The sample was then 
applied to a 120 mL Superdex 200 gel filtration column and eluted with 50 mM Tris- 
HCl or HEPES, 100 mM NaCl, pH 7.6. The workflow for this purification is 
summarised in Figure 3.2. The purity of the purification fractions was assessed by 
SDS-PAGE (Figure 3.3). The molecular weight and isoelectric point of MPH were 
predicted to be 31538.9 Da and 7.87 respectively by ProtParam 
(http://web.expasy.org/protparam/).
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Harvested cells lysed with French Pressure Cell Press and clarified with centrifugation
Column 1: 20 mL SP Sepharose or 5 mL Hitrap SP FF (Cationic exchange column)
Binding buffer: 20 mM KH2P04 or HEPES, pH 7
Elution buffer: 20 mM KH2P04 or HEPES. pH 7 with linear gradient of 0 -  1 M NaCl over 10 column volumes
Fractions pooled, buffer exchanged and concentrated
Column 2: 120 mL Superdex 200 (Gel filtration column)
Elution buffer: 50 mM Tris-HCl or HEPES. 100 mM NaCl, pH 7.6 over 1.5 column volumes
Figure 3.2: Purification workflow I.
a) M SL P FT 9 10 11 12 13 14 15 16 17
4ft M» ted
b) M 22 33 34 35 36 37 38 39 40 41 42 42 51 52
Figure 3.3: SDS-PAGE profiles of the purified fractions done with purification workflow I.
a) shows the eluted fractions from SP Sepharose column and b) shows the eluted fractions from Superdex 
200. Molecular weights of proteins in the molecular marker, M, from top to bottom, are 97.4. 66.2, 45.0, 
31.0, 21.5 and 14.4 kDa. SL denotes the soluble lysate after clarification from the total lysate, P denotes 
the insoluble fraction, FT denotes column flow through and the numbers denote the eluted fractions.
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From Figure 3.3, a band that corresponded to MPH was observed in the SDS- 
PAGE profiles for eluted fractions obtained from the cationic exchange column and gel 
filtration column. However, a slightly smaller band below the MPH band was also 
observed for both SDS-PAGE profiles, which indicated proteolysis. It was interesting 
that the smaller band was not separated from MPH when passed through the gel 
filtration column, suggesting the proteolysis happened throughout the purification. It is 
also possible that the degraded product was not significantly different enough to be 
separated by gel filtration chromatography. Supplementing protease inhibitors such as 
phenlymethylsulfonyl fluoride (PMSF) or 4-(2-Aminoethyl) benzenesulfonyl fluoride 
(AEBSF) to the lysis buffer did not stop the degradation, suggesting that the protease 
involved was not a serine protease (data not shown). At this stage, it was uncertain if 
the proteolysis was due to protease action from the expression host or due to 
autoproteolysis. One example of enzyme exhibiting promiscuous protease activity was 
shrimp alkaline phosphatase (SAP).8 It was suggested that the autoproteolytic activity 
exhibited by metal-depleted SAP was to regulate the level of phosphatase activity in 
response to changes in physiological condition. Therefore, the possibility of 
autoproteolysis cannot be ruled out at this point.
MPH was eluted from Superdex 200 column at 82.425 mL. By fitting the 
elution volume of MPH to the Superdex 200 calibration curve (section 2.6.5, Figure 
2.3), MPH was estimated to be 60.3 kDa, closer to the calculated dimeric molecular 
weight of 63.1 kDa, indicating that MPH was a dimer in solution. The observation was 
consistent with the dimeric crystal structure solved by Dong et al., but differed from the 
oligomeric state obtained by Fu et a l5 and Yang et al.9 Fu et al. predicted MPH from 
Pseudomonas sp. M6 to be a monomer, with gel filtration chromatography while Yang 
et al. predicted MPH from Pseudomonas sp. WBC-3 to be a monomer with analytical 
ultracentrifugation. The MPH monomer observed by Fu et al. might be due to the 
presence of C-terminal His-Tag affecting the dimeric structure. The N and C-termini of 
MPH form the dimerisation interface of the dimer. The MPH monomer observed by 
Yang et al. might be due to the dilute MPH sample (~25 nM) used for the 
ultracentrifugation analysis. Proteins that primarily exist in oligomeric state generally 
have dissociation constants in the nanomolar range while some proteins have 
dissociation constants in the micromolar or milimolar range, thus the oligomeric 
structure might dissociate at concentrations lower than the dissociation constant.10
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During gel filtration or crystallisation, the protein samples used are often very 
concentrated.
3.2.2. Attempts to overcome proteolytic degradation
3.2.2.1. Identifying proteolytic cleavage site
In order to identify the cleavage site in MPH, a purified MPH sample that 
contained both MPH and the smaller band was analysed with Fourier transform ion 
cyclotron resonance mass spectroscopy (FTICR-MS). Mass spectroscopy can give 
accurate measurement of protein mass and therefore can be used to measure the mass of 
the smaller band. The mass obtained was then used to predict the cleavage site of the 
protease. The protein sample for FTICR-MS was prepared as described in section 2.6.5, 
and the FTICR-MS measurement and analysis were performed by Professor Thomas 
Huber.
25761.42
31406 4416828.84
12621 60
Figure 3.4: Deconvoluted FTICR-MS spectrum of MPH purified with purification workflow I.
The numbers on the peak indicates the molecular weight of the detected species in Dalton.
According to the deconvoluted mass spectrum of the MPH sample (Figure 3.4), 
four species with masses 31406.44 Da, 25761.42 Da, 16828.84 Da and 12621.60 Da 
were found. The 31406.44 Da species corresponded to the mass of MPH without the N- 
terminal methionine (149.21 Da). The loss of N-terminal methionine was most likely 
due to the activity of methionine aminopeptidase (MetAPl) that is responsible for 
catalysing the N-terminal methionine cleavage of newly synthesised polypeptides." 
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The specificity of MetAPl depends on the amino acid residue at PT and P2’ positions 
(N-terminal methionine being PI position), and it was found that E. coli MetAPl 
prefers small amino acid residues with small side chain at P I’ position and hydrophilic 
or small residues at P2’ position. Both the amino acid residues at P I’ and P2’ positions 
of MPH are Ala, suggesting that MetAPl was most likely reason for the loss of N- 
terminal methionine."
The species with masses 16828.84 Da and 12621.60 Da were not observed from 
the SDS-PAGE profiles (Figure 3.3) and the masses were deemed too small to 
correspond to the smaller band below the MPH band. Moreover, sequential removal of 
amino acid residues from either terminus to calculate the molecular weight of MPH 
fragment with ProtParam did not produce molecular weights corresponding to those 
two values. Therefore, the most likely species that corresponded to the smaller band 
observed in the SDS-PAGE was the species with a mass of 25761.42 Da, and this was 
used for the prediction of cleavage site. It is worth noting that the apparent molecular 
weight of the MPH band was heavier than expected in the SDS-PAGE profile. The 
protein molecular weight estimation from SDS-PAGE was done by constructing a 
standard curve based on the migration of the molecular weight markers. The molecular 
weight for MPH and the smaller band obtained from this estimation were approximately 
36 kDa and 28 kDa respectively. Anomalous SDS-PAGE migration is not uncommon 
and can be attributed to the variation in SDS binding of different proteins,12'13 hence the 
accuracy of molecular weight estimation from SDS-PAGE is an approximation at best.
The proteolytic cleavage site was then predicted by removing amino acid 
residues sequentially from the N or C-terminus and matching the resulting molecular 
weight to the fragment obtained from FTICR-MS. Two possible cleavage sites were 
identified, one from each terminus and were listed below. The blue bolded font 
indicates the cleaved fragment.
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MAAPQVRTSAPGYYRMLLGDFEITALSDGTVALPVDKRLNQPAPKTQSALAKSFQKAPLETSVTGYLVNT
GSKLVLVDTGAAGLFGPTLGRLAANLKAAGYQPEQVDEIYITHMHPDHVGGLMVGEQLAFPNAWRADQK
EADFWLSQTNLDKAPDDESKGFFKGAMASLNPYVKAGKFKPFSGNTDLVPGIKALASHGHTPGHTTYWE
SQGQKLALLGDLILVAAVQFDDPSVTTQLDSDSKSVAVERKKAFADAAKGGYLIAASHLSFPGIGHIRAE
GKGYRFVPVNY SW N PK
Calculated Molecular Weight: 25762.2 Da
MAAPQVRTSAPGYYRMLLGDFEITALSDGTVALPVDKRLNQPAPKTQSALAKSFQKAPLETSVTGYLVNT
GSKLVLVDTGAAGLFGPTLGRLAANLKAAGYQPEQVDEIYITHMHPDHVGGLMVGEQLAFPNAWRADQK
EADFWLSQTNLDKAPDDESKGFFKGAMASLNPYVKAGKFKPFSGNTDLVPGIKALASHGHTPGHTTYWE
SQGQKLALLGDLILVAAVQFDDPSVTTQLDSDSKSVAVERKKAFADAAKGGYLIAASHLSFPGIGHIRAE
GKGYRFVPVNYSWNPK
Calculated Molecular Weight: 25783.2 Da
The N-terminus cleavage site was thought to be the likely cleavage site as the 
calculated molecular weight was in good agreement with the molecular weight obtained 
from FTICR-MS (25762.2 Da and 25761.4 Da).
3.2.2.2. Site directed mutagenesis
One approach in overcoming the proteolysis is to engineer MPH to be more 
proteolytic resistant. Several successful examples of proteolytic resistance enhancement 
were achieved by altering the amino acid residues at the proteolytic cleavage site.1415 In 
MPH, the cleavage site was predicted to be between F88 and Q89. Therefore, F88A site 
directed mutagenesis (SDM) was performed using sequence overlap extension (SOE) 
method as described in section 2.5.4.2 and the resulting mutant was designated 
MPHF88A. The forward and reverse flanking primers used were F-SSM-Flank-M1T- 
Ase and R-SSM-Flank-MIT-Eco while the forward and reverse mutagenic primers used 
were F-SDM-M1T-F54A and R-SDM-M1T-F54A (Appendix C). The resulting 
construct, pETMCSI M1T F88A, was transformed into BL21(DE3)AWy4', and protein 
expression was done similarly as WT MPH (section 3.2.1). MPH F88 was then 
purified with column I (20 mL SP Sepharose) with the condition described in section 
3.2.1. Superdex 200 was not used in this purification as it was deemed just a polishing 
step for the purification. The purity of the purification fractions was assessed by SDS- 
PAGE (Figure 3.5). From Figure 3.5, the proteolysis persisted even after the predicted 
cleavage site was mutated (Fraction 29).
86
CHAPTER 3
M SL P 15 17 19 21 23 25 27 29 31 33
Figure 3.5: SDS-PAGE profile of the purified MPHF88A fractions done with 20 mL SP Sepharose 
column.
Molecular weights of proteins in the molecular marker, M, from top to bottom, are 97.4, 66.2, 45.0, 31.0, 
21.5 and 14.4 kDa. SL denotes the soluble lysate after clarification from the total lysate, P denotes the 
insoluble fraction and the numbers denote the eluted fractions.
3.2.2.3. Purification workflow II -  cationic exchange column and anionic
exchange column
Another approach in getting around proteolysis is to optimise the purification 
procedure so that the protease and the degraded fragment can be removed, giving a 
homogenous MPH enzyme. This is of course assuming that the cause of degradation is 
due to host protease rather than autoproteolysis of MPH. This purification protocol was 
adopted from Ms. Nur Hafizah Azizan, who is also working with MPH. The 
purification procedure involved a cationic exchange column and an anionic exchange 
column. For this purification workflow, MPH was expressed in E. coli BL21(DE3)/<Ytv,‘ 
harbouring pETMCSI M1T WT and harvested as described in purification workflow I 
(section 3.2.1). The purification of MPH with the first column was performed as 
described in purification workflow I (section 3.2.1). The eluted fractions with the 
highest MPH activity were pooled, concentrated and buffer exchanged to 20 mM 
piperazine, pH 10. The sample was then applied to a 90 mL Q Sepharose column and 
the bound protein was eluted using a linear gradient of 0 to 1 M NaCl in 20 mM 
piperazine, pH 10 over five column volumes. The workflow for this purification was 
summarised in Figure 3.6. The purity of the purification fractions was assessed by 
SDS-PAGE (Figure 3.7).
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Harvested cells lysed with French Pressure Cell Press and clarified with centrifugation
Column 1: 20 mL SP Sepharose or 5 mL Hitrap SP FF (Cationic exchange column)
Binding buffer: 20 mM KH2P04 or HEPES, pH 7
Elution buffer: 20 mM KH2P04 or HEPES, pH 7 with linear gradient of 0 -  1 M NaCl over 10 column volumes
Fractions pooled, buffer exchanged and concentrated
Column 2: 90 mL Q Sepharose (Anionic exchange column)
Binding buffer: 20 mM piperazine, pH 10
Elution buffer: 20 mM piperazine. pH 10 with linear gradient of 0 -  1 M NaCl over 5 column volumes
Figure 3.6: Purification workflow II.
a) M SL P FT 23 24 25 26 27 28 29 30 31 32
Figure 3.7: SDS-PAGE profiles of the purified fractions done with purification workflow II.
a) shows the eluted fractions from SP Sepharose column and b) shows the eluted fractions from Q 
Sepharose. Molecular weight of proteins in the molecular marker, M, from top to bottom, are 97.4, 66.2, 
45.0, 31.0, 21.5 and 14.4 kDa. SL denotes the soluble lysate after clarification from the total lysate, P 
denotes the insoluble fraction, FT denotes column flow through, FP denotes the sample loaded into Q 
Sepharose column and the numbers denote the eluted fractions.
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From the SDS-PAGE profiles (Figure 3.7), the purity of the purified enzyme 
seemed acceptable and no degradation was observed from the purified fractions from Q 
Sepharose column. However, when examining the final purity of the purified MPH after 
concentration and buffer exchanged into 50 mM HEPES, 100 mM NaCl, 50% (v/v) 
glycerol, pH 7.6, a small amount of degraded product was observed below the MPH 
band (Figure 3.8).
M SL SP Q
zn
Figure 3.8: MPH purity progression with purification workflow II.
Molecular weights of proteins in the molecular marker, M, from top to bottom, are 97.4, 66.2, 45.0, 31.0, 
21.5 and 14.4 kDa. SL denotes the soluble lysate after clarification from the total lysate, SP denotes the 
pooled purified fractions from SP Sepharose column and Q denotes the purified enzyme from Q 
Sepharose
While purification workflow II provided better purity and less degraded product, 
there were several drawbacks with the purification method. One major drawback was 
that the enzyme was exposed to denaturing pH range for a considerable duration. Due 
to deviation from calculated isoelectric point, lower pH values cannot be used when 
purifying MPH with Q Sepharose. It was found that MPH would not bind to Q 
Sepharose column with a pH 9 binding buffer, indicating an upward deviation from the 
theoretical isolectrical point of 7.87 (data not shown). The workflow also gave a lower 
yield in purified enzyme. It was pointed out that the pi calculations in ProtParam were 
defined by pKa values obtained by examining polypeptide migration between pH 4.5 
and 7.3 under denaturing conditions and that the software might not be adequate for pi 
prediction of highly basic proteins.16 18
3.2.2.4. Purification workflow III -  anionic exchange column and cationic
exchange column
Purification workflow III also involved an anionic exchange column and a 
cationic exchange column. However, the strategy used in purification workflow III was 
different from that of purification workflow II. For this purification workflow, MPH 
was expressed in E. coli BL21(DE3)Wtcvl' harbouring pETMCSI MIT WT and
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harvested as described in purification workflow I (Section 3.2.1). Clarified lysate was 
loaded onto a 5 mL HiTrap DEAE Fast Flow column and the flow through was 
collected without NaCl gradient. The flow through was then loaded onto a 5 mL HiTrap 
SP Fast Flow column and bound MPH was eluted with 0 -  1 M NaCl linear gradient in 
20 mM HEPES, pH 7 over 10 column volumes. The workflow for this purification is 
summarised in Figure 3.9. The purity of the purification fractions was assessed by 
SDS-PAGE (Figure 3.10).
Harvested cells lysed with French Pressure Cell Press and clarified with centrifugation
▼
Column 1: 5 mL HiTrap DEAE Fast Flow (anionic exchange column) 
Buffer: 20 mM HEPES, pH 7
Flowthrough pooled for 2nd column
Column 2: 5 mL HiTrap SP Fast Flow (cationic exchange column)
Binding buffer. 20 mM HEPES. pH 7
Elution buffer: 20 mM HEPES, pH 7 with linear gradient of 0 -  1 M NaCl over 10 column volumes
Figure 3.9: Purification workflow III.
M SL EL FT 18 20 21 22 23 24
mmm 6
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Figure 3.10: SDS-PAGE profile of the purified fractions done with purification workflow III.
Molecular weights of proteins in the molecular marker. M, from top to bottom, are 97.4, 66.2. 45.0. 31.0, 
21.5 and 14.4 kDa. SL denotes the soluble lysate after clarification from the total lysate, EL denotes the 
eluate from HiTrap DEAE FF column, FT denotes column flow through from HiTrap SP FF column, and 
the numbers denote the eluted fractions from HiTrap SP FF.
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From the SDS-PAGE profile (Figure 3.10), a small amount of impurities can be 
observed. While the purity of this purification workflow was not better than purification 
workflow II, this workflow allowed rapid purification of MPH with reasonable purity. 
Compared to purification workflow II, the whole purification workflow III only 
required 6 - 7  hours, while purification workflow II required overnight purification. 
The shorter time was possible due to the use of smaller columns and buffers of the same 
pH on both columns, eliminating the need to exchange buffer in between columns. In 
the first column (HiTrap DEAE FF), MPH, which has an alkaline pi, was not bound to 
the column and was collected in the flow through. The flow through, without any buffer 
exchanging step, was then applied onto the second column (HiTrap SP FF) for 
purification. This method was used since a big bulk of E. coli proteins has acidic pi, as 
shown in a theoretical 2D map of E. coli proteins obtained from the E. coli Protein 
Database (http://eecoli.kaist.ac.kr/theoretical.html) (Figure 3.11). Therefore, when 
using a buffer of pH 7, a large amount of E. coli host protein was eliminated prior to the 
purification with HiTrap SP FF. The simple purification procedure for this workflow 
also cuts down the time needed between cell lysis and storage of purified enzyme and 
this would minimise proteolysis. As shown in later sections, purified MPH is stable 
when stored in -20°C.
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Figure 3.11: 2D map of E. coli protein obtained from E. coli Protein Database.
The x-axis shows the theoretical pi and the y-axis show the theoretical molecular weight of proteins 
found in E. coli. The map was obtained from the E. coli Protein Database 
(http://eecoli.kaist.ac.kr/theoretical.html)
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Purification workflow III was used to purify the MPH variants isolated in 
Chapter 4. The purity and homogeneity of the purified enzyme produced with this 
workflow was deemed sufficient and the proteolysis should not affect the results if the 
purification was performed quickly and the purified MPH was stored in -20°C as soon 
as possible. A simplified version of purification workflow III was also used for the 
rapid purification of MPH variants in Chapter 5. Due to the smaller culture volume 
used for the purification of MPH variants in Chapter 5, column 1 of purification 
workflow III was omitted and the purification was done with just column 2.
3.2.2.5. Purification workflow IV -  nickel affinity column
Immobilised metal-affinity chromatography (IMAC) is widely used to purify 
recombinant proteins containing polyhistidine affinity tag. This method provides a 
simple one-step purification process with up to 95% purity19. However, the addition of 
a His-tag to N or C-terminus of MPH might affect the dimeric assembly of MPH since 
the N and C-termini of each monomer form the dimerisation interface as discussed in 
Chapter 1. In some cases, polyhistidine affinity tag was also found to affect enzymatic 
activity20 and crystal structure21. It was with these considerations in mind that 
traditional purification procedures were pursued instead of the more convenient IMAC. 
Nevertheless, an MPH construct containing polyhistidine tag can be used to probe the 
cause of the proteolysis. If the proteolysis was due to a protease, IMAC might be able to 
separate it from His-tagged MPH and the proteolysis would cease. On the other hand, if 
the proteolysis was due to autoproteolytic activity of MPH, the proteolysis would 
persist. This purification workflow was developed for the sole purpose of identifying 
the cause of proteolysis.
For this purification workflow, MPH was expressed in E. coli BL21(DE3)^tcv1' 
harbouring pET47b_MlT_WT with 0.5 mM IPTG induction at 37°C for 16 hours. The 
growth media was supplemented with 0.1 mM ZnCF to ensure that sufficient Zn2 ions 
were available to the cell due to the findings in Chapter 4. The MPH construct was 
made by cloning the MPH sequence coding for the mature protein downstream of the 
N-terminus His-Tag. The cells harvested were resuspended in 50 mM HEPES, 20 mM 
imidazole, 500 mM NaCl, 1 mM AEBSF, pH 7.6 prior to lysis with French pressure 
cell press. Two different operation methods were used in this purification workflow: 
manual elution with syringe (purification workflow IVa) and automated elution with
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FPLC purification system (purification workflow IVb). In purification workflow IVa, 
the clarified lysate were loaded onto a 5 mL Histrap FF column equilibrated with 50m 
mM HEPES, 20 mM imidazole, 500 mM NaCl, pH 7.6 and bound MPH was eluted 
with a one-step elution with 500 mM imidazole in 50 mM HEPES, 500 mM NaCl, pH 
7.6. Whereas for purification workflow IVb, the clarified lysate was loaded onto the 
column similarly, and bound MPH was eluted using a linear gradient of 0 to 500 mM 
imidazole in 50 mM HEPES, 500 mM NaCl, pH 7.6. The workflow for this purification 
was summarised in Figure 3.12 and the purity of the eluted enzyme was assessed by 
SDS-PAGE (Figure 3.13).
Harvested cells lysed with French Pressure Cell Press and clarified with centrifugation
(a) Syringe operated
Column : 5 mL HisTrap FF
Binding buffer: 50 mM HEPES, 20 mM imidazole, 500 
mM NaCl, pH 7.6
Elution bufTer: 50 mM HEPES, 500 mM NaCl, 500 mM 
imidazole, pH 7.6 with 1-step elution (6 column volumes)
(b) FPLC operated
Column : 5 mL HisTrap FF
Binding buffer: 50 mM HEPES, 20 mM imidazole, 500 
mM NaCl, pH 7.6
Elution buffer: 50 mM HEPES, 500 mM NaCl, pH 7.6 
with 0 -  500 mM linear gradient over 12 column volumes
Figure 3.12: Purification workflow IV -  (a) syringe and (b) FPLC operated.
a ) M SL P FT W EL
Figure 3.13: SDS-PAGE profiles of purified fractions done with purification workflow IV.
a) shows the profile for syringe operated elution and b) shows the profile for FPLC operated elution. 
Molecular weights of proteins in molecular marker, M, from top to bottom are 97.4, 66.2, 45.0, 31.0, 
21.5, 14.4 kDa. SL denotes the soluble lysate after clarification from the total lysate, P denotes the 
insoluble fraction, FT denotes the column flow through, W denotes the sample collected from washing 
after sample application, EL denotes the eluate from the syringe-operated elution and numbers denote the 
eluted fractions from FPLC.
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From the SDS-PAGE profiles (Figure 3.13), the purified enzyme obtained from 
syringe elution gave better purity than FPLC operated elution. However, this was most 
likely due to dilution of the purified enzyme during one-step MPH elution with syringe. 
The bound protein was eluted with six column volumes (~30 mL) of elution buffer. 
Figure 3.14 shows the purified MPH from purification workflow IVa after 
concentration. The purity of FPLC eluted MPH would be better since some of the 
contaminants were eluted at different fractions than MPH. It should be noted that 
thorough optimisation was not performed for this purification workflow due to time 
constraints and the purity would be better after the purification is optimised. The 
smaller bands below the MPH band can still be seen from samples of both purifications 
workflows, albeit in small amounts. At this point, it was not conclusive if the smaller 
band observed here was a result of contaminant co-purification or degradation. In order 
to further investigate this, a series of MPH degradation studies were conducted.
Figure 3.14: Purity of syringe purified MPH with purification workflow IV after concentration.
Molecular weights of proteins in molecular marker, from top to bottom are 97.4, 66.2, 45.0, 31.0, 21.5, 
14.4 kDa.
3.2.2.6. MPH degradation study
To observe if further degradation occurred after purification, a series of MPH 
degradation studies were conducted. The outcome of the study might also be able to 
implicate the reason of degradation. For this stability study, MPH was expressed in E. 
coli DH5a or BL21(DE3)^etv*' and purified with the purification workflows described in 
sections above. The purified MPH was then kept at different temperatures and a small 
aliquot of the enzyme was taken out at different intervals and subjected to SDS-PAGE 
to observe if degradation has taken place. The samples were clarified via centrifugation 
prior to sampling the aliquots to remove any aggregate or precipitate that has formed. 
Three purified MPH preparations were made and the conditions are summarised in
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Table 3.1. The degradation profiles of the three samples are shown in Figures 3.15, 
3.16 and 3.17.
Table 3.1: The three purified MPH samples prepared for degradation study.
Sample 1 Sample II Sample III
Expression pCY76 vector in E. pET47b vector in E. coli pET47b vector in E. coli
system coli DH5u BL21(DE3)Wwv'- BL21(DE3)^CV,‘
Expression 16 hours constitutive 16 hours, 0.5 mM IPTG 16 hours, 0.5 mM IPTG
condition expression, 37°C inductive expression, 
37°C
inductive expression, 37°C
Purification III IVa IVb
workflow
Incubation -20, 4, 25, 37 -20, 4, 25, 37 25,37
temperature
M -20°C 4°C 25°C 37°C
Day 1
Day 30 g^jp
Figure 3.15: Degradation study of Sample I.
The purified MPH samples were incubated at -20°C, 4°C, 25°C and 37°C for up to 30 days with an 
aliquot of the sample taken out at days 1, 3 and 30. Day 0 was the start of the incubation. The molecular 
weights of proteins in the molecular marker, from top to bottom are 97.4, 66.2, 45.0, 31.0, 21.5 and 14.4 
kDa. Samples from each temperature were loaded into the gel in triplicates for this experiment.
From Figure 3.15, degradation can be observed for Sample I from day 3’s 25°C 
and 37°C samples. At day 30, the MPH bands for 4°C and 24°C had almost totally 
disappeared. The degradation product that first appeared in day 3’s samples had 
degraded into even smaller products. The sample that was kept frozen in -20°C
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remained largely unchanged throughout the 30-day period. The 37°C day 30’s sample 
was not available due to the shutdown of 37°C incubators for lab relocation.
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Figure 3.16: Degradation study of Sample II.
The purified MPH samples were incubated at -20°C, 4°C, 25°C and 37°C for up to 41 days with an 
aliquot of the sample taken out at days 1. 2, 30 and 41. Day 0 was the start of the incubation. The 
molecular weights of proteins in the molecular marker, from top to bottom are 97.4, 66.2, 45.0. 31.0, 21.5 
and 14.4 kDa. Samples from each temperature were loaded into the gel in duplicates for this experiment.
For Sample II (Figure 3.16), degradation product was first observed for day 2’s 
37°C sample. By day 30, significant degradation product can be observed for 24°C and 
37°C samples. On day 41, the amount of degradation product for 24°C and 37°C
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samples remained largely similar. However, more degradation product can be observed 
for 4°C sample on day 41. Interestingly, the appearance of the degradation product 
coincided with the appearance of heavier bands, observed in the upper region of the 
SDS-PAGE profiles corresponding to 66 -  99.4 kDa of the molecular weight marker.
For Sample III (Figure 3.17), no significant degradation was observed for 
samples incubated at 25°C and 37°C throughout the incubation period. The SDS-PAGE 
profile of the samples remained largely similar by day 34 of the degradation study, 
indicating the source of proteolysis was eliminated. The heavier bands observed for 
sample II were also not observed in for Sample III.
Day 2 Day 13 Day 34
M 25°C 37°C M 25°C 37°C M 25°C 37°C
T  _  1 m
Figure 3.17: Degradation study of Sample III.
The purified MPH samples were incubated at 25°C and 37°C for up to 34 days with an aliquot of the 
sample taken out at days 2, 13 and 34. Day 0 was the start of the incubation. The molecular weights of  
proteins in the molecular marker, from top to bottom are 97.4, 66.2, 45.0, 31.0, 21.5 and 14.4 kDa.
3.3. Discussion
Proteolysis proved to be a difficult problem to troubleshoot due to the many 
possible routes in which proteolysis can occur. In this study, we narrowed down the 
possibilities for proteolysis to the protease from expression host or autoproteolysis. The 
possibility of N-end rule degradation was considered and ruled out due to the absence 
of destabilising residues at the N-terminus for the rule.22 23 Due to the various types of 
proteases that are present in E. coli, as shown in the E. coli Protease Database, 
identifying the protease that could have been responsible for the degradation is no easy 
feat. One of the most common approaches to this problem was to use commercially 
available protease inhibitor cocktails that contain various protease inhibitors that would 
cover the different types of proteases such as serine, cysteine, aspatatic and
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metalloproteases. However, the metalloprotease inhibitors in such cocktails might 
inhibit the activity of MPH, since MPH is a metalloenzyme. Therefore, the idea to 
engineer an MPH variant that is more resistant to proteolytic degradation was 
conceived. An enzyme that is more resistant against protease not only gives enzyme of 
better purity; it is also relevant to the application of MPH as a candidate for 
organophosphate bioremediation.
Based on the FTICR-MS analysis on a mixture of enzyme containing both full 
length and degraded MPH, the cleavage site of the proteolysis was predicted and an 
F88A MPH mutant was generated. However, the F88A mutant did not stop the 
degradation. This might be due to the mutation not performed on the protease 
recognition residues or the protease was tolerable to alanine at this position. F88A is the 
N-terminal residue from the predicted cleavage site (PI position). Some proteases such 
as Asp-N endopeptidase recognise the C-terminal residue from the cleavage site (P I’ 
position)24. In order for this approach to be successful, more than one mutation to the 
cleavage site region might be required.
Subsequently, various purification methods were attempted to eliminate the 
degradation product so that reasonably pure enzyme could be obtained for 
characterisation of WT MPH and variants isolated in Chapters 4 and 5. Purification 
workflow III that involved a SP Sepharose cationic exchange column and a Q 
Sepharose anionic exchange column produced acceptable purity but at the expense of 
yield and exposure of MPH enzyme to extreme pH. This led to the development of 
purification workflow IV that also used a HiTrap DEAE FF anionic exchange column 
and a HiTrap SP FF cationic exchange column. However, the different implementation 
from purification workflow III allowed the purification to be done rapidly at a neutral 
pH and this workflow was eventually used in the purification of the mutants isolated 
from the thermostability evolution (Chapter 4) and substrate specificity alteration 
evolution (Chapter 5). In the process of developing purification workflow III, it was 
also discovered that the pi of MPH appeared to be more alkaline than the calculated pi 
due to the limitation of ProtParam in predicting pi for highly basic proteins.16 The 
purity obtained from purification workflow III was deemed sufficient for enzyme 
characterisation work and if the enzyme is stored in -20°C as quickly as possible, 
further significant degradation can be prevented. In terms of stability against
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proteolysis, MPH did not suffer significant further degradation when kept in -20°C for 
at least a month, as demonstrated by the degradation studies for Samples I and II.
The degradation pattern shown by Sample I was different than that observed for 
Sample 11 and highlights the sensitivity of MPH to proteolytic degradation (Figure 
3.15). The degradation in Sample 1 continued to progress and much smaller degradation 
products of various molecular weights can be observed. The degradation process also 
progressed more rapidly relative to Sample II. The MPH band had almost disappeared 
by day 30 of the degradation study. While the reason for this observation is unknown, 
the difference in degradation pattern might be related to the fact that Sample I was 
produce in E. coli DH5a. Compared to E. coli DH5ct, E. coli BL21(DE3)/^ cvl does not 
express Ion protease and ompT outer membrane protease.2^  While it was observed that 
MPH expressed in E. coli DH5a suffered more proteolysis (data not shown), there was 
no direct evidence implicating Ion and ompT proteases to be responsible for the 
degradation observed here.
The different degradation profiles shown by Samples II and III shed some light 
on the degradation. This was because the proteins for both samples were expressed 
similarly and purified using the same column, the samples exhibited different 
degradation profiles. The only difference in preparing the samples was; Sample II was 
purified using syringe one-step elution, while Sample 111 was purified using FPLC 
linear gradient elution, and only one of the fractions was used for the degradation study 
(Fraction 19 from Figure 3.13b). No significant degradation was observed at the end of 
the experiment for Sample III while significant degradation can be seen from the SDS- 
PAGE profile for Sample II for the same period. This result implied that the 
degradation was most likely due to a protease from the expression host and was 
eliminated during gradient elution when preparing Sample III. For Sample II, the one- 
step syringe elution might not eliminate the protease since the bound MPH protein was 
eluted into a single fraction. As seen from the purity of purification workflow IVa 
(Figure 3.14), some background proteins were present in the purified enzyme, showing 
a lesser purity. As with Sample I, the proteases responsible for the degradation should 
only be present in very small quantities. If the proteases were present in large quantities, 
the degradation would happen more rapidly. Another possibility was the non-specific 
interaction between the proteases and MPH. The proteolysis persisted with purification 
workflows I (cationic exchange and gel filtration chromatography), II (cationic 
exchange and anionic exchange), III (anionic exchange and cationic exchange
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chromatography) and IVa (Ni2 affinity chromatography). It would seem unlikely that 
the proteases was so similar to MPH in terms of pi, molecular weight and binding 
capacity to Ni2 charged column and co-purify with MPH in cationic exchange, gel 
filtration and Ni2 charged columns, leading to the initial suspicion that MPH is capable 
of autoproteolysis.
The increasing intensity of higher molecular weight species observed for 
Sample II is a curious observation (Figure 3.16) The appearance of these higher 
molecular species coincided with the appearance of the degraded species and the 
disappearance of species with molecular weight lower than the degraded species. One 
hypothesis to explain this observation is the formation of soluble aggregates by the 
degraded species and lower molecular weight species. Insoluble aggregates were ruled 
out of consideration. Even though insoluble aggregates were observed for 37°C 
incubated samples, all samples were clarified by centrifugation before aliquots were 
removed for SDS-PAGE. This was consistent with the observation that although 
considerable degradation can be seen for the sample incubated at 37°C, lesser amount 
of higher molecular weight species was observed than that of 4°C and 24°C. It was 
however not clear as to why the soluble aggregate was not dissociated by SDS when 
subjected to SDS-PAGE if the hypothesis is true.
3.4. Summary
This chapter described the development and optimisation of MPH purification 
procedures. During the course of developing the purification protocols, it was 
discovered that MPH was susceptible to proteolytic degradation. The initial strategy to 
overcome proteolysis was to engineer MPH to be more resistant to proteolysis by site 
directed mutagenesis on the predicted cleavage site, based on data obtained from mass 
spectroscopy. However, the degradation persisted when MPH F88A was purified. One 
plausible reason was while the cleavage site was correctly predicted, the mutagenesis 
was not performed on key recognition residue by the protease or that the protease can 
tolerate the mutated residue.
Subsequently, a purification workflow was developed (purification workflow 
III) to produce purified MPH enzymes with acceptable purity and homogeneity for 
MPH variants characterisation in Chapters 4 and 5. In order to obtain more information
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about the proteolysis, i.e., if the proteolysis was due to host protease or autoproteolysis, 
immobilised-metal affinity chromatography (IMAC) using Ni2 charged column was 
performed. Two different elution methods were used (syringe elution and FPLC 
elution) and the difference observed from the degradation study of the two methods led 
us to conclude that host protease was the most likely culprit in MPH proteolysis. The 
different degradation pattern showed by MPH produced in E. coli DH5a highlighted 
the susceptibility of MPH to proteolytic degradation. Miss Nur Hafizah Azizan, in her 
work with investigating metal binding affinities of MPH, uses pETMCSI vector and 
BL21(DE3)Wcc 1 for expression of MPH and should only see minimal degradation if the 
protein is purified and stored quickly.
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4. Directed Evolution of Methyl Parathion Hydrolase 
for Enhanced Thermal Stability
4.1. Preamble
As mentioned in Chapter 1, organophosphate-degrading enzymes have 
received considerable attention due to their potential applications in bioremediation of 
organophosphate (OP) contamination, biosensor for OP detection and therapies for OP 
poisoning.1 Methyl parathion hydrolase (MPH), as a newer OP degrading enzyme, has 
aroused considerable interest due to its potential to be used as an alternative to OPH 
and OPDA from Pseudomonas diminuta and Agrobacterium radiobacter respectively.
Stability is one of the most desired characteristics when considering an 
enzyme’s suitability to be used in commercial or industrial application. Despite the 
impressive catalytic properties of many enzymes, they are frequently not very stable, 
limiting their applicability in industry. In order for MPH to be an effective 
bioremediator, the enzyme has to be stable -  showing good thermal and chemical 
stabilities, as well as the possibility of repeated use to keep the production cost low. 
Unfortunately, MPH does not have exceptional thermostability and could benefit from 
extra thermostability. One approach is to raise the overall stability with directed 
evolution. While there are many successful examples of enzyme evolution to improve 
thermal properties, there are no clear and universal rules to improve protein thermal 
stability.2 Yana and Poulos compiled a detailed review of important factors for 
enhancing protein stability. They surveyed the literature and illustrated the many 
possible ways by which thermostability enhancement could be achieved.3 They also 
concluded that there are many routes to increase thermal stability, and directed 
evolution can offer alternative routes to those used by natural evolution.
It has been suggested that enhanced stability promotes the evolvability of the 
protein.4 6 By “evolvable”, I mean that the function of a protein can be altered with 
mutations and the altered phenotypes are heritable. One major factor that is thought to 
contribute to evolvability is mutational robustness. Wagner defined mutationally robust 
biological system as a system that exhibits persistence in its structure or function after 
mutations of its parts.7 In order for a protein to function, it must fold into its native
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structure, and retention of that native structure is a prerequisite to obtain new or 
modified functions.4 Bloom and co-workers proposed that enhanced thermodynamic 
stability can contribute to mutational robustness of a protein by demonstrating that a 
stabilised TEM-1 mutant, when used as the template for error-prone PCR, showed 
higher mutational tolerance compared to the wild type template.6 Enhanced 
thermostability increases the robustness of a protein by increasing the fraction of 
mutants that possess the minimal stability required to fold.5 Bloom and co-workers 
further illustrate the link between thermostabiliy and evolvability by using thermostable 
P450 variants and marginally stable variants as starting points for directed evolution 
toward a new range of P450 substrates.4 The thermostable variants produced more 
variants with improved catalytic activity as only the thermostable variants can 
accommodate the highly destabilising but beneficial mutations to attain new functions. 
In addition, active site residues are inherently destabilising, as these residues must often 
satisfy functional constraints.4,8 Accumulation of destabilising mutations was also found 
to be negatively epistatic, causing the protein fitness to exponentially decline as more 
mutations are introduced in protein evolution.5 9 Therefore by generating thermostable 
MPH variants, these variants can be used as starting points in future evolution 
experiments for obtaining new functions through mutations that are too destabilising for 
wild type MPH to accommodate.
The objective of the work described in this chapter was to enhance the thermal 
stability of MPH by employing directed evolution techniques such as error-prone PCR 
and DNA shuffling. During the course of this work, the zinc content of MPH, as well as 
the effects of additives on MPH was also investigated.
4.2. Directed evolution experimental procedures
A schematic flowchart of the steps taken to evolve for thermostability is given 
in Figure 4.1. One round of evolution typically consists of library construction (section 
4.2.1), library growth (section 4.2.2) and library screening (section 4.2.3). The 
screening procedures and strategies used in this section were adopted and modified 
from various references on directed evolution and thermostability evolution.10 12
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Figure 4.1: Thermostability screening overview.
Schematic o f the screening process used in directed evolution o f MPH thermostability. The mutants were 
selected based on their thermostability index, calculated using Equation 4.1.
4.2.1. Library construction
For the work described in this chapter, the first 34 amino acid residues o f the 
intact MPH sequence that constitute the signal sequence were removed and designated 
M IT  for the reasons described in section 3.2 (MPH-l-Trucncation). One factor that had 
to be considered during library construction was the choice between a constitutive 
vector (pCY76) and an inducible vector (pETMCSI). pCY76 vector was chosen as the 
vector due to three main reasons:
i. Electrocompetency o f E. coli BL21(DE3)^cv1' was found to be at least 10-fold 
less than E. coli D H 5a13. pETMCSI is a modified T7 pET vector that requires 
E. coli BL21 (DE3)Wtt/f for heterologous protein expression to work, while 
pCY76 protein expression can work in E. coli DH5cx. Using pETMCSI and E. 
coli BL21 (DE3)WtvA~ for library generation could result in cumbersome steps in 
order to generate large libraries.
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ii. The yield of pETMCSI obtained during plasmid extraction is found to be much 
lower that that of pCY76 (data not shown). Bigger volumes of cell culture are 
often required for plasmid isolation, when using pETMCSI vector to obtain 
sufficient amounts of plasmid for DNA sequencing or DNA digestion. While 
this is not be a problem when isolating plasmid for only a few samples, directed 
evolution work often involves plasmid isolation of a large number of samples 
and this would lead to very laborious steps in plasmid isolation.
iii. MPH is a highly efficient enzyme and very little enzyme is required for activity 
measurement. When an inducible protein expression system is used, large 
amount of enzyme would be produced. Using cell lysate from this preparation, 
even in very small volumes, would result in a reaction rate that is too rapid to 
measure. Multiple cell dilution steps would be required to obtain measurable 
initial activity and this could result in an even more laborious screening 
procedure. Constitutive protein expression system gives lower level of protein 
expression and can reduce the number of dilution steps required, simplifying the 
screening workflow.
The pCY76_MlT_WT construct was constructed similarly to 
pETMCSI MlT WT and was described in section 3.2. Error-prone PCR (ePCR) and 
staggered extension process error-prone PCR (StEP-ePCR) were used to introduce 
mutations into MIT. ePCR was used in the first round of evolution and StEP-ePCR was 
used in rounds two to four to shuffle selected mutations, in addition to introducing new 
mutations. The ePCR and StEP-ePCR steps were performed as described in sections 
2.5.1 and 2.5.3. The mutagenic PCR products were digested with AseI and EcoR\ and 
ligated into pCY76 digested with Nde\ and EcoRA as described in sections 2.3.6 and 
2.3.8. The ligated plasmid was transformed into E. coli DH5a and the library was 
analysed with enzymatic assay based on procedures described in sections 2.3.9 and 
2.5.5.
4.2.2. Library growth
The library master plates were grown in round bottom 96-well microtitire plates 
at 37°C for 24 hours in an orbital shaking incubator. The plates were prepared either by 
picking single colonies or by culture dilution method developed by Dr. Bradley
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Stevenson13, and both methods were described in section 2.5.6. During the course of 
this work, it was observed that the cultures in wells located at the edges of the plates 
underwent evaporation, causing inconsistencies in cell density. To minimise this 
problem, the plates were sealed by petroleum jelly and masking tape prior to 
incubation.
4.2.3. Library screening
After the plates were removed from the incubator, the cells were resuspended 
manually with multi channel pipettes to ensure that the cultures were homogenous. 50 
pL of cells was transferred from the growth plates (master plate) to round bottom 96- 
well microtitre plates (lysis plates) and the lysis plates were kept in -80°C until 
required. 50 pL of 50% (v/v) glycerol (final concentration 12.5%) was added to the 
remaining culture in master plates and kept in -80°C for storage. To lyse the cells, the 
lysis plates were removed from -80°C and were left to stand at room temperature to 
thaw. Freeze thawing is part of the protocol for cell lysis with rLysozyme™(Novagen). 
150 pL of 50 mM Tris-HCl, 100 mM NaCl, 0.1% Tween 20, pH 7.6 containing 0.24 
U/pL rLysozyme™ was added to the lysis plates to initiate lysis and the plates were 
incubated on a plate shaker for 30 minutes at 24°C. After lysis, the plates were 
centrifuged at 3700 rpm for 15 minutes to pellet the cell debris. 50 pL of supernatant 
was transferred to 96-well PCR plates (heat treatment plate), and 20 pL of supernatant 
was transferred from the heat treatment plates to 96-well flat bottom microtitre plates 
(initial activity plate). The heat treatment plates were heated with a thermocycler and 
were left to stand at room temperature for at least 30 minutes. The conditions of the 
heat treatment are discussed in section 4.2.3.2. 20 pL of lysate was then transferred to 
96-well flat bottom microtitre plates for activity assay (residual activity plate).
4.2.3.I. Choosing the screening substrate
While the most active substrate for MPH is methyl parathion (MPS), using MPS 
as the screening substrate in this work has several disadvantages. Due to the high 
activity MPH has on MPS, obtaining the initial velocity with low variability was 
difficult. The initial velocity cannot be measured accurately if too much enzyme is 
used, as the reaction goes to completion before measurements can be made. When using 
such active substrates for screening, one can use very small amount of lysate ( 1 - 2  pL), 
or diluting the lysate to a more dilute concentrations, so that the initial velocity can be
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measured. However, pipetting very small volumes would introduce pipetting errors that 
affect the variability of the measurements, while introducing dilution steps into the 
already complicated screening workflow would also affect the accuracy and throughput 
of the screen. With these considerations in mind, ethyl parathion (EPS) was used as the 
screening substrate in this work. As discussed in Chapter 5, MPH was approximately 
10-fold less active toward EPS and that would decrease the number of dilution steps 
needed to achieve measurable initial velocity. The libraries were assayed with 119 pM 
EPS in 50 mM Tris-HCl, 100 mM NaCl, 0.1% Tween 20, pH 7.6 and the reactions were 
monitored by the liberation ofp-nitrophenolate at 405 nm at 30°C.
4.2.3.2. Choosing the screening condition
Prior to screening the mutant libraries, the thermostability of WT MPH was 
assessed by constructing a melting curve for WT MPH. A plate containing WT MPH 
was prepared as described in section 4.2.2 and was assayed as described in section 
4.2.3, except that 25 pL of clarified lysate was transferred from the lysis plate to PCR 
tubes for different heat treatments. Aliquots left at 4°C served as the controls without 
heat treatment (initial activity, A;) and samples were heat treated from 20°C to 100°C 
for 15 minutes to obtain the residual activity after heat treatment. Three wells were 
picked randomly for the assay to represent the technical replicates for this experiment. 
For this work, the stability (s) of the protein is defined by the percentage of residual 
activity (Ar) to initial activity (Aj), as given by Equation 4.1.12 The WT MPH 
thermostability profile is presented in Figure 4.2.
s = ^ x l0 0 %  (4.1)
A,
8 60
Tem perature (°C)
Figure 4.2: The thermostability profile of wild type MPH obtained with crude lysate.
The error bars represent the standard deviation of the sample in triplicates.
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From the melting curve, it was observed that the stability decreases rapidly from 
60°C to 70°C. Thus, 70°C was chosen as the heat treatment condition for library 
screening. Note that the heat treatment did not result in total inactivation as low levels 
of activity were observed even for higher temperatures.
After all the parameters have been considered, a screening validation assay was 
performed to assess the variability of the screen.10 It is important to quantify the quality 
of a screening method as screening variability can influence the detection of real 
improved variants. Repeated measurements of a single variant library (i.e., wild type 
MPH) was used to quantify the reproducibility and uncertainty of a screen. The quality 
of a screening method was evaluated by calculating the coefficient of variation (CV) 
and plotting the activity distribution of the single variant library. The coefficient of 
variation is given by the percentage of standard deviation to the mean of the activity 
measurements (CV = [standard deviation / mean] x 100%). The ideal CV value would 
be less than 10%!0. However, it is difficult to achieve such low CV values without 
automated high throughput screening robots. With that said, the screening workflow 
was optimised as much as possible to achieve the lowest CV value with the existing 
laboratory setup.
To assess the variability of the screen, WT MPH was grown in a 96-well 
microtitre plate, and was assayed as described in sections 4.2.2 and 4.2.3, identical to 
the screening workflow for mutant library. The heat treatment was 70°C for 15 minutes 
and was done as described in section 4.2.3.
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Clone number
Figure 4.3: Evaluating the screening method with a plate of 96 wild type MPH samples, (a) shows 
the initial activity distribution of WT MPH and (b) shows the stability distribution of WT MPH.
In both (a) and (b) plot, the bar charts represent the initial activity and stability of WT MPH with respect 
to their positions in the 96-well plate. The line graphs in both (a) and (b) show the same initial activity 
and stability data sorted in descending order.
The CV values for the WT MPH initial activity and stability were 14.4% and 
15.4% respectively. The initial activity and stability distributions of the single sequence 
library are shown in Figure 4.3. By plotting the WT MPH stability distribution data for 
the assay method, the sensitivity of the screen can be obtained by dividing the highest 
(13.6%) and lowest (6.3%) WT MPH stability indices obtained from the validation 
screen. This method of assessing the quality of the screening method was described by 
Salazar and Sun in a textbook.10 Figure 4.3, a CV value of 15.4% allowed us to identify
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mutants with at least 2.2-fold stability improvement. A more sensitive screen (smaller 
CV values) would be required if smaller improvements are to be detected.
4.3. Results
4.3.1. Directed evolution of MPH
Four rounds of directed evolution, consisting of one round of ePCR and three 
rounds of StEP-ePCR, were performed on MPH to isolate variants with improved 
thermostability. The results for the directed evolution are discussed in this section of the 
chapter.
4.3.1.1. Screening and selection
In all rounds of the evolution, mutants with less than 60% wild type MPH 
activity at 30°C (initial activity) were removed from further consideration. This was to 
prevent the selection of mutants with improved thermostability but hugely 
compromised initial activity. Mutants with low initial activity would also generate 
artificially high thermostability values contributing to false positives.12
Examples of the microplate screening plots are shown in Figure 4.4. A 
summary of the library generation methods, growth methods, library sizes, error rates 
and selection criteria for the evolution in each round can be found in Table 4.1. Unique 
mutants selected at the end of round four are displayed in Table 4.2 and unique mutants 
selected from all four rounds can be found in Appendix F. In each round, the libraries 
were subjected to at least a primary and a secondary screen to identify mutants with 
enhanced thermostability. In rounds two and three, a tertiary screen was introduced to 
further eliminate false positive clones. The unique mutants, isolated from each round 
based on the criteria listed in Table 4.1, were used as the parent for the subsequent 
round of evolution. In round four, the heat treatment pressure was increased in an 
attempt to isolate mutants with further thermostability enhancements. After four rounds 
of evolution, all mutants carry the L256Q and K316E double mutations, suggesting that 
the evolution had converged under the experimental conditions that were used.
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Figure 4.4: Examples of screening plots from microplate screens.
In this example of a primary screen, the initial and residual activities of the same master plate were 
measured and the stability value of every variant was calculated using Equation 4.1. The stability of the 
mutants were then compared to that of wild type and those with better stability, while maintaining 
activity at lower temperatures, were selected for secondary screening. The wild type and vector only 
controls were located in columns 1 and 12 of the plates in an alternate pattern, as labelled in the figure.
Table 4.1: Summary of the library generation methods, growth methods, library sizes, error rates 
and selection criteria for MPH thermostability evolution.
The error rate for rounds two to four show the introduction of new mutations in addition to DNA
shuffling._________________________________________________________________________________
Error rate per gene Selection criteria
Primary
screen
Mutagenesis growth Library Amino Heat Initial
Round method method size Nucleotide Acid treatment activity Stability
1 ePCR
Culture
dilution 3480 3.22 ±3.63 2.13 ± 2.8
70°C, 15 
mins
> 70% 
WT
> 100% 
WT
2 StEP-ePCR
Culture
dilution 2880 1.11 ± 1.27 0.67 ±0.71
70°C, 15 
mins
> 60% 
WT
> 100% 
WT
3 StEP-ePCR
Culture
dilution 2880 0.44 ± 1.01 0.44± 1.01
70°C, 15 
mins
> 80% 
WT
> 200% 
WT
4 StEP-ePCR
Single
colony 1600 1.45 ± 1.29 1.09 ±0.99
80°C, 20 
mins
> 80% 
WT
> 400% 
WT
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Table 4.2: Mutants isolated after round four of thermostability evolution.
The numbers and alphabets at the top of the table indicate the position of the mutations and the wild type 
residues at the corresponding position. The stability indices of the mutants w ere normalised to that of WT
MPH.
Relative
90 113 164 202 211 237 256 275 278 281 300 316 stability (%)
W T K T F A G G L S K A A K 100
R o u n d
4
1A4 E Q E 571
1D5 Q G E 588
1 E6 A Q V E 644
5H6 Q E 553
6A10 Q G E 485
6B3 Q E 483
6C11 Q E 523
8A6 A D D Q E 535
8C8 Q E 494
8H6 Q E 486
9B8 S Q I E 582
11 A3 Y Q E 558
10112 Q E 530
10G8 Q E 555
13D4 Q E 497
13D11 E Q E 515
13G6 S 0 T E 536
13G9 Q N E 515
14A7 Q E 479
14H9 Q G E 496
15 E2 Q E 513
15F3 Q T E 564
15H5 Q E 477
17F11 Q V E 677
16A4 Q E 636
20A6 E Q E 619
16H7 Q N E 582
\7E\0 Q G E 603
20H9 Q E 660
4.3.1.2. Thermal activation of MPH variants
During the course of library screening, it was observed that mutants carrying 
L256Q and K316E double mutations consistently exhibit thermal activation after heat 
treatment (Figure 4.5). From the round four secondary screening data, R413D4 that 
carries the L256Q and K316E double mutation gave 83.9% activity increase after 
heating at 80°C for 20 minutes, exhibiting thermal activation.
The thermostability profile of WT MPH was subsequently investigated with 
purified enzyme. The enzyme was expressed in E. coli BL21(DE3)/tecv4' harbouring 
pETMCSl MIT WT as described in section 2.6.1 and was purified with 5 mL HiTrap 
DEAE FF and 5 mL HiTrap SP FF columns as described in section 3.2.2.4, To obtain 
the thermostability profile using purified enzyme, the enzyme was heat treated from 
40°C to 100°C for 15 minutes prior to activity measurement. The assay mixture
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contains 134 nM WT MPH enzyme and 119 pM ethyl parathion in 50 mM HEPES, 100 
mM NaCl, pH 7.6. The thermostability profile o f the purified enzyme is shown in 
Figure 4.6. From the figure, the WT MPH activity increased after heat treatment at 
temperatures 40°C to 60°C before declining rapidly. Similar to the melting curve 
constructed with crude lysate (Figure 4.2), MPH did not undergo total inactivation at 
higher temperatures.
Initial activity Residual activity
■WT 
■ R413D4
Figure 4.5: Initial and residual activities comparison between R413D4 that carries the L256Q and 
K316E double mutations and wild type MPH in the round four secondary screen.
The residual activities were obtained by heating the lysate at 80°C for 20 mins. The error bars for WT 
MPH represent the MPH WT replicates on the same screening plate.
200 -I
180 -
160
140
100
Temperature (°C)
Figure 4.6: The thermostability profile of wild type MPH obtained with purified enzyme.
The error bars represent the standard deviation o f the sample in triplicates.
The observation o f thermal activation in WT MPH prompted a search of 
literature for similar observation. Thermal activation is a feature found in various 
thermophilic enzymes. Catalase I from Bacillus stearothermophilus was found to be
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irreversibly converted to high-activity form upon heating.14 Cyclodextrin 
glucanotransferase from Thermococcus sp. B1001 underwent changes in activity profile 
due to conformational change upon heating.1^ The cyclisation activity of the enzyme 
increases while the hydrolysis activity decreases after in vitro heat treatment leading to 
suggestions that thermal environment is important for the folding of the thermophilic 
enzyme.
4.3.2. Characterisation o f  MPH variants
In addition to R413D4 (L256Q, K316E), the stability indices of R31A10 
(L256Q), R32C11 (TI 13A, K316E), R33D5 (K90E, L256Q), R31E3 (L256Q, A300G, 
and K316E), R33H8 (K90E, L256Q, and K316E) at 70°C and 80°C were reassessed to 
the shortlisted variants for purification and characterisation. From the library screening 
data, it was observed that variants carrying L256Q and K316E mutations gave the most 
improvement over WT MPH. R31E3 and R33H8 were selected to investigate if K90E 
and A300G would contribute to any further thermostability enhancement on top of 
L256Q and K316E mutations. R31A10, R32C11 and R33D5 were selected to reaffirm 
the observation that both L256Q and K316E are required for significant thermostability 
enhancement. R413D4 was the only mutant selected for purification and subsequent 
characterisation since the thermostabilities of R31E3 and R33H8 were found to be 
similar to R413D4 (data not shown).
In order to further investigate the properties of the isolated double site mutant, 
R413D4 was subcloned into pETMCSI vector for protein expression, purification and 
characterisation. This was done to maintain consistency as WT MPH purified enzyme 
used for thermostability characterisation was expressed in BL21(DE3)Wttvi". The 
subcloning and protein expression were done as described in section 2.6.1 and 
purification was done as described in section 3.2.2.4.
4.3.2.1. Activity variation between batches of purified MPH
During the course of protein purification, it was discovered that WT MPH 
enzyme of different purification batches exhibit variation in activity (Figure 4.7). The 
activity assays were performed as described in section 4.3.1.2. This would affect the 
thermostability analysis of the enzyme since the thermostability value would depend on 
the initial activity of the enzyme. Enzyme concentrations were measured with a
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Nanodrop spectrophotometer in triplicates as described in section 2.6.4. The triplicate 
measurements showed good agreement, indicating that the measurements were 
accurate, while repeating the dilutions and assays also showed similar trend, suggesting 
that the dilutions were done properly and the activity variation was not due to dilution 
error (data not shown). An SDS-PAGE profile was used to visually assess any 
concentration variation that might be present for enzyme used for the assay (Figure 4.8) 
The SDS-PAGE was loaded with the same amount of enzyme used in the assay in 
triplicates. While SDS-PAGE is not suitable for quantitative protein measurement, the 
differences in activity between some of the purification batches should be large enough 
to be observed on a gel. Batch 1 MPH WT is approximately 3-fold and 2-fold less 
active than Batch 2 and Batch 3 respectively. From the SDS-PAGE profile (Figure 
4.8), no apparent difference in terms of enzyme amount can be observed, further 
suggesting that the enzyme loads used in measuring the activity were the same and the 
activity variation was caused by a different factor.
Batch 1 Batch 2 Batch 3
■Initial Activity 
■ Residual activity (70°C)
Figure 4.7: Initial and residual activities comparison between three batches of similarly purified 
MPH WT enzyme.
The blue columns show the initial activity of MPH WT enzyme without heat treatment while the red 
columns show the residual activity after heat treatment at 70°C for 15 minutes. The error bars represent 
the standard deviation of the quadruplicate measurements. Activity against EPS was measured as 
described section 4.3.2.1.
120
CHAPTER 4
M 1-1 1-2 1-3 2-1 2-2 2-3 3-1 3-2 3-3
Figure 4.8: SDS-PAGE profile of the enzyme used for activity assay.
Three batches of purified WT MPH were each diluted to 2.68 pM and 10 pL of each of the enzyme was 
loaded onto the gel. 1-1, 1-2, and 1-3 are the replicates from one preparation; 2-1, 2-2 and 2-3 are the 
replicates from one preparation and so on. The molecular weights of protein in the molecular marker (M), 
from top to bottom are 97.3, 66.2, 45.0. 31.0, 21.5, 14.4 kDa.
4.3.2.2. Selected variant does not display the same enhancement observed in 
screening
To obtain a simple thermostability profile of the MPH variants, the WT MPH 
and R413D4 purified enzyme were incubated at 70°C and 80°C for 15 minutes prior to 
activity assay. The samples incubated at 4°C serve as the control without heat treatment 
and the data are presented in Figure 4.9. The assay was performed as described in 
section 4.3.I.2. While R413D4, which carries the L256Q and K316E double mutations, 
is more stable than WT MPH, the variant did not display the thermal activation 
characteristic seen during library screening. The stability obtained with purified enzyme 
for R413D4 was also much less compared to the stability obtained during screening. 
R413D4 was only 1.31 and 1.74 folds more stable than WT MPH after heat treatment at 
70°C and 80°C respectively. In terms of activity, R413D4 retained 91.30% of WT 
activity (Figure 4.9 inset).
MPH variants
Figure 4.9: Stability comparison between purified WT MPH and R413D4.
The main panel shows the stability of WT MPH and R413D4 after heat treatment at 70°C (red) and 80°C 
(green). The samples incubated at 4°C (blue) were used as the non-heat treated control. The inset shows 
the activity comparison without heat treatment between WT MPH and R413D4, with WT MPH being 
100%. The error bars represent the standard deviation of duplicate measurements in an experiment.
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4.3.2.3. Enzyme pre-incubation with Zn2+ enhances activity and 
thermostabilty
In an attempt to explain the variation between results obtained with crude lysate 
and those obtained with purified enzyme, as well as the activity variation between 
batches of purified enzyme, it was decided that the effect of Zn2 on MPH would be 
investigated. To illustrate this, the thermostability profile study of WT MPH and 
R413D4 was repeated with 0.1 mM ZnCf pre-incubation prior to heat treatment. 0.1 
mM ZnCf was the chosen concentration as Zn2 will form Zn(OH)2, a white precipitate, 
in the presence of alkali. The assay buffer, 50 mM Tris-HCl or HEPES, contains alkali, 
as the buffer was pH adjusted to 7.6 with 10 M NaOH during preparation. A white 
precipitate could be observed when the Zn2 concentration was higher than 0.2 mM. 
One way of overcoming the zinc metal concentration restriction was to avoid using 
hydroxides to titrate the buffers. The samples were pre-incubated with Zn2 at 4°C for 
two hours prior to heat treatment. This pre-incubation period was chosen, as there was 
no considerable activity change after two hours of incubation (data not shown). The 
presence of 0.1% Tween 20, a component of the assay buffer for library screening, was 
also found to reduce the solubility of Zn2 and was excluded from the assay buffer 
recipe in further assays. Tween 20 was included in the assay buffer to help solubilise 
phosphorothioate substrates that have low solubility in aqueous solution. As a result, 
methyl chlorpyrifos oxon that is more soluble was used as the substrate in subsequent 
thermostability characterisation assays. The concentration of enzyme used in assays 
was reduced to 67 pM, as MPH is more active towards methyl chlorpyrifos oxon. 
0.1 mM ZnCb was also included in the assay buffer for metal pre-incubated samples to 
ensure that the metal is always available in excess.
The activity and stability comparisons between WT MPH, ZnCh pre-incubated 
WT MPH, R413D4 and ZnC^ pre-incubated R413D4 are shown in Figure 4.10. The 
stabilities and activities of WT MPH and R413D4 were similar to those discussed in 
section 4.3.2.2 for WT MPH and R413D4. R413D4 is 1.29 and 2.06 folds more stable 
than WT MPH after heat treatment at 70°C and 80°C respectively. R413D4 retained 
87.59% WT MPH initial activity, consistent with the results shown in the previous 
section. However, upon pre-incubation with 0.1 mM ZnCE, the initial activity for WT 
MPH increased to 371.15%. The stabilities for metal pre-incubated WT MPH after heat 
treatment at 70°C and 80°C were 419.17% and 3.72%, a drastic difference from the WT
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MPH enzymes assayed without additional metals. The stability o f ZnCU pre-incubated 
WT MPH after heat treatment at 80°C was also notably less than WT MPH without 
addition metals.
While R413D4 was as active as WT MPH before supplementing metals, the 
initial activity o f R413D4 increased to 272.42% when it was pre-incubated with ZnCh, 
a smaller increase compared to that o f WT MPH. The stabilities o f ZnCh pre-incubated 
R413D4 after heat treatments at 70°C and 80°C were 4.94% and 0.70% respectively, 
much lower than that o f R413D4 without additional ZnC^.
WT WT + Zn R413D4 R413D4 + Zn
MPH variants
Figure 4.10: Stability comparison between purified W T  M PH, W T MPH pre-incubated with 0.1 
mM ZnCl2. R413D4 and R413D4 pre-incubated with 0.1 mM ZnCl2.
The main panel shows the stability o f WT MPH, ZnCl2 pre-incubated WT MPH, R413D4 and ZnCl2 pre- 
incubated R413D4 after heat treatment at 70°C (red) and 80°C (green). The samples incubated at 4°C 
(blue) were used as the non-heat treated control. The inset shows the activity comparison without heat 
treatment between WT MPH, ZnCl2 pre-incubated WT MPH, R413D4 and ZnCl2 pre-incubated R413D4 
with WT MPH being 100%. The error bars represent the pooled standard deviation o f two independent 
experiments.
It is worth noting that for both WT MPH and R413D4 variants; samples without 
additional metals did not undergo total heat inactivation even as the samples were 
heated at higher temperatures. However, for ZnCH pre-incubated samples, they were 
heat inactivated at higher temperatures. This is illustrated in Figure 4.11 with the 
thermostability profiles o f WT MPH and ZnCh pre-incubated WT MPH. After being 
heat-treated at 80°C, metal pre-incubated WT MPH was inactivated while WT MPH 
without additional metal retained low level o f activity. In addition, the low level o f
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activity for WT MPH without additional metal was observed even after 90°C and 
100°C heat treatment. This phenomenon was observed despite ZnCf pre-incubated WT 
MPH is more active and more stable up to 70°C.
• —*
90 100
Temperature (°C)
Figure 4.11: The thermostability profiles of WT MPH and ZnCl2 pre-incubated WT MPH purified 
enzymes.
The blue line indicates the stability of WT MPH and the red line indicates the stability of ZnCl2 pre- 
incubated WT MPH. The stability values were calculated using WT MPH activity incubated at 4°C 
without metal supplementation as the initial activity. The samples were heated for 15 minutes at various 
temperatures to obtain the profile The error bars represent the standard deviation of the samples in 
triplicates.
4.3.2.4. Zinc composition of wild type MPH
Due to the effects of excess Zn“ on the activity and thermostability of MPH 
variants, the zinc content of WT MPH was investigated. WT MPH enzyme was diluted 
from concentrated stock to 20 pM with 50 mM HEPES, 100 mM NaCl, 0.1 mM ZnCh, 
pH 7.6 and was incubated at 4°C for 16 hours. The enzyme concentration was carefully 
chosen with two considerations: a concentration high enough that it will still be 
measurable after dilution, and a concentration low enough that the amount of Zn2 
would be in excess of the enzyme. This preparation would give a metal: enzyme ratio of 
5:1. Another WT MPH sample was similarly diluted with the exception that the buffer 
did not contain ZnCE. This was done to assess the metal content of WT MPH as 
purified. The excess ZnCf was removed by 5 mL HiTrap Desalting column and the 
samples were prepared for metal content measurement as described in section 2.6.6. 
The zinc content of MPH was measured by inductively coupled plasma-optical 
emission spectroscopy (ICP-OES) and was performed by Ms. Nur Hafizah Azizan. The 
data obtained is summarised in Table 4.3. The oxidation state of zinc was not verified
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but zinc is believed to be stable in its divalent state. MPH enzyme expressed and 
purified as it is, was found to contain 1.07 Zn2 per MPH monomer while the enzyme 
was found to contain 1.38 Zn2 per MPH monomer after overnight incubation with 0.1 
mM ZnCb. One MPH monomer is expected to contain two metal ions.
Table 4.3: The zinc metal content of MPH enzyme as purified and MPH enzyme with metal pre-
incubation.
MPH was produced in B L 21(D E 3/^‘harbouring pETMCSI M1T_WT.
Sample Zn (mol/MPH)
MPH as purified (without signal sequence) 1.07
MPH pre-incubated with 0.1 mM ZnCl2 1.38
4.3.2.5. Effect of buffer additives on WT MPH
Another aspect that was investigated as an attempt to explain the results 
obtained in section 4.3.2.2 was the effect of buffer additives on the activity of WT 
MPH. As mentioned earlier, the initial assay condition adapted from the literature 
contained Tween 80 to solubilise OP substrates.16 OP substrates are hydrophobic 
molecules that have low solubility in aqueous solution and require additives to remain 
soluble at high concentrations. This is particularly important in kinetic characterisation 
where very high concentrations of substrates are used. However, sometimes these 
additives might have detrimental effects on the activity of the enzyme. To investigate 
how these buffer additives affect the activity, MPH was incubated for 30 minutes with 
0.1% to 1% of additive. 0.1% or 1% of the additive was then included in the assay 
buffer and the assays were performed as described in section 4.3.1.2. The assay recipe 
contained 67 pM purified WT MPH and 119 pM methyl chlorpyrifos oxon in 50 mM 
HEPES, 100 mM NaCl, 0.1 or 1% additives, 0.1 mM ZnCl2, pH 7.6. The additives 
investigated were mainly organic solvents, such as ethanol, methanol, acetone and 
acetonitrile, and some other additives that are commonly used together with protein, 
such as glycerol, ethylene glycol and Tween 20. The activities obtained were then 
normalised to that of WT MPH without additives and are shown in Figure 4.12. It was 
observed that most additives had a detrimental effect on MPH activity, with the 
exception of 2-methyl-2,4-pentanediol, DMSO, glycerol and PEG 8000 (all showed 
above 90% relative activity). These detrimental effects would be even more severe 
when the additives are used at their typical working concentrations of 10 -  20%.17-20
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Buffer additives
Figure 4.12: The effect of various additives on W T MPH activity.
1% was used for organic solvents while 0.1% was used for other additives. The error bars represent the 
standard deviations obtained for duplicate or triplicate measurements. The activities obtained for assay 
mixtures containing additives were normalised to the activity obtained without additives.
Methanol is one o f the more commonly used cosolvent when dissolving OPs. 
Ely and co-workers found that at a final concentration o f 10% (v/v) methanol, the 
activity o f OPDA towards ethyl paroxon decreased 2.4-fold.19 To further investigate the 
effect o f methanol on the activity o f MPH, the hydrolysis o f methyl parathion was done 
in assay mixtures containing increasing concentrations o f methanol. The assay mixtures 
contained 20 pL o f lOx diluted cell lysate and 119 pM methyl parathion in 50 mM 
HEPES, 100 mM NaCl, 0 -  20% methanol, 0.1 mM ZnCE, pH 7.6. The cell lysate was 
pre-incubated with 90 pL o f the buffer containing methanol for 30 minutes and another 
90 pL o f the buffer containing methanol and the substrate to initiate the reaction. This 
was done to ensure that the enzyme was adequately exposed to the solvent before 
activity measurements were taken. The relative activity obtained is shown in Figure 
4.13. The MPH activity decreased, as the methanol concentration was increased. By 
20% methanol, only 18.89% o f activity was retained.
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Figure 4.13: The effect of increasing methanol concentration on WT MPH activity.
The error bars represent the standard deviations obtained for 24-replicate measurements on a 96-well 
microtitre plate. The activities obtained for assay mixtures containing additives were normalised to the 
activity obtained without additives.
4.4. Discussion
4.4.1. Stability discrepancies between library screening and purified 
enzyme
As noted in the section 4.3.2.2, there were stability discrepancies between the 
stability values observed during screening and stability values observed during 
characterisation with purified R413D4 enzyme. One possibility for such observation 
was due to the different E. coli strains used for protein expression. E. coli DH5a was 
used during library screening while E. coli BL21(DE3)Wttv1' was used for large scale 
protein expression. It was suggested that different E. coli strains might have different 
metal uptake and regulation, leading to different metal or different metal content in the 
expressed enzyme.20
The possibility of molecular crowding was also considered due to reports of 
stability enhancement. Molecular crowding is usually used to compare the environment 
in the cell and the in vitro environment during activity assay with purified enzyme. 
Molecular crowding is found to enhance native state stability of proteins due to 
excluded volume effects.21 A detailed review of the effects of molecular crowding on 
protein stability can be found in a review written by Despa et al~~ One of the effects 
discussed in the review was thermostability enhancement due to molecular crowding. 
Egger and Valentine mimicked the effects of molecular crowding and confinement by 
sol-gel encapsulation of several proteins and observed thermostability enhancement.2’
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However, this possibility was ruled out, as it was unlikely that the environment of crude 
cell lysate assay would be similar to the environment described for molecular crowding. 
The more likely explanation would be the non-specific interactions introduced by the 
protein and other macromolecules present in the soluble lysate during library screening, 
affecting its thermostability. It was estimated that the cytoplasm of exponential or 
stationary phase E. coli contains 0.3 to 0.4 g/mL macromolecules24, while the 
concentration of purified enzyme used in the assays was 2.11 to 4.22 pg/mL (67 to 134 
nM). The difference between assay environments in library screening (soluble lysate) 
and enzyme characterisation (purified enzyme) due to the presence of host 
macromolecules might affect the behaviour of the enzyme. It is unclear at this point, 
which cellular component interacted with the MPH mutant or if the mutations in 
R413D4 promoted interactions of the enzyme with host macromolecules since such 
stability discrepancy was not observed for WT MPH.
4.4.2. Implications of MPH zinc composition
Metal content variations in metalloenzymes are not uncommon and indeed 
various examples of metal content variation in metallo-enzymes were found in a 
literature search. Dr. Jee-Loon Foo, in his PhD work, found a correlation between 
cobalt content and hydrolytic activity when OPDA was expressed and purified in media 
and buffer supplemented with CoCL.20 Dr Foo also found that OPDA expressed in E. 
coli DH5a contain a lesser proportion of Co2 compared to OPDA expressed in 
BL21(DE3)/^ tvf', despite Co2 supplementation in the expression and purification in both 
cases, suggesting different metal regulatory mechanisms in different E. coli strains. Dr. 
Foo also noted that none of the OPDA enzymes expressed without supplementing any 
metal had full metal occupancy. Omburo et al. found that supplementing growth 
medium with divalent ions improves OPDA expression in E. coli and OPDA purified in 
buffers containing divalent ions increases the proportion of the supplemented ion in 
OPDA. Limphong and colleagues characterised human glyoxalase II enzymes that were 
expressed in rich medium and minimal medium containing Zn“ , Fe and Co“ . They 
found that glyoxalase II expressed in LB has a partially occupied metal centre and that 
the metal content of the enzyme can be influenced by the metal included in minimal 
media. Human glyoxalase II is a metallo-ß-lactamase superfamily enzyme that contain 
an active site metal centre that is identical to MPH.26
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While MPH expressed in BL21(DE3)AVt/1 with LB media contained 1.07 
equivalence of Zn2 and incubation of the enzyme with Zn2 post-purification did not 
increase the Zn2 content to two equivalence, it is possible that a population of the metal 
binding site was occupied by other divalent metals due to depletion of Zn“ during 
overexpression, preventing the formation of a bi-zinc metal centre during post-
purification metal incubation. This phenomenon was observed in work done by Dr. Jee- 
Loon Foo, where OPDA expressed in BL21(DE3)Wt‘4 with LB media contained 0.631 
and 0.319 equivalences of Fe2 and Zn2 with no traces of Co2 detected. When the 
same enzyme was expressed in BL21(DE3)W ttwith LB media supplemented with 1 
mM CoCf, the enzyme was found to contain 1.855 equivalence of Co“ . If the enzyme 
already contained 0.631 and 0.391 equivalences of Fe2 and Zn2\  it is unclear if Co2 
will be able to displace these metals to obtain a full Co2 occupied metal centre if the 
enzyme is incubated with Co“ post-purification. OPDA is a binuclear metalloenzyme. 
Another possibility for the failure to obtain two equivalence of Zn2 would be due to the 
different binding affinities of the metal sites. If one of the metal binding sites has a 
weaker affinity towards Zn2 , the metal occupying said site might be lost when passing 
the enzyme through HiTrap Desalting column. It was suggested that the more solvent 
exposed metal (ß-metal) binds less tightly than the more buried metal (a-metal), 
resulting in the displacement of Zn2 by Cd2 at the ß-metal position during protein 
crystallisation, as the crystallisation solution contained 0.1 M CdC^.27 Therefore, the 
reason for activity variation of purified MPH discussed in section 4.5.1 is most likely 
due to the metal content variation of the expressed MPH since the MPH enzymes 
prepared were not expressed and purified in media and buffers supplemented with Zn2 
metals.
The reason for the metal content variation in MPH was not clear-cut and more 
studies are required to investigate the metal binding properties of MPH. The metal 
binding properties of MPH were not previously explored in the various MPH 
publications that have appeared to date.16,2829 The metal binding studies of MPH is 
currently being undertaken by Ms. Nur Hafizah Azizan, using site-directed mutagenesis 
on the first and second shell metal coordinating ligands. Foo et al. demonstrated that 
mutations of outer-shell metal coordinating ligands significantly weaken the metal 
coordinating strength of OPDA, providing evidence for metal binding affinity 
modulation by outer-shell residues.30 Campos-Bermudez and co-workers attributed the
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metal promiscuity of Salmonella typhimurium glyoxalase II to the presence of an 
aspartate residue in the second shell ligands, increasing the hardness of a primary shell 
coordinating histidine.31
Other than having catalytic roles, metal ions are shown to have structural roles 
in enzymes. Yeast alcohol dehydrogenase contains two zinc ions, one catalytic and one 
structural whereby removal of the structural zinc does not affect the activity, but
' X ' )
compromises the stability of the protein. Rochu and co-workers investigated the 
effects of different catalytic metal ions (Zn2f, Co2 and Cd2 ) on the thermostability of 
OPH and found Zn2 -OPH to be the most thermostable while Cd2 -OPH to be the least 
thermostable.33 They also noted in their study that the stability of OPH is correlated to 
the substrate affinity of OPH with the most stable Zn2 -OPH displaying the lowest Km 
and Cd2 -OPH displaying the highest Km. Epting et al. compared the effects of divalent 
ions on the thermostability and thermal inactivation of mesophilic, thermophilic and 
hypothermophilic class II xylose-isomerases, found evidence suggesting Thermotoga 
neapolitana xylose isomerase requires one metal for stability and two metals for 
activity.34 Thermotoga neapolitana xylose isomerase is a bi-nuclear metalloenzyme 
with a TIM-barrel fold (PDB ID: 1AOE). While MPH contains a binuclear metal centre 
at its active site, it is unclear if the enzyme requires two Zn2 for activity or if the metals 
have any roles in maintaining stability. However, the difference in melting curves of 
MPH and Zn" pre-incubated MPH shown in Figure 4.11 suggests that the metals do 
provide stability benefits to the enzyme.
The stability of MPH and Zn2 pre-incubated MPH at higher temperatures
2+(above 80°C) also showed unexpected but interesting observations (Figure 4.11). Zn" 
pre-incubated MPH was fully inactivated at temperatures higher than 80°C while MPH 
without additional metals retained low levels of activities at the same temperatures. 
This was observed despite MPH that was pre-incubated with Zn2 showed higher 
thermostability values at temperatures below 70°C. In other words, the Zn2 pre- 
incubated WT MPH enzyme exhibited better thermostability and a thermostability 
profile that is expected from a typical enzyme, while WT MPH enzyme without Zn2 
supplementation showed anomalous thermostability profile. The activation 
characteristic observed from WT MPH without Zn2 supplementation was not observed 
in the thermostability profile for Zn2 pre-incubated MPH suggesting the possibility that 
the activation phenomenon was an artefact introduced by the incomplete metal centre.
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Work done by several groups to engineer more thermostable MPH enzymes also 
showed low-level activity retention at higher temperatures, indicating the possibility 
that the enzymes expressed had lower than expected metal content since no metals were 
supplemented during expression, purification and activity measurement of the 
enzymes.35 37 It is also not clear at this point, if WT MPH without a completely 
occupied metal centre follows a different unfolding kinetics from WT MPH with a 
completely occupied metal centre.
While far from conclusive, it is plausible that the thermostability evolution 
described in this chapter conferred a higher stability to the “metal-free” enzyme. The 
stability value of R413D4 without metal supplementation was indeed higher than MPH 
without metal supplementation when heat-treated at 70°C and 80°C (Figure 4.10), 
suggesting a more stable “metal-free” enzyme. The catalytic activity of R413D4 
increased when the enzyme was pre-incubated with ZnCL suggesting that the mutant 
too was expressed without a fully occupied metal centre. Roodveldt and Tawfik 
inadvertently stabilised the metal-free state of OPH when evolving the enzyme towards 
a promiscuous substrate. The result is an OPH variant with a higher functional 
expression of OPH.
4.4.3. Structural implications o f  mutations
During screening, the best improvement was seen when L256Q and K316E 
were present in a variant, suggesting cooperativity between the two mutations. This was 
further supported by the much lower stability improvement seen in L256Q and K316E 
single mutants (data not shown). However, the two residues are not located near each 
other as shown in Figure 4.14.
The mutations were modelled onto the b-subunit of WT MPH structure (PDB 
ID: 1P9E-B) using SWISS-MODEL homology modelling server.39 41 L256Q is located 
near the binuclear metal centre. D255 is the metal bridging aspartate residue. The 
L256Q mutation could introduce a hydrogen bonding between the side chain of Q256 
and the backbone of E283, possibly increasing the rigidity of the overall structure 
(Figure 4.15). E283 is located on a helix strand, next to the loop where L256Q is 
located.
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Figure 4.14: The positions of L256 and K316 in the dimeric MPH structure.
Figure 4.15: The hydrogen bonding between L256Q and E283.
The dashed line and the number show the hydrogen bond and the distance between the side chains of 
L256Q and E283.
K316 is a surface residue and the effect of K316E is unclear at this point. The 
mutation from lysine, a positively charged residue, to glutamate, a negatively charged 
residue resulted in an isoelectrical point (pi) shift due to the large difference in the pKa 
values of lysine and glutamate. The calculated pi decreased from 7.87 to 6.71. The 
K316 residue in WT MPH does not seem to form interaction with any residues (Figure 
4.16a). From the modelled mutant structure, the side chain of K316E is located near the 
side chain of D265, potentially introducing repulsion (Figure 4.16b). This might affect
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the interaction introduced by L256Q since D265 and Q256 are located on the same 
strand (Figure 4.16c).
a) b)
Figure 4.16: (a) The location of K316 in WT MPH. (b) The possible repulsion introduced by K316E 
mutation and (c) L256Q and D265 are located on the same strand.
The dashed line and number in (b) shows the distance between K316E side chain and D265 backbone. 
The dashed line and number in (c) shows hydrogen bonding between L256Q and E283.
4.4.4. Implications of MPH susceptibility to buffer additives
The investigation on the effects various buffer additives have on MPH revealed 
the susceptibility of the enzyme toward them. Due to the very low solubility of OP 
compounds in aqueous solutions, additives are required to solubilise these compounds 
when used in high concentrations. It is also undesirable for MPH to be negatively 
affected by various additives, since the enzyme is considered for deployment in OP 
bioremediation applications. MPH activity decreased by 1.8 and 5.3 folds at 10% and 
20% methanol respectively. This presented us with another aspect of MPH that required 
improvement. Directed evolution can be applied on MPH to generate variants that can 
better tolerate organic solvents, thus increasing the overall stability of the enzyme.
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4.4.5. Ideas to improve the thermostability evolution and future directed 
evolution of MPH
From the various observations noted during the library screening and enzyme 
characterisation experiments, several ideas to improve the thermostability and other 
future directed evolution experiments on MPH were conceived.
From the metal content of WT MPH without metal supplementation and other 
reports on metalloenzymes in the literature, it is obvious that overexpression of 
metalloenzymes in E. coli strains requires metal supplementation during expression and 
purification to obtain enzymes with fully occupied metal centre. The results obtained in 
MPH characterisation implied that the active site metal is important both catalytically 
and structurally. The evolution experiment performed in the absence of additional 
metals seemed to favour the stabilisation of the metal free enzyme, following a different 
pathway in enzyme stabilisation. Therefore, it is crucial in future thermostability and 
other directed evolution experiments of MPH that Zn2 ion are supplemented to the 
growth media and assays buffers to maintain a fully occupied metal centre. The 
purification buffers should also be supplemented with Zn2 ions for the same reason. 
This will ensure that the evolution will not select for metal free enzymes that are more 
stable.
In this thermostability evolution experiment, only two mutations were found to 
be responsible for thermostability enhancement. The difficulty in obtaining new 
mutations that confer substantial thermostability improvement might suggest that the 
pathway to attain stability enhancement was restricted by the criteria imposed during 
processing of selected enhanced variants. Giver and co-workers, in their work in 
evolving a thermostable esterase, found that the evolutionary pathway to better 
thermostability was restricted by selecting only highly active mutants at ambient 
temperature as parental template for subsequent evolution. 12 They suggested that by 
relaxing the requirement for high activity at ambient temperature, more evolution 
pathways to thermostability would be available and more mutants with upward shift in 
optimum temperature would be found. Gumulya and Reetz in evolving epoxide 
hydrolase, found that the best variants were obtained from parents consisting of neutral 
or inferior mutants and suggested using parents consisting of unimproved mutants as a 
technique to escape from local minima (“dead ends”) in evolution.42 In this experiment,
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mutants with less than 60% WT MPH initial activity were removed from consideration. 
Relaxing this requirement in future thermostability evolution experiments might open 
up more evolutionary pathways and allow the selection of mutants with upward shift in 
activity profile.
Another possible improvement to the thermostability evolution experiment 
would be to adopt a high throughput activity-independent biophysical screen. One such 
method is the Hot-CoFi agar screening method developed by Asial and co-workers.4’ 
The method allows for the isolation of better performing mutants at the colony level. 
This method worked on the premise that only soluble enzymes will be able to pass 
though a filter membrane and insoluble aggregate would be eliminated. By exposing the 
colonies to a temperature range, a varying degree of enzyme aggregation can be 
obtained to construct a biophysical thermo stab ilty profile. A secondary activity screen 
can then be performed on isolated mutant to ensure that the mutants are still active and 
not dead because of mutations that confer enhanced stability at the expense of activity.
4.5. Summary
This chapter described the directed evolution of MPH for better thermostability. 
Four rounds of directed evolution and variants with enhanced thermostability were 
selected. A single variant, R413D4, containing L256Q and K316E double mutations 
gave the most thermostability improvement. Unexpectedly, the stability of the purified 
R413D4 was much lower than anticipated. Although there was an enhancement, the 
mutant showed only two-fold stability improvement, unlike the marked improvement 
seen during screening. Various possibilities for the issue were discussed and the most 
likely explanation is the increase of non-specific interaction between R413D4 and some 
cellular component introduced by the mutations, thus stabilising the enzyme. During the 
course of investigating the reason behind the discrepancy, it was also discovered that 
MPH is expressed in E. coli without additional metal had a lower than expected Zn2 ' 
content, leading to compromised stability. Therefore, it is very plausible that we had 
generated a mutant that was more stable in its “metal free” form and stability 
enhancement seen in this work was metal independent. The mutant, expressed and 
purified without metal supplementation was more stable than the WT variant, expressed 
and purified without metal supplementation.
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Investigation on the effect of additives on MPH had exposed its susceptibility 
toward organic solvents. This revelation is important, as this can potentially be a major 
weakness of the enzyme when deployed in the field for bioremediation. Either protein 
engineering or protein entrapment methods can be used to improve and protect the 
protein against solvent-induced denaturation.
The experiment was terminated at this point due to time constraint. However, 
suggestions on how the experiment could be improved had been given and discussed. 
The uncovering of the metal requirement during growth and expression subsequently 
contributed to a successful evolution experiment in altering the substrate specificity of 
MPH to various organophosphates (see Chapter 5).
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5. Altering the Substrate Specificity of Methyl 
Parathion Hydrolase
5.1. Preamble
As noted in Chapter 1, methyl parathion hydrolase (MPH) has a pronounced 
substrate preference for methyl parathion (MPS). Altering any of the phosphorous 
substituent of the substrate causes a significant drop in activity -  this stands in stark 
contrast to the substrate specificities of OPH and OPDA that show a preference for 
some substrates, but still exhibit a significant level of activity for a broad range of 
substrate. MPH, like OPDA and OPH, is a binuclear metalloenzyme -  the metal centre 
of MPH differs in detail to those observed in OPDA and OPH, but one would not 
expect these differences to result in a narrowing of substrate specificity. Furthermore, 
the overall structure of MPH is similar to a variety of other enzymes -  MPH is part of a 
structural superfamily that has diverse range of substrates.1" These latter observations 
suggest that it should be possible to alter the substrate specificity of MPH. The 
objective of the work described in this chapter was to alter the substrate specificity' of 
MPH, to examine the activity of selected mutants against various substrates and to 
examine the mechanistic implications of the resulting mutations that resulted in the 
altered specificity. The overall workflow of the work described in this chapter is given 
in Figure 5.1.
Investigate W T  MPH substrate profile by measuring relative specific activities for various OPs
Enhanced multiple-site mutants were isolated, purified and characterised against a range of OPs
Better performing mutants from each library were isolated, purified and characterised against a range of 
OPs. All enhanced mutants were used as parents for DNA shuffling
Site saturation mutagenesis performed on active site lining residues and libraries were screened for 
enhanced activity against ethyl paraoxon (EPO)
Two rounds of DNA shuffling were done and libraries were screened for further activity enhancement
against EPO
Figure 5.1: Workflow overview in altering MPH substrate specificity.
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5.2. Approach -  site saturation mutagenesis of active site 
residues
There were several approaches that could have been taken to alter the substrate 
specificity of MPH. Rational approaches require a detailed knowledge of the protein 
and how it interacts with the substrate -  this is usually obtained from an examination on 
the structure of the protein with a bound substrate mimic or an inhibitor. The structure 
of MPH was known3, but the structure of a suitable complex was not known at the time 
that this work commenced -  so rational approaches were not feasible. Model complexes 
could have been made, but these were not deemed accurate enough to allow the 
redesign of MPH active site.
Other approaches to altering the substrate specificity of MPH were considered. 
Evolutionary approach involving error prone PCR (ePCR) of the MPH gene was one of 
the other approaches considered. However, these approaches, as with evolutionary 
approach, did not concentrate mutagenesis on the active site residues of the enzyme -  
the residues most likely to be responsible for substrate specificity. Furthermore, high 
throughput screening for increased stability of MPH (as described in Chapter 4) proved 
to be subject to considerable experimental error. Given these considerations, it felt best 
to use site saturation of active site residues to alter the substrate specificity of MPH -  
these residues being the most likely to affect substrate specificity. Furthermore, this 
approach requires screening of relatively small libraries. Whole gene random 
mutagenesis can be applied to further optimise the enzyme once the active site has been 
optimised for a particular substrate.
5.3. Choosing substrate for primary and secondary screens
The aim of our experiments was to alter substrate specificity, however some 
consideration was given to the possible changes that could be brought about by site 
saturation mutagenesis. First, it was deemed an uphill task to convert MPH to a 
different type of enzyme -  the possible substrates would be restricted to those that could 
undergo hydrolysis reaction. Secondly, it was thought that it would be possible to work 
with a substrate for which the native enzyme has a low level of activity. In other words, 
it was thought possible to enhance the activity of the enzyme for a specific substrate, 
but it was not thought feasible to generate activity with a completely new substrate.
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Therefore, the activities of MPH towards various substrates were measured and the 
results are shown in Figure 5.2. The activity measurements were performed as 
described in Section 2.7.1,
From the various OP substrates investigated, MPH showed preference towards 
dimethyl-substituted substrates such as MPS, methyl paraoxon (MPO) and methyl 
chlorpyrifos oxon (MCO) over diethyl-substituted analogues such as ethyl parathion 
(EPS), EPO and ethyl chorpyrifos oxon (ECO). The enzyme also showed preference 
towards substrates having 3,5,6-trichloro-2-pyridinol (TCPy) leaving group compared 
to the/?-nitrophenol (pNP) analogues (e.g. MPO vs MCO).
It was thought that it was reasonable to enhance the activity of MPH towards 
ethyl paraoxon (EPO) as the native enzyme displayed weak, but detectable activity 
towards this substrate -  about 1% of the activity of the enzyme towards MPS. In 
addition, EPO possessed two features that were common to other poor substrates of 
MPH -  it had ethyl substituents, as opposed to the methyl substituents of MPS. 
Furthermore, the phosphoryl group (P=0) of EPO was also found in other substrates for 
which MPH exhibited low activity. It was thought that an enzyme with enhanced 
activity towards EPO would also show increased activity towards a variety of other 
substrates.
Figure 5.2: MPH activity towards various substrates.
The activities towards various substrates were measured with purified MPH. 119 pM of each substrate 
was assayed in 50 mM HEPES, 100 mM NaCl. 0.1 mM ZnCl2. The Y-axis error bars represent the 
standard deviation between replicates in an experiment. The substrates investigated were as follows: 
methyl parathion (MPS), methyl paraoxon (MPO), ethyl parathion (EPS), ethyl paraoxon (EPO), p- 
nitrophenyl acetate (pNPA), jp-nitrophenyl phosphate (pNPP), />/s-(p-nitrophenyl) phosphate (bpNPP), 
methyl chlorpyrifos oxon (MCO) and ethyl chlorpyrifos oxon (ECO).
1200 i  1116.98
MPS MPO EPS EPO pNPA pNPP bpNPP MCO ECO
Substrates
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5.4. Choosing residues to mutate
There were many residues lining the active site -  too many to mutate them all in 
the time permitted for thesis work. Residues to be mutated were selected based on 
sequence and structure comparisons with related enzymes -  enzymes with similar 
structures and catalytic activities, but with different types of substrates. During the 
course of this work, differences were observed in the conformations of residues lining 
the active sites of the two crystallographic subunits. These differences and their 
implications on the catalytic mechanism of MPH were not mentioned in previous 
publications and will be described in more detail below. The residues that had different 
conformations in the two subunits were also marked for mutagenesis.
5.4.1. Sequence and structure comparison with related enzymes
The residues around the metal centre that form an essential section of the 
substrate-binding pocket were identified in the report of the crystal structure for MPH 
and the coordinates are available from the Protein Data Bank (PDB ID: 1P9E). The 
authors of the structure report noted that hydrophobic residues including Leu65, Leu67, 
Phel 19, Trpl79, Phel96, Leu258 and Leu273 line the putative substrate-binding pocket 
and investigated the roles of aromatic amino acid residues present in the substrate-
binding pocket, namely Phel 19, Trpl79 and Phel96 by site directed mutagenesis.3 
They noted that converting any of these residues to alanine caused a reduction of 
catalytic activity towards MPS and attributed the reduction to the disruption of substrate 
binding. However, closer inspection of the provided kinetic values revealed that while 
W179A and F196A mutations resulted in Km increase, Fl 19A mutation did not show 
significant Km increase. While the latter result implicated some residues in substrate 
binding, it did not give clues as to how the substrate specificity could be altered.
It has been noted that MPH is part of a structural superfamily -  it is said to have 
a metallo-ß-lactamase or aßßa fold. Structures of numerous members of the 
superfamily are available from the Protein Data Bank (PDB
http://www.rcsb.org/pdb/home/home.do). Seven structures were downloaded for 
comparison -  these included examples of Bl, B2 and B3 ß-lactamases for which a 
number of similar structures are available. PyMOL was used to visualize the structures 
and superimpose the coordinates onto subunit B of MPH that contains two Zn‘ ions.
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The superimposition was done in two stages. First, PyMOL’s Cealign command was 
used was for the superimposition. Cealign aligns protein structures based on structural 
similarities and is useful for comparing structurally similar proteins with low sequence 
similarity. Minor adjustments to the superimposition were then done with PyMOL/s 
pair fitting function by using the two active site metals, the bridging water and the metal 
coordinating residues as points of alignment, and the RMSD for the alignments can be 
found in Table 5.1. It was noted that the metals and metal-binding ligands 
superimposed with good agreement -  as is evident in Figures 5.3, 5.5 and 5.7. It was 
also noted that the MPH active site was the most crowded of all the structures compared 
-  all the other active sites were more open than that of MPH. This difference can be 
seen clearly in Figures 5.4, 5.6 and 5.8 in which MPH structure was displayed in 
cartoon mode with side chains displayed in lines, while the other protein structures were 
displayed in the surface representation mode. Identifying the residues that contribute to 
the active site confinement could be the key in altering the substrate preference for 
MPH. Examples of the individual structural comparisons are given below.
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Table 5.1: List of MBL superfamily members used in superimposition study.
The table lists down the MBL superfamily enzyme used, their enzyme type. PDB ID, the organism the 
enzyme originated from, the ligands used for pair fitting and RMSD values of the pair fitting._________
Protein
name Enzyme class PDB ID Organism of origin
Ligands used for 
pair fitting
RMSD
(A)
MPH MBL superfamily 
phosphotriesterase
1P9E3 Pseudom onas sp. 
WBC-3
H I47, H I49, 
D151. H I52, 
H234. D255 
H302, Znl5 Zn2, 
bridging OH'
N/A
AIM-1 B3 metallo-ß- 
lactamase
4AWY4 Pseudom onas
aeruginosa
HI 16, HI 18. 
D120, H121,
H I96, H263,Zn,, 
Zn2, bridging OH'
0.387
Bell Bl metallo-ß- 
lactamase
1BVT5 Bacillus cereus H86. H88. D90. 
HI49. C l68. 
H210. Zn|, Zn2
0.761
CphA B2 metallo-ß- 
lactamase
1X8G6 Aerom onas hydrophil a N116. HI 18. 
D120, H I96, 
C221. H263, Zn,
0.782
LI B3 metallo-ß- 
lactamase
1SML7 Stenotrophom onas
m altophilia
H84. H86. D88, 
H89, H I60. H225, 
Znh Zn2, bridging 
OH'
0.393
Glx2 MBL superfamily 
glyoxlase
IQH58 Homo sapiens H54, H56, D58, 
H59, HI 10. D134. 
H173, Zn,. Zn2, 
bridging OH'
0.262
GloB MBL superfamily 
glyoxalase
2QED9 Salm onella
typhimurium
H53, H55, D57, 
H58, HI 10. D127, 
H\s\65, Fei, Fe2, 
bridging OH'
0.271
AHL
lactonase
MBL superfamily 
lactonase
2BR610 Bacillus thuringiensis H I04, H I06, 
DI08. H I09, 
H I69, D191, 
H235, Zx\\, Zn2, 
bridging OH'
0.454
ZiPD MBL superfamily 
phosphodiesterase
2CBN" Escherichia co li H64, H66, D68, 
H69, H141, D212,
0.337
H270, Zn,,Zn2,
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5.4.1.1. MPH/AIM-1 superimposition
In general, AIM-1 has a more open active site when compared to MPH -  it has 
extra helices and sheets as is evident in the superimposition shown in Figure 5.4. Both 
proteins have the same metal-binding ligands with the exception of Asp255 that bridges 
the two metal ions in MPH - Ser207 in AIM-1 that is equivalent to Asp255 in MPH 
(Figure 5.3).
Figure 5.3: Structural superimposition of MPH and AIM-1 metal-binding ligands.
The amino acid numbering scheme from MPH was used in labelling the metal-binding ligands. The MPH 
ligands were coloured yellow while AIM-1 ligands were coloured wheat. The metal-binding ligands of 
the two enzymes are similar with the exception of Asp255, which its equivalent is replaced by a non-
bridging serine in AIM-1.
region
Q272, L273 
F196
Figure 5.4: Structural superimposition of MPH and AIM-1.
Figure shows the structural superimposition of MPH and AIM-1, where MPH is coloured cyan and A1M- 
1 coloured grey in surface representation mode. The red box indicates the active site region. The maroon 
coloured elements are MPH elements that are not present in AIM-1. L: Loop; S: Sheet; H: Helix.
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5.4.1.2. MPH/GloB superimposition
As is evident in the superimposition shown in Figure 5.6, GloB has a more open 
active site cavity. The residues Leu67, Pro68. Arg72, Phe 119, Pro 150, Phel96 and 
Leu258 of MPH protrude into what would be the active site of GloB. Both the human 
glyoxalase II (Glx2) and Salmonella thyphimurium glyoxalase II (GloB) share identical 
metal-binding ligands with MPH (Figure 5.5). However, when comparing the two 
glyoxalases, GloB has a bi-iron center whereas human Glx2 has a bi-zinc centre (figure 
not shown). MPH appears to function with two Zn2 ions, but the protein was 
crystallised from a solution containing Cd2 and this ion has displaced one of the Zn2 
ions in the crystalline protein -  one subunit has a Cd2 -Zn2 centre while the other has 
two Zn2 ions.
Figure 5.5: Structural superimposition of MPH and GloB metal-binding ligands.
The amino acid numbering scheme from MPH was used in labelling the metal-binding ligands. The MPH 
ligands are coloured yellow while GloB ligands are coloured wheat. The metals are Zn in MPH and Fe in 
GloB.
Figure 5.6: Structural superimposition of MPH and GloB.
Figure shows the structural superimposition of MPH and glyoxalase, where MPH is coloured cyan and 
GloB coloured grey in surface representation mode. The red box indicates the active site region. The 
MPH residues that line the active site are different from GloB and are coloured maroon.
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5.4.1.3. MPH/ZiPD superimposition
Similar to GloB, ZiPD has a much more open active site compared to MPH. The 
MPH residues that protrude into the active site of GloB also protrude into the active site 
of ZiPD (Figure 5.8). The metal-binding ligands are the same in MPH and ZiPD 
(Figure 5.7). The physiological function ZiPD appears to be in tRNA processing, but 
its exact role is not clear." ZiPD is also found to hydrolyse the phosphodiesters bpNPP 
and thymidine-5’-/?-nitrophenyl phosphate.12
Figure 5.7: Structural superimposition of MPH and ZiPD metal-binding ligands.
The amino acid numbering scheme from MPH was used in labelling the metal-binding ligands. The MPH 
ligands were coloured yellow while ZiPD ligands were coloured wheat. The bridging hydroxide is not 
present in the ZiPD crystal structure.
Active site region
Figure 5.8: Structural superimposition of MPH and ZiPD.
Figure shows the structural superimposition of MPH and ZiPD where MPH is colored cyan and ZiPD 
colored grey in surface representation mode. The maroon colored fragments are the extra residues around 
MPH active site when compared to ZiPD. The red box indicates the active site region.
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5.4.1.4. Summary of MPH superimpositions
As mentioned above, MPH was compared to seven other proteins in the ß- 
lactamase superfamily. The results for AIM-1, GloB and ZiPD were very similar to 
each other and to the other members of the superfamily. A summary of the observations 
made from all the superimposition studies is given below in Table 5.2. From these 
comparisons, it was evident that much of the MPH active site overlapped with those of 
many other enzymes suggesting that these residues fulfilled a structural role and were 
not important for discriminating between substrates. The residues that did not appear to 
overlap with the active site residues of the other proteins were taken to be those that 
were important for determining the substrate specificity of MPH -  these residues are 
marked with a red highlighter in Table 5.2.
The program ConSurf was also used to identify residues that might be 
important for substrate binding based on sequence conservation. This program accesses 
protein sequence databases and finds the 150 most similar sequences to an input 
sequence -  MPH in this case. Most of the sequences that were found were part of the ß- 
lactamase superfamily and had a diverse range of substrates. Despite the differences in 
function, a number of conserved residues were found in all the proteins. For example, a 
number of metal-binding residues were found in all the sequences. ConSurf also 
quantifies the degree of conservation for each residue -  a score of nine indicates very 
highly conserved residue while a score of one indicates a variable residue. With one 
exception, the residues identified in the previous section as being important for 
substrate binding had conservation scores that indicated that they were not highly 
conserved. The exception Leu258, although highly conserved, did show some 
variability -  four substitutions had previously been observed. The residues listed in 
Table 5.2 and highlighted in red were selected for site saturation mutagenesis.
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Table 5.2: Summary of MPH superimposition with MBL superfamily enzymes.
Residues that contribute to MPH active site confinement compared to other structure are marked with 
asterisks and sites selected for SSM are shaded red. The ConSurf conservation scores for the selected
sites are also listed in the table.___________________________________________________________
AHL ConSurf
Residue AIM-1 Bell CphA LI GloB Glx2 lactonase ZiPD rating
V65 * * *
A66 * * * *
L 67 * * * * * * * 5
P68 * * * * * * * 5
V69 * * *
D70 * * *
K71 * * *
R 72 * * * * * * * * 6
L73 * * * *
N74 * *
Q75 * *
P76 * * ♦
A77 * * *
P78 * * *
K.79 * * *
T80 * * *
Q81 * * *
S82 * * *
A83 * * *
L84 * * ♦
A85 * * *
K86 * * *
S87 * * *
F88 * * ♦
Q89 * * *
K90 * * * *
A91 ♦ * * *
P92 * * * *
L93 * * ♦ *
E94 ♦ * * ♦
T95 * * *
S96 ♦
■  1119 I * * * * ♦ * * 5
G120 *
P121 *
B  P150 | * * * 6
D190 *
SI 93 *
196 I * * * * * * 3
1257 *
■  1.258 1 * * ♦ * * * 9
V259 * * * *
A260 * *
A261 * ♦
V262 * *
Q263 * * *
D265 *
D266 ♦
Q272 * * * *
|  L273 I * * * * * * * * 7
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5.5. Site saturation mutagenesis
Having decided which residues would be altered, there were still a number of 
issues to be considered before libraries could be generated. The bottleneck of directed 
evolution studies is the library screening throughput. First, if the residues were altered 
simultaneously, the number of possible variants was enormous. Consider 20 residues at 
each of eight sites would give 256 x 1010 variants - only a very small fraction of such a 
library could be screened. Simultaneously mutating three residues would produce about 
8000 variants -  this is feasible.
A second point to consider is that there are duplications when making random 
mutations. Therefore, a much larger library needs to be generated to compensate for 
duplications and to ensure that a reasonable fraction of the possible mutants are 
generated -  this is referred to as oversampling. There are published formulae to 
calculate the number of mutants that should be generated to give a specified coverage of 
a randomly generated library consisting of a given number of possible variants. 
Appendix H provides a review of this literature and the formulae used in the 
calculation required to produce Tables 5.3 and 5.4. The program CASTer 2.014 was 
used to calculate the oversampling necessary for the libraries used in this work.
Some consideration should be given to the codons used to generate the mutant 
library -  the third consideration. An amino acid is specified by a codon, consisted three 
nucleotides, generally represented as NNN where N=A/T/G/C. Normally, site saturation 
mutagenesis is done by specifying the amino acids with NNK codons -  where K = G/T. 
All 20 amino acids are generated with the NNK specification and combinations of 
codons are required. Alternatively, Reetz and colleagues have suggested the use of an 
NDT library14 -  where D=AGT and T=T (Thiamine). This gives 12 codon 
combinations and 12 amino acids (Phe, Leu, lie, Val, Tyr, His, Asn, Asp, Cys, Arg, Ser, 
Gly) -  which Reetz describes as a balanced mix of polar and non-polar, aliphatic and 
aromatic, and negatively and positively charged representatives while excluding mostly 
structurally similar amino acid residues. Table 5.3 lists the library size required to give 
95% coverage of the NNK and NDT libraries for different numbers of mutation sites.
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Table 5.3: Oversampling required in achieving 95% coverage for NNK & NDT.
No of sites
Codons
NNK NDT
Transfromants needed Codons Transformants needed
1 32 94 12 34
2 1.024 3,066 144 430
3 32.768 98.163 1,728 5,175
4 1.048,576 3,141,251 20,736 62,188
5 33,554.432 100,520.093 248.832 745,433
For the work described in this chapter, the gene for WT MPH was cloned into 
pJWL1030 vector without the signal sequence (designated pJWL1030 M1T WT). 
MPH was amplified from pCY76_MlT_WT with F-MlT-pJWL1030flank_Ase and R- 
MlT-pJWL1030flank_Pst primers and cloned into NdeI and Pst\ sites in pJWL1030. 
The construction of pCY76 M1T WT can be found in Chapter 4. Site saturation 
mutagenesis (SSM) was performed on sites listed in Table 5.2 using the megaprimed 
ligase-free SSM method on pJWL1030_MlT_WT, as described in section 2.5.4.3.
5.5.1. Library size
It was decided that the amino acids Leu67, Pro68 and Arg72 would be mutated 
simultaneously using NDT randomization codons. It was thought that Arg72 and 
Trpl79 could be important for activity so they were mutated separately with NNK 
randomisation. Other amino acids were mutated with NDT libraries as shown in Table 
5.4 -  this table also gives the number of variants that must be screened to obtain at least 
95% of the theoretically possible library and the number of variants screened, as 
described in the next section. Any mutants displaying increased activity would be 
shuffled with the aim of producing recombined mutants with further enhanced activity.
5.5.2. Library screening with ethyl paraoxon
As described in section 2.5.6, primary and secondary screenings involved the 
use of 96-well microtitre plates with the reaction monitored by measuring increased 
absorption due to the formation of /7-nitrophenolate ion. 10 pL of cells were used in the 
activity screens. The results of these screens are shown in Table 5.5. A small number of 
mutants with deteriorated activity were also sampled to examine the mutations that 
caused the decrease in activity. Only changes to Phel 19, Phel96, Leu258 and Leu273 
gave enhanced activity.
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Table 5.4: Summary of libraries generated, randomisation used, and number of mutants screened.
*The number of possible variants and oversampling required for 95% coverage was calculated using
CASTer 2.0.
SSM
Library
Codon
randomisation
Number of 
possible variants*
Library size to XT , r
, .  J ncn/ Number ol
achieve 95% , , ,
* mutants screened
coverage*
L67P68R72 NDT-NDT-NDT 1278 5175 5800
R72 NNK 32 94 80
FI 19 NDT 12 34 40
PI 50 NDT 12 34 40
W179 NNK 32 94 80
FI 96 NDT 12 34 40
L258 NDT 12 34 40
L273 NDT 12 34 40
Table 5.5: Mutants isolated from the SSM libraries.
Table shows the mutants with improved activity and mutants with activity loss for all the libraries 
screened. The numbers in bracket indicate the relative activity of the mutant to WT MPH on EPO.
Library Improved mutant Deteriorating mutation
L67P68R72 Triple 
NDT
None Did not sample
R72 NNK None A (-36%), T (-14%), G (-11%)
FI 19 NDT Y (-188%) G (-19%), N (-18%)
PI50 NDT None Y (-27%), H (-8%), G (-65%)
W179 NNK None S (-4%), H (-10%), Y (-17%), M 
(-20%)
FI96 NDT 1 (~ 142%), L (-151%), Y (113%) R (-15%), D (-9%)
L258 NDT 1 (-124%), S (-198%), N (198%), H 
(-479%)
R (5%)
L273 NDT I (-158%), V (-155%) C (-9%), D (-6%)
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5.5.3. Implications for mutational tolerance
While analysing the mutants from the various site saturation libraries, it was 
obvious that mutations to some sites gave a higher number of detrimental mutants than 
others. The plots shown in Figure 5.9 show the activity for each mutant plotted. While 
these plots do not represent a thorough mutational tolerance study on MPH, they give 
an indication of the mutational tolerance for each site. By looking at the distribution of 
mutants retaining less than 50% WT MPH activity on EPO, the mutational tolerance of 
the chosen sites can be classified into intolerable (>70% mutants), moderately tolerable 
(40 -  70% mutants) and tolerable (<40% mutants). Mutation intolerable sites include 
Arg72, Phe 119 and Trpl79; moderately tolerable sites include Prol50, Phel96 and 
Leu273; and L258 is the only highly tolerable site. For example, most of the changes to 
Trpl79 resulted in a substantial loss of activity (Figure 5.9e) while most of the changes 
to Phe 196 resulted in some loss of activity, although very few of the changes caused a 
total loss of activity (Figure 5.9f). Analysing the mutational tolerance can draw some 
hypotheses regarding the possible roles of these sites. For example, Phel 19 and Phe 196 
exhibited different mutational tolerance and could be an indication to which of these 
phenylalanine residues is essential for MPH activity. The highly tolerant L258 residue 
could suggest that L258 is the key to enzyme promiscuity on MPH.
a) L67P68R72 Triple NOT
200
180
1 201 401 601 801 1001 1201 1401
Mutants sorted in ascending activity
Percentage of mutants with more than 100% activity = 5.5% 
Percentage of mutants with le ss  than 50% activity = 82.0%
b) R72NNK
Mutants sorted in ascending activity
Percentage of mutants with more than 100% activity = 16.5%  
Percentage of mutants with le ss  than 50% activity = 80.0%
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C) F119NDT
. i . » I I  » 1 111 ill lil» ill
Mutants sorted in ascending activity
Percentage of mutants with more than 100% activity = 25.0% 
Percentage of mutants with less than 50% activity = 72.5%
d ) P150 NDT
Mutants sorted in ascending activity
Percentage of mutants with more than 100% activity = 18.75% 
Percentage of mutants with less than 50% activity = 50.5%
e ) W 179NNK
Mutants sorted in ascending activity
Percentage of mutants with more than 100% activity = 5.0% 
Percentage of mutants with less than 50% activity = 85.0%
0  F196NDT
Mutants sorted in ascending activity
Percentage of mutants with more than 100% activity = 22.5% 
Percentage of mutants with less than 50% activity = 47.5%
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g) L258 NDT
Percentage of mutants with more than 100% activity = 47.5%  
Percentage of mutants with le ss  than 50% activity = 35.0%
L273 NDT
180 -
—  140
Mutants sorted in ascending activity
Percentage of mutants with more than 100% activity = 17.5% 
Percentage of mutants with le ss  than 50% activity = 67.5%
Figure 5.9: Mutant activity for all the libraries sorted in ascending order.
The activities for all the individual mutants were normalised to WT MPH. The red line indicates where 
the WT MPH activity was and the numbers in x-axis indicate the designated mutant number. The first red 
line indicates 100% relative activity to WT and the second red line indicated 50% relative activity to WT.
5.5.4. Explanation for loss of activity at positions 72, 150 and 179
In R72 NNK library, it was found that mutations R72T, R72A and R72G 
resulted in activity loss with 14%, 36% and 11% relative activities retained 
respectively. While the Arg72 side chain is not interacting with other residues in the 
structure, mutation to uncharged amino acid (Thr) and abolishing the side chain (Ala, 
Gly) seemed to cause the activity loss, indicating that the charged side chain is 
important in maintaining activity. However, when comparing the two MPH 
crystallographic subunits, some anomalies involving Arg72 were observed and are 
discussed in section 5.8.
In PI50 NDT library, P150Y and P150H mutations were found to result in 
activity drop with the mutants having 27% and 8% relative activities retained 
respectively. This was probably due to steric effect introduced by the relatively bigger 
sides chains. PI50 is located in between the metal coordinating His 149 and Asp 151. 
From the wild type crystal structure, Pro 150 is surrounded by Phell9, Leull8 and 
Phel96 (Figure 5.10). Mutating Pro 150 into residues with larger side chain (His, Tyr)
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would introduce clash with the aforementioned residues, causing a loss in activity. 
Phe 119 and Phel96 are key substrate binding residues and will be discussed in later 
sections.
Figure 5.10: The residues in the vicinity of Prol50.
Leul 18. Phel 19 and Phe 196 are located in the vicinity o f  Pro 150. Phel 19 and Phe 196 are thought to be 
involved in substrate binding. The surrounding residues with bulky side chains restrict Prol50 to only 
tolerate residues with small side chain. This was supported by the importance o f  Phel 19 and Phe 196 that 
will be discussed in later sections.
In W179 NNK library, four deleterious mutations sampled were W179S, 
W179H, W179Y and W179M and their respective relative activities were 4%, 10%, 
17%, and 20%. This activity deterioration could be due to the disruption of hydrogen 
bonding between the side chains of Trpl79 and Glut75. Glul75 seems to act as a 
bridging residue between the side chain of Trpl79 and the backbone of M l48 (Figure 
5.11). Replacing W179 with other amino acid residue would result in the disruption of 
the interaction that might have negative structural repercussions. Interestingly, W179H 
mutation also showed a detrimental effect to the activity. W179H seemed to be able to 
form a hydrogen bond with E l75 due to similarity of the imidazole ring in histidine 
with the pyrole ring in tryptophan (Figure 5.12a). However, histidine can exist in two 
tautomeric structures (Figure 5.12b), possibly affecting the interaction with E l75. 
Dong et al. found that W179F mutant retains WT-like kca, and Km while W179A shows 
diminished kca, and increased Km against MPS.1 While the observation for W179A is 
consistent with the hypothesis that W179 interaction is required for stability, 
observation for W179F suggests a different role for W179.
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Figure 5.11: The interaction between Trpl79, Glul75 and Metl48.
The numbers and dashed lines show the distances of the interactions between Trpl79, Glul75 and 
Met 148. Glul75 is acting as a bridging residue for Trpl79 and Met 148. possibly providing structural 
stability.
Figure 5.12: The structural comparison of histidine, tryptophan and the tautomeric forms of 
histidine.
a) The histidine imidazole ring is similar to the pyrole ring in tryptophan, allowing hydrogen bond to 
form, b) Histidine can exist in two tautomeric forms affecting where the hydrogen bond would be 
formed.
5.6. Shuffling o f single site mutants
A brief relative activity validation test was done as described in section 2.7.1 on 
the mutants that showed improvement against EPO during screening to shortlist 
mutants for purification and kinetic studies (data not shown). Ten mutants, namely 
Fl 19Y, F196L, F196I, F196Y, L258S, L258I, L258H, L258N, L273I and L273V were 
picked for purification and kinetic studies. The expression and purification were done
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as described in Chapter 3. However, the scales of expression and purification were 
smaller. The MPH variants in this chapter were expressed in 30 mL LBK supplemented 
with 0.1 mM ZnCL and purified with Column 2 (5 mL HiTrap Sp FF) of purification 
workflow III (section 3.2.2.4). ZnCf was maintained at 0.1 mM during purification to 
ensure sufficient Zn2 ions were available to the enzyme. Kinetic parameters for methyl 
parathion (MPS), methyl paraoxon (MPO), ethyl parathion (EPS), ethyl paraoxon 
(EPO), methyl chlorpyrifos oxon (MCO), ethyl chlorpyrifos oxon (ECO) were obtained 
for all the MPH variants and are discussed in section 5.7. The substrates used cover the 
variable substituents of the substrate -  dimethyl vs diethyl, P=S vs P=0 moieties and p- 
nitrophenolate vs 3,5,6-trichloro-2-pyridinol leaving groups.
All ten MPH mutants and wild type variants were used as the parents to shuffle 
the single site mutations. Including the wild type variant in the shuffling procedure 
would allow us to use it as a control for the screening process -  the confidence of the 
screen is higher if none of the selected variants returns as wild type even though it is 
included in the parent mix. The shuffling was done using staggered extension process 
(StEP) as described in section 2.5.2.15 Error-prone StEP was not used at this stage to 
avoid the introduction of mutations remote from the active site and interfere with 
mechanistic assessment of MPH -  we would like to confine any activity changes to 
only active site residue mutations. The shuffled mutants were screened similarly as the 
single site saturation library -  for further enhancement in EPO activity. Further activity 
enhancement was deemed possible via shuffling as all the selected single site mutants 
showed enhanced activity against EPO. The ten single site mutants represent the 
possible amino acid variations at four different sites for activity improvement against 
EPO. Two rounds of StEP shuffling were carried out, with multiple site variants from 
the first shuffling being used as the parent for the second shuffling and the results for 
these screens are summarised in Table 5.6. After two rounds of StEP, only double and 
triple-site mutants were found. This could be due to the distance between some of the 
mutations. For example, L258 and L273 are only separated by 45 nucleotides. The 
recombination efficiency decreases as the distance between mutations decreases.^ The 
apparent lack of shuffling could also be due to silent crossovers in DNA shuffling. 
Shuffling that occured in the region without mutation would result in silent crossover.
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Table 5.6: Summary of (a) StEP libraries generated and number of mutants screened and (b) 
improved mutants selected from the screen and the mutations found in them.
a) _____________________________________
Number of mutants screened 
Round 1 StEP 400
Round 2 StEP 400
b)
Round 1 StEP
Round 2 StEP
Selected mutants Mutation
R1B2 F119Y, L258N
R1D4 F l961, L273V
R1A6 F119Y, L258S
R1B6 F1961, L258N
R2B2 F l961, L258H
R2C2 F l961, L273I
R2D2 F119Y, L258H
R2F2 F196Y, F258H
R2G4 F196F, F258H
R2A2 F119Y. F196FF273V
R2E3 F119Y, F196FL258N
R2F3 F119Y, F196I, F258H
R2C4 F119Y, F196Y, F258H
R2D4 Ft 19Y, F1961, L2731
5.7. Kinetic characterisation of MPH variants
As mentioned in the previous section, all improved MPH single site mutants 
from the site saturation mutagenesis libraries and the wild type variant were 
characterised against six organophosphate substrates and the kinetic parameters can be 
found in Figures 5.13a (kcal), 5.13b (Km) and 5.13c (kcJ K m). In general, all of the single 
site mutants selected from the EPO screening showed modest enhancement in kcJ K m.
The substrate concentrations used for the kinetic measurements for all variants 
were based on concentrations used for wild type MPH. As a result, higher curve fitting 
errors were observed in some mutants with greatly increased Km on some substrates. 
However, the changes in some Km values were so large that the overall trend in 
substrate specificity of a given variant can still be observed even after the errors were
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taken into consideration. For all the kinetic data presented, the errors obtained for the 
kinetic parameters represent the fitting error of the data to Michaelis-Menten equation.
The substrate profiles for the selected mutants (listed in Table 5.6b) from the 
shuffling libraries were investigated using crude lysate for activity validation (data not 
shown). The assay procedure was similar to the library screen described in section 2.5.6 
except that the growth scale was larger. R1A6, R1B6, R2B2, R2C2, R2D2, R2A2, 
R2F3 and R2D4 were shortlisted for purification and kinetic studies. These mutants 
were picked for further study based on improvement seen in the crude lysate assay. 
Mutants that were not shortlisted either had only moderate improvements, or were 
represented by other variants that exhibited similar profile. The purification and kinetic 
characterisation were performed similarly to the single site mutants and were described 
in sections 5.6 and 2.7.2 respectively. Kinetic parameters for the selected multiple-site 
mutants on six OP substrates are also found in Figures 5.13a (kcai), 5.13b (Km) and 
5.13c (kca/K m). As hypothesised, all the multiple site variants showed further 
improvement towards EPO in terms of kcai and catalytic efficiencies. Unexpectedly, 
improvement was also seen against ECO for all variants since not all single site mutants 
show improvement towards ECO. Most mutants showed lower kca, and catalytic 
efficiencies towards MPS and EPS, probably due to a shift of specificity away from 
phosphorothioate. The kinetics for L258S, L258H, R2B2, R2C2, R2F3 and R2D4 
towards EPS were difficult to determine due to the low kca, and Km of these mutants. 
Tables detailing the kinetic parameters for all MPH variants characterised are given in 
Appendix G. Detailed discussion of the substrate specificity and possible active site 
change in MPH variants are given in sections 5.7.1 -  5.73.
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Variants Mutations
R1A6 F119Y, L258S
R1B6 F196I, L258N
R2B2 F 1961, L258H
R2C2 F 1961, L273I
R2D2 F119Y, L258H
R2A2 F119Y, F l961, L273V
R2F3 F119Y.F196Y, L258H
R2D4 F119Y, F196I, L273I
Figure 5.13: Kinetic parameters for the hydrolysis of various OPs by MPH variants isolated in this 
study.
The graphs showing a) kca, (s'1), b) Km (pM ) and c) kca/Km (s 'm M 1) o f MPH variants. R1A6, R1B6. 
R2B2. R2C2, R2D2, R2A2, R2F3 and R2D4 are multiple-site mutants obtained from DNA shuffling and 
the mutations are specified in the table above. In graphs (a) and (c), the graphs are separated into top and 
bottom panels to accommodate the large value difference between MPH variants for the respective 
kinetic parameter.
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5.7.1. Wild type MPH
By comparing the kca, values of different substrates, wild type (WT) MPH is 
most active on MPS, followed by MCO, MPO, and EPS. The kcat values for EPO and 
ECO were similar. This shows that the WT variant was most active towards dimethyl- 
substituted monothiophosphates (MPS), with the lowest activity coming from diethyl- 
substituted oxon substrates (EPO, ECO). It is also worth noting that WT MPH was 
more active towards dimethyl-substituted oxons (MPO) than diethyl-substituted 
thiophosphate (EPS). This shows the priority dimethyl-diethyl factor has over oxon- 
thion factor. Interestingly, WT MPH showed a higher activity towards 3,5,6-trichloro-2- 
pyridinol (TCPy) leaving group oxons (MCO, ECO) than pNP leaving group oxons 
(MPO, EPO) indicating the influence the leaving group has on the kca, value. Due to the 
low substrate solubility of methyl chlorpyrifos (MCS) and ethyl chlorpyrifos (ECS), the 
kinetic parameters for these two substrates were not determined. Based on the trend in 
pNP based substrates, it could be postulated that the kcut for MCS and ECS are higher 
than the oxon counterparts (MCO and ECO), and higher than pNP counterparts (MPS 
and EPS). This would require further confirmation in future.
In terms of Km, WT MPH had higher Km for oxon substrates when compared to 
thiophosphate substrates. The Km values for diethyl substituted substrates (EPS, EPO, 
ECO) were lower compared to the dimethyl substituted substrates (MPS, MPO, MCO). 
The Km values for TCPy oxons (MCO and ECO) were lower when compared to the 
pNP counterparts (MPO and ECO). The kca/K m ratio was approaching diffusion rate for 
MPS at 1.01 x 106 s^M'1, consistent with the kinetics reported by Dong et al. at 0.99 x 
106 s  'M 1.3 A summary of WT MPH kinetics towards various substrates can be found 
in Table 5.7.
Table 5.7: Kinetic parameters for MPH WT on various OPs.___________________________________
. c . , . , / -K Relative „  . . . .  Relative kca/ K m Relative
Vanam Substrate t „ , ( s )  ^  Km  (MM) ^  (s-i mM-.) kn JK _
MPS 27.5 ± 1.800 1.00 27.3 ± 6.0 1.00 1007.3 1.00
MPO 4.5 ± 0.300 1.00 72.2 ± 10.2 1.00 62.3 1.00
EPS 1.1 ± 0.004 1.00 10.8 ± 1.4 1.00 101.9 1.00
EPO 0.3 ± 0.010 1.00 49.0 ± 5.5 1.00 6.1 1.00
MCO 6.9 ± 0.100 1.00 21.4 ± 1.6 1.00 322.4 1.00
ECO 0.3 ± 0.010 1.00 15.6 ± 2.5 1.00 19.2 1.00
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5.7.2. Single site mutants
In order to understand what the mutations at each of the sites do and how they 
change the substrate binding pocket, SWISS-MODEL homology modelling server was 
used.16 18 For reasons discussed in section 5.8, subunit B of WT MPH structure (PDB 
ID: 1P9E-B) was used as the template for mutation modelling.
5.7.2.1. FI 19 variants
Residue FI 19 seemed to be essential for activity. From the activity distribution 
plot for FI 19 site saturation library, as shown in Figure 5.9c, only the wild type residue 
FI 19 and Fl 19Y, retained high EPO hydrolysing activity. Approximately two thirds of 
the screened mutants had less than 50% EPO activity compared to wild type. The only 
improved variant against EPO, Fl 19Y, suggests that the Ji-bonds on the aromatic rings 
are important in substrate binding, particularly the potential to form n-stacking with the 
OP substrates. From the modelled F119Y structure, the mutation altered the shape of 
the active site opening (Figure 5.14) and introduced a hydroxyl group that can form 
hydrogen bond with the backbone of A66, possibly stabilising the residue at position 
119 (Figure 5.15).
The kcat values of Fl 19Y for MPO, EPS and EPO increased, while remaining 
similar to WT for MPS and ECO. The only substrate that observed a drop in kca, was 
MCO. There was an overall increase in Km for all substrates examined with the 
exception of MPS and EPS. Km values for MPS and EPS remained similar to WT. EPS 
and EPO were the only two substrates that observed an increase in kca,/Km (2.39 fold 
and 1.56 fold, respectively).
Dong et al. reported that Fl 19W shows a decrease in kcat and Km while Fl 19A 
shows a very small increase in Kmand a decrease in kcal against MPS.3 The small Km 
increase reported for Fl 19A (37.4 pM to 41.1 pM) might be within error since the error 
values were not reported. They proposed that FI 19 is part of an aromatic cluster that is 
involved in enzyme-substrate binding, analogous to those in OPDA. While the Fl 19W 
data agreed with the proposal, Fl 19A did not. In this work, Fl 19G and Fl 19N were 
sampled from the pool of deleterious mutations, consistent with the proposal that the ji - 
bond on the aromatic rings in phenylalanine and tyrosine are responsible for substrate
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interaction. Fl 19G mutation abolishes the benzene ring while Fl 19N mutation changes 
a hydrophobic residue to a polar residue, affecting the interaction. Since the NDT 
randomisation used for site saturation mutagenesis in this library does not code for 
alanine, Fl 19A was not isolated in this work. A summary of Fl 19Y kinetics towards 
various substrates can be found in Table 5.8.
a) b)
Figure 5.14: The active site pocket of (a) WT MPH and (b) Fl 19Y mutant.
The residue at position 119 is coloured red and the grey surfaces represent the solvent excluded surfaces 
of WT MPH in (a) and Fi 19Y in (b). The mutation was modelled with SWISS-MODEL using subunit B 
of WT MPH as template. The grey sphere represents Zn metal and the wheat sphere represents the Cd 
metal.
Figure 5.15: Possible hydrogen bond interaction between F119Y and A66.
Table 5.8: Kinetic parameters for Fl 19Y on various OPs.
The relative kca„ Km and kca/K m were obtained by dividing the values obtained for Fl 19Y with that of WT 
MPH for each of the substrate. The relative kca„ Km and kca/K m are colour-coded for easy reference. 
Green: increase in value, pink: decrease in value._______________________________________________
Variant Substrate K a ,  (s'1)
Relative
kca t
K m (pM)
Relative
K m
k c a / K m
(s^mM1)
Relative
K J K m
F119Y MPS 28.8 ± 0.300 1.05 29.8 ± 1.0 1.09 966.4 0.96
MPO 8.6 ± 1.500 1.91 241.9 ± 65.3 3.35 35.6 0.57
EPS 3.6 ± 0.200 3.27 14.8 ± 2.2 1.37 243.2 2.39
EPO 0.8 ± 0.100 2.67 84.3 ± 21.1 1.72 9.5 1.56
MCO 3.3 ± 0.040
.Ö
51.5 ± 1.7 2.41 64.1 0.20
ECO 0.3 ± 0.002 1.00 23.1 ± 0.9 1.48 13.0 0.68
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5.7.2.2. F196 variants
Three variants that were more active against EPO were selected for at this site, 
namely F196L, FI961 and F196Y. As with the Fl 19Y mutant, F196Y gave an increase 
in kcal values for all substrates tested. F196Y also retained the aromatic ring, as seen in 
Fl 19Y. The increase in kca, was accompanied by an increase in Km for all substrates, 
resulting in EPS and EPO being the only substrates that observed an overall increase in 
kca/K m (1.10 fold and 1.32 fold, respectively).
F196L and F l961 are two interesting mutations; they replace an aromatic side 
chain with smaller hydrophobic side chains. The difference between leucine and 
isoleucine is a rearrangement of the methyl groups in the side chain to accommodate 
bulkier OPs. F196L gave a decrease in kcat for all substrates except EPO, the screening 
substrate, while F l961 gave a decrease in kca, for dimethyl-substituted OPs (MPS, MPO, 
MCO). The kcat values for F l961 against diethyl-substituted substrates EPS, EPO and 
ECO increase 1.73, 4 and 2 folds respectively. The Km values for both F196L and FI961 
increased for all substrates, except F l961 for MPS where the Km decreases. F196L sees 
an overall decrease in kca,/Km except EPO, where the kca/K m increased 1.19 fold. FI961 
gave a decrease in kcJ K m against most substrates except EPS and EPO where the in 
kca/Km increased 1.45 and 1.80 folds, respectively. It is worth noting that despite all the 
FI96 variants showing increase in kcat and kca,/Km against EPO, they were still lower 
than that of MPS, the fastest substrate examined. A summary of FI96 variants kinetics 
towards various substrates can be found in Table 5.9 and a comparison of active site 
changes can be found in Figure 5.16.
Dong et al. reported the kinetics of F196W and F196A against MPS to 
demonstrate that FI96 is part of an aromatic cluster responsible for substrate binding.’ 
F196W gave an increase in kcai and Km against MPS, leading to a small increase in 
kca/Km- Meanwhile, F196A gave a large increase in Km and a large decrease in kcat 
against MPS, consistent with the observation made here where an aromatic ring is 
required to retain the high hydrolysing efficiency of MPH. In this work, FI961 and 
F196L retained only 0.05 and 0.06 folds £ca, compared to WT MPH in hydrolysing 
MPS, while F196Y showed 1.25 fold kcat improvement for the same substrate.
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Jeong et al. found F196A increases the kca, against pNPDPP by 78 fold while 
the Km increases 2.7 fold leading to an overall increase in kca/K m of 29.2 fold (2.16 x 
104 s-'lVT1) in evolving MPH against /7-nitrophenyl diphenylphosphate (pNPDPP) 
(Figure 5.17). The authors attributed the improvement in catalytic efficiency to the 
reduction in side chain size from phenylalanine to alanine -  enlargement of the 
substrate-binding pocket that eventually facilitated the substrate access.19 Based on this 
information, we deduce that the lack of activity against bpNPP observed in this work is 
probably due to the charge on the phosphate core rather than the bulk of bpNPP, since 
bpNPP is smaller than pNPDPP (Figure 5.17). This is supported by the presence of 
predominantly hydrophobic residues that line the substrate-binding pocket. We can also 
deduce that kca, improvements seen for some of the substrates in F196L and F196L were 
partly due to the enlargement of the substrate-binding pocket to accommodate larger 
substrates such as EPO.
Another possible role FI96 might have is the interaction with HI49, a metal 
coordinating ligand. The imidazole ring of histidine residues and benzene ring of 
phenylalanine residues are capable of forming Ji-interaction due to its delocalized 
electrons. FI96 contains a benzene ring that is perpendicular to HI49 at approximately 
3.6 A away (Figure 5.18). The decrease in catalytic efficiencies of F196I and F196L 
mutants on most substrates examined might be an indication of the importance of the 
aromatic ring.
Mutations that were found to be detrimental are F196R and F196D, consistent 
with the premise that hydrophobic residues are required in the substrate-binding pocket 
and the aromatic ring is critical for kcal.
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Figure 5.16: The active site pocket of (a) WT MPH, (b) F196Y, (c) F196L and (d) F196I variants.
The residue at position 196 is coloured red and the grey surfaces represent the solvent excluded surfaces 
of WT MPH in (a), F196Y in (b), F196L in (c) and F I961 in (d). The mutation was modelled with 
SWISS-MODEL using subunit B of WT MPH as template. The grey sphere represents Zn metal and the 
wheat sphere represents the Cd metal.
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bis(/?-nitrophcnyl) phosphate p-nitrophenyl diphenylphosphate
Figure 5.17: Chemical structures of bis-/?-nitrophenyl phosphate (bpNPP) and p-nitrophenyl 
diphenylphosphate (pNPDPP).
172
CHAPTER 5
Figure 5.18: The possible interaction between F196 and H149.
The yellow dash line and number indicate the measured distance of the two residues, the wheat sphere 
illustrates Cd2+, grey sphere illustrates Zn2+ and the red sphere illustrates the bridging water.
Table 5.9: Kinetic parameters for F196 variants on various OPs
The relative kcal, Km and kca/K m were obtained by dividing the values obtained for F I96 variants with that 
o f WT MPH for each of the substrate. The relative kcah Km and kca/K m are colour-coded for easy 
reference. Green: increase in value, pink: decrease in value.______________________________ __________
Variant Substrate kca, (s'1)
Relative
u i
(pM)
Relative
Km
KJKm (s'1 
mM'1)
Relative
k^/Km
F196L MPS 1.5 ± 0.060 0.05 45.6 ± 4.5 1.67 32.9 0.03
MPO 1.1 ± 0.100 0.24 297.9 ± 53.1 4.13 3.7 0.06
EPS 0.6 ± 0.020 0.55 21.2 ± 2.7 1.96 28.3 0.28
EPO 0.7 ± 0.030 2.33 96.3 ± 9.5 1.97 7.3 1.19
MCO 0.5 ± 0.010 0.07 48.3 ± 4.0 2.26 10.4 0.03
ECO 0.2 ± 0.010 0.67 37.8 ± 4.4 2.42 5.3 0.28
Fl 961
F196Y
MPS 1.7 ± 0050 0 06 129 ± 1.7 0.47 131.8 0.13
MPO 1.3 ± 0.100 0.29 286.8 ± 45.6 3.97 4.5 0.07
EPS 1.9 ± 0.100 1.73 12.9 ± 1.8 1.19 147.3 1.45
EPO 1.2 ± 0.100 4.00 109.1 ± 9.8 2.23 11.0 1.80
MCO 1.5 ± 0.040 0.22 57.9 ± 4.1 2.71 25.9 0.08
ECO 0.6 ± 0.004 2.00 33.7 ± 0.9 2.16 17.8 0.93
MPS 34.5 ± 0.700 1.25 37.8 ± 2.2 1.38 912.7 0.91
MPO 6.6 ± 0.600 1.47 208.8 ± 30.9 2.89 31.6 0.51
EPS 1.8 ± 0.040 1.64 16.1 ± 0.8 1.49 111.8 1.10
EPO 0.7 ± 0.070 2.33 86.7 ± 18.8 1.77 8.1 1.32
MCO 9.5 ± 0.400 1.38 72.5 ± 7.8 3.39 131.0 0.41
ECO 0.5 ± 0.010 1.67 31.7 ± 2.6 2.03 15.8 0.82
I
5.7.2.3. L258 variants
L258 is the most interesting site because four different mutants were found to 
have increased activity against EPO and about half of the library exhibited at least WT 
activity against EPO (Figure 5.9g). L258 forms part of the base of the active site pocket 
(Figure 5.19b). The beneficial mutations can be grouped into hydrophilic (L258H, 
L258N, L258S) and hydrophobic mutations (L2581). From the WT crystal structure, 
there are a few potential residues in the vicinity, with which L258 mutants could 
interact with, namely D255 and T271 (Figure 5.19a). Interactions with T271 might
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further affect residues L273 and D274 since they are close to T271. D255 is the metal 
bridging ligand, D274 is a secondary shell metal coordination ligand (interacting with 
H234, a primary shell metal ligand) and L273 is an active site lining residue. All these 
might contribute to the flexibility of this site.
Thr271
Figure 5.19: (a) L258 and nearby residues and (b) location of L258 in the active site pocket.
(a) There are a number of nearby residues that can interact with L258 variants, particularly Thr271 and 
Asp255. Thr271 seems to interact with Leu273. another candidate for substrate binding, and Asp274. 
Asp255 is the metal-bridging residue. The dashed lines represent the distance and the numbers represent 
the distance in Angstrom, (b) Leu258 is located at the bottom of the active site pocket and is coloured 
red.
a)
Leu273
L2581 is a conservative mutation that fine-tunes the substrate-binding pocket for 
oxon substrates. The kca, for all oxon substrates increased while the Km for most 
substrates decreased, except MCO where the Km increased two fold. This leads to an 
overall increase in kca/K m for all substrates, except MCO where the efficiency 
decreased by half. Figure 5.20 illustrates the difference in solvent excluded surface for 
L258 and 1258 modelled using SWISS-MODEL. The L258I mutation changes the 
position of its side chain, altering the shape of the substrate pocket.
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Figure 5.20: The changes in surface for position L258I possibly altering the substrate-binding 
pocket.
The mesh represents the surface for L258 while the grey surface represents the surface for L258I. The 
L258I mutant (orange) was modelled with SWISS-MODEL using WT MPH as template.
The mutations that introduce hydrophilic groups are the most interesting 
mutations of all the changes in libraries. The hydrophilic mutations (L258N, L258S and 
L258H) introduce side chain with functional groups that are capable of interacting with 
surrounding residues and possibly the substrate. The kca, trends for L258S and L258N 
were similar with both variants displaying an overall increase in kca, for oxon OPs and 
decrease in kca, for thiophosphate OPs. The kinetics of L258S against EPS was not 
determined due to very low activity against the substrate. Both variants showed large 
increase in kca, for TCPy leaving group substrates (MCO and ECO), with L258S 
showing 11.03 and 32.33 folds increase respectively while L258N showed an increase 
of 19.29 and 91.33 folds increase respectively. It is worth noting that the kcat values of 
L258S and L258N against MCO were 76.1 s'1 and 133.1 s'1 respectively, approximately 
2.7 and 4.8 folds better than the kcal value of WT MPH against MPS (27.5 s'1).
The L258S mutation gave an overall Km increase, with the exception of MPS 
and ECO, where the Km values were similar to WT. L258N saw an overall increase in 
Km values for all the substrates examined. In terms of overall catalytic efficiency, 
L258S gave an increase with EPO, MCO and ECO while a decrease for the rest. L258N 
gave an increase in catalytic efficiency against MPO, EPO, MCO and ECO while a 
decrease against MPS and EPS. The kca,/Km of L258S against MCO and ECO were 2.42 
x 106 s 'M '1 and 0.96 x 106 s 'M '1 respectively while kca,/Km of L258N against MCO and 
ECO were 3.74 x 106 s 'M '1 and 1.13 x 106 s 'M '1 respectively. This represents a shift in
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substrate specificity from pNP leaving group substrates towards TCPy leaving group 
substrates.
While the cause for these improvements is not well understood, L258S 
introduces an alcohol group that might interact with the substrate and has a smaller side 
chain than leucine (Figure 5.21a). From the modelled L258S structure, the active site 
pocket has a deeper groove that might accommodate larger substrate. It is also observed 
that the alcohol group can form intramolecular hydrogen bond with its backbone, which 
in turn interacts with Gln263. (Figure 5.21b). L258N side chain is similar in size to 
L258 and again introduces an amide group that might interact with the substrate 
(Figure 5.22).
Residue 258
Figure 5.21: (a) The changes in surface for L258S and (b) The intramolecular hydrogen bond 
introduced by L258S.
a) The mesh represents the surface for L258 while the grey surface represents the surface for L258S. The 
L258S mutation is coloured orange and was modelled with SWISS-MODEL using WT MPH as template. 
L258S represents a reduction in surface while introducing an alcohol group, b) The possible 
intramolecular hydrogen bond due to the introduction of alcohol group. The dashed lines represent the 
interaction and the numbers represent the distance in Angstrom.
I o w e
Figure 5.22: The changes in surface for L258N.
The mesh represents the surface for L258 while the grey surface represents the surface for L258N. The 
mutant is coloured orange and was modelled with SWISS-MODEL using WT MPH as template.
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The kcal improvements for L258H were modest compared to L258N. The kcat 
values for EPO, MCO and ECO increased 2.67, 3.35 and 5.33 folds, respectively, while 
the kcat values for MPS and MPO decreased. Kinetic parameters against EPS were not 
determined due to low activity against EPS. The Km for most substrates decreased 
except MCO. With regards to catalytic efficiency, L258H gave the biggest increase out 
of all the single site mutants characterised for EPO, the screening substrate, by 7.05 fold 
improvement. L258H retained only 0.1 fold of MPS catalytic efficiency. The L258H 
mutation introduces an imidazole ring that can possibly interact with the backbone of 
D255, the metal bridging residue (Figure 5.23b). The imidazole ring is also within 
distance (2.9 Ä) to form Jt-stacking with the imidazole ring of H234, another metal 
coordinating ligand.
The detrimental mutation found in L258 NDT library was L258R. The bulk and 
charge of the side chain seem to be the cause of the loss in activity. A summary L258 
variants kinetics towards various substrates can be found in Table 5.10.
a)
4 ^
Figure 5.23: (a) The changes in surface for L258H and (b) possible L258H interaction with D255 
and H234.
a) The mesh represents the surface for L258 while the grey surface represents the surface for L258H. The 
L258H mutations is coloured orange and was modelled with SWISS-MODEL using WT MPH as 
template, b) The L258H mutation introduced an imidazole ring that is capable of interacting with the 
backbone of D255, the metal bridging ligand. There is also a possibility L258H jc-stacks with H234, 
another metal coordinating ligand. The dashed line and number represents the distance in Angstrom.
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Table 5.10: Kinetic parameters for L258 variants on various OPs.
The relative kcah Km and kca/K m were obtained by dividing the values obtained for L258 variants with that 
of WT MPH for each of the substrate. The relative kca„ Km and kca/K m are colour-coded for easy 
reference. Green: increase in value, pink: decrease in value. ND: not determined
Variant Substrate kca, (S'1)
Relative
Ka<
Km (pM) Relative
Km (s_1 mM'1)
Relative
kca/^ m
L258S MPS 1.2 ± 0.050 0.04 25.8 ± 3.7 0.95 46.5 0.05
MPO 6.4 ± 1.000 1.42 187.7 ± 47.3 2.60 34.1 0.55
EPS
EPO
MCO
ECO
ND
0.5
76.1
9.7
0.003
2.700
0.200
9.0
4.0 
1.5
ND
1.27
1.47
0.65
ND
8.0
2415.9
960.4
L2581 MPS 
MPO 
EPS 
EPO 
MCO 
ECO
14.1 ± 0.500 0.51 5.2 ± 0.9 0.19 2711.5 2.69
8.7 ± 0.200 1.93 57.9 ± 2.8 0.80 150.3 2.41
0.7 ± 0.010 0.64 4.0 ± 0.5 0.37 175.0 1.72
0.5 ± 0.010 1.67 18.6 ± 1.9 0.38 26.9 4.41
7.0 ± 0.200 1.01 42.9 ± 4.2 2.00 163.2 0.51
0.4 ± 0.004 1.33 12.7 ± 0.7 0.81 31.5 1.64
L258H
L258N
MPS
MPO
EPS
EPO
MCO
ECO
MPS
MPO
EPS
EPO
MCO
ECO
1.7 
3.0 
ND 
0.8
23.1 
1.6
3.5
15.2 
0.1
1.7 
133.1 
27.4
± 0.070
± 0.200
0.040
0.200
0.010
0.300
0.900
0.010
0.040
2.400
0.600
16.9
27.4 
ND 
18.6
64.5 
11.8
2.7
5.9
3.9 
1.6 
0.5
100.6
109.5 
ND 
43.0 
358.1
135.6
5.7.2.4. L273 variants
L273I and L273V were the improved variants against EPO. L273I and L273V 
mutations are conservative since lie and Val are hydrophobic and probably represent 
the rearrangement of side chains to allow better access to substrates. The opening of the 
substrate pocket seems to be enlarged that might increase substrate access (Figures 
5.24b and c).
Both L273I and L273V showed kca, improvements towards oxon OPs and 
diminished kca, towards thiophosphate OPs. L273I showed Km decrease towards MPS, 
EPS and EPO while L273V showed Km decrease towards MPS, EPS, EPO and ECO. 
The overall catalytic efficiency for both variants increased for oxon OPs and reduced 
for thiolphosphate OPs. L273V seems to offer better improvement than L273I. A 
summary L273 variants kinetics towards various substrates can be found in Table 5.11.
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Figure 5.24: The active site pocket of (a) WT MPH, (b) L273I and (c) L273V mutants.
The residues at position 273 are coloured red and the grey surfaces represent the solvent excluded surface 
of WT MPH in (a), L273I in (b) and L273V in (c). The opening of the active site pocket seems to be the 
biggest with L273V mutation due to the smaller side chain. The mutations were modelled with SWISS- 
MODEL using WT MPH as template.
Table 5.11: Kinetic parameters for L273 variants on various OPs.
The relative kca„ Km and kcJ K m were obtained by dividing the values obtained for L273 variants with that 
of WT MPH for each of the substrate. The relative kcal, Km and kca/K m are colour-coded for easy 
reference. Green: increase in value, pink: decrease in value.______________________________________
Variant Substrate h a t  (s'1)
Relative
k-i a t
Km(pM) Relative
A»
k c a / K m  
(s'1 mM'1)
Relative
KJKm
L2731 MPS 3.0 ± 0.100 0.11 12.8 ± 1.8 0.47 234.4 0.23
MPO 16.4 ± 0.700 3.64 116.5 ± 10.5 1.61 140.8 2.26
EPS 0.2 ± 0.003 0.18 5.5 ± 0.4 0.51 36.4 0.36 |
EPO 0.7 ± 0.030 2.33 46.7 ± 6.1 0.95 15.0 2.46
MCO 13.6 ± 0.200 1.97 31.7 ± 2.0 1.48 429.0 1.33
ECO 0.5 ± 0.020 1.67 18.5 ± 3.3 1.19 27.0 1.41
L273V MPS 7.7 ±
MPO 18.7 ±
EPS 0.3 ±
EPO 0.7 ±
MCO 17.4 ±
ECO 0.3 ±
0.050 0.28 8.9 ±
3.000 4.16 108.1 ±
0.030 0.27 10.3 ±
0.010 2.33 27.3 ±
0.500 2.52 23.4 ±
0.006 1.00 8.5 ±
0.3 0.33 865.2 0.86
35.3 1.50 173.0 2.78
4.0 0.95 29.1 0.29
2.5 0.56 25.6 4.20
2.9 1.09 743.6 2.31
1.3 0.54 35.3 1.84
The detrimental mutations found for this site were L273C and L273D. L273C is 
a polar mutation that might repel the hydrophobic substrate. L273D has a side chain 
that is similar in size the L273. The detrimental effect might be due to the negative 
charge on Asp. Jeong et al. reported that L273A mutant has lower Km towards pNPDPP, 
a much larger substrate, and attributed the improvement to better substrate access due to 
reduction in side chain bulk.19
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Since L273 and L258 mutations improved catalytic efficiency towards oxon 
substrates and the two residues are located near each other, it is possible that this part of 
the substrate-binding pocket determines the specificity for oxon/thiolphosphate 
substrate (Figure 5.25). It is also worth noting that L2581 did not change the specificity 
towards oxon substrates. The shift towards oxon OPs only happened when L258 is 
mutated to a polar residue.
Figure 5.25: The locations of L258 and L273 in the substrate-binding pocket.
5.7.3. Multiple site mutants 
5.7.3.1. R1A6
R1A6 contains F119Y and L258S mutations. R1A6 showed kca, improvements 
for all substrates examined except MPS. The kcat towards MPO, EPS, EPO, MCO and 
ECO improved 6.82, 1.45, 14.67, 36.1 and 304.33 folds respectively. The Km for MPS, 
EPO, MCO and ECO remained similar to WT MPH while Km for MPO and EPS 
increased by 3.20 fold and 3.19 fold, respectively. With the exception of MPS and EPS, 
the catalytic efficiencies for MPO, EPO, MCO and ECO improved. The kca,/Km for 
MCO and ECO were 1.47 x 107 s 'M '1 and 5.13 x 106 s 'M '1 respectively, approaching 
the diffusion limit. Those figures represent the catalytic efficiency improvement of 
45.72 fold and 267.15 fold, respectively. The kca,/Km for MCO and ECO were also 15 
and 5 folds larger than that of WT MPH for MPS, making R1A6 more efficient at 
turning over TCPy leaving group substrates. From the single-site variant kinetic data, it 
can postulated that a variant having Fl 19Y and L258N mutations would give an even 
better improvement towards TCPy leaving group substrates. Figure 5.26 shows the 
changes in surface with F119Y and L258S modelled onto WT MPH. The changes
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introduced by F119Y and L258S altered the shape of the active site pocket to a 
narrower and deeper pocket. Table 5.12 summarises the kinetic parameters for RI A6.
a) b)
Figure 5.26: The active site pocket of (a) WT MPH and (b) R1A6.
The shape of the active site is altered by F119Y and L258S in R1A6 as compared to WT MPH. The 
residues at position 119 and 258 are coloured red and the grey surfaces represent the solvent excluded 
surfaces of WT MPH in (a) and R1A6 in (b) respectively. The grey sphere represents Zn metal and the 
wheat sphere represents the Cd metal. The mutations were modelled with SWISS-MODEL using subunit 
B of WT MPH as template.
Table 5.12: Kinetic parameters for R1A6 on various OPs.
The relative kca„ Km and kca/K m were obtained by dividing the values obtained for R1A6 with that of WT 
MPH for each of the substrate. The relative kcah Km and kcJ K m were colour-coded for easy reference. 
Green: increase in value, pink: decrease in value
Variant Substrate k c a ,  (S'')
Relative
k r a i
(pM) Relative
K m
k c a / k  m  
(s"1 mM'1)
Relative
k c a / K m
R1A6 MPS 6.3 ± 0.20 0.23 22.5 ± 2.2 0.82 280.0 0.28
MPO 30.7 ± 5.50 6.82 231.4 ± 65.2 3.20 132 7 2 13
EPS 1.6 ± 0.10 1.45 34.5 ± 4.5 3.19 46.4 0.46
EPO 4.4 ± 0.10 14.67 46.6 ± 2.6 0.95 94.4 15.48
MCO 249.1 ± 10.30 36.10 16.9 ± 4.1 0.79 14739.6 45.72
ECO 91.3 ± 5.20 304.33 17.8 ± 5.1 1.14 5129.2 267.15
5.73.2. R1B6 and R2B2
This group of variants contains mutations at position FI 96 and L258.
R1B6 contains F1961 and L258N mutations. R1B6 showed decreased kca, 
against MPS, MPO, and EPS while kcat values against EPO, MCO and ECO have 
increased by 24.67, 20.90 and 365.67 folds, respectively. The Km values for all substrate 
have increased except MPS. This led to a decrease in kcat/Km for MPS, MPO and EPS. 
The kcat/Km values for EPO, MPO and ECO have increased 6, 3.31 and 114.5 folds, 
respectively. As seen in single-variants, L258H shifts the specificity towards EPO while 
L258N shifts the specificity towards MCO and ECO. In this variant, the increase in Km
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for MCO due to F l961 decreasing the efficiency for MCO. F l961 and L258N seem to 
work synergistically to improve the kcat for EPO and ECO.
R2B2 contains the F l961 and L258H mutations. The kcat values against oxon 
OPs increased while kca, against MPS decreased. Kinetics towards EPS was not 
determined due to low activity. The kca, against MPO, EPO, MCO, and ECO increased 
4.31, 48.33, 8.72 and 101 folds, respectively. The Km for MPS and ECO decreased, 
while the Km for MPO, EPO and MCO increased. The catalytic efficiencies for EPO, 
MCO and ECO increased 34.75, 2.65 and 125.25 folds, respectively. It is worth noting 
that while R1B6 and R2B2 shared similar catalytic efficiency against ECO, R1B6 had 
higher kcat and Km while R2B2 had lower kca, and Km. The L258H mutation in R2B2 
seems to increase the catalytic efficiency for EPO more than L258N in R1B6. Figure 
5.27 shows the changes in the substrate-binding pocket with regards to mutations in 
R1B6 and R2B2. Mutation at F l961 seems to be largely responsible for enlarging the 
pocket opening in both MPH variants. Table 5.13 summarises the kinetic parameters 
for RI B6 and R2B2 on various OPs.
a)
Figure 5.27: The active site pocket of (a) WT MPH, (b) R1B6 and (c) R2B2.
The shape of the active site is altered by Fl 961 and L258N mutations in R1B6 and Fl 961 and F258H in 
R2B2 as compared to WT MPH. The residues at positions 196 and 258 are coloured red and the grey 
surfaces represent the solvent excluded surfaces of WT MPH in (a), R1B6 in (b) and R2B2 in (c) 
respectively. The grey sphere represents Zn metal and the wheat sphere represents the Cd metal. The 
mutations were modelled with SWISS-MODEF using subunit B of WT MPH as template.
182
CHAPTER 5
Table 5.13: Kinetic parameters for R1B6 and R2B2 on various OPs.
The relative kca„ Km and kca/K m were obtained by dividing the values obtained for R1B6 and R2B2 with 
that of WT MPH for each of the substrate. The relative kcah Km and kcJ K m are colour-coded for easy 
reference. Green: increase in value, pink: decrease in value_______________________________________
Variant Substrate kca, (s'1)
Relative
kcat
Km (gM) Relative
Km
kca/Km (s'1 
mM'1)
Relative
kca/^ rn
R1B6 MPS 0.3 ± 0.01 0.01 19.1 ± 1.5 0.70 15.7 0.02
MPO 2.6 ± 0.40 0.58 213.3 ± 51.1 2.95 12.2 0.20
EPS 0.3 ± 0.01 0.27 11.5 ± 0.7 1.06 26.1 0.26
EPO 7.4 ± 0.20 24.67 202.2 ± 10.5 4.13 36.6 6.00
MCO 144.2 ± 8.47 20.90 135.3 ± 18.5 6.32 1065.8 3.31
ECO 109.7 ± 6.10 365.67 49.9 ± 8.0 3.20 2198.4 114.50
R2B2 MPS 0.7 ± 0.01 0.03 I 16.1 ± 0.8 0.59 43.5 0.04
MPO 19.4 ± 1.60 4.31 321.0 ± 39.1 4.45 60.4 0.97
EPS ND ND ND ND ND ND
EPO 14.5 ± 0.80 48.33 68.4 ± 8.9 1.40 212.0 34.75
MCO 60.2 ± 1.70 8.72 70.4 ± 5.9 3.29 855.1 2.65
ECO 30.3 ± 0.90 101.00 12.6 ± 2.8 0.81 2404.8 125.25
5.7.3.3. R2C2, R2D4 and R2A2
This group of variants does not have any of the L258 mutations.
R2C2 contains F l961 and L273I mutations. The kca, values towards EPO, MCO 
and EPO increased while kca, values towards MPS an MPO decreased. Kinetic 
parameters for EPS were not determined due to low activity towards EPS. FI961 and 
L273I worked synergistically to increase the kca, by 11 fold and 14 fold towards EPO 
and ECO. The Km values towards MPO and MCO increased while the Km values 
towards MPS and EPO decreased. The Km for ECO remained similar to WT. The 
catalytic efficiencies for EPO and ECO have increased by 17.12 fold and 15.09 fold, 
respectively. The F l961 and L273I mutations seem to enlarge the opening of the active 
site, increasing the access of larger substrates.
R2D4 contains F119Y, FI961 and L273I mutations. Compared to R2C2, R2D4 
has one extra mutation at FI 19. The inclusion of F119Y further increased the kca, 
towards EPO to 45.33 fold. The kcal towards MCO and ECO also saw improvements. 
The catalytic efficiencies towards EPO and ECO improved 40.61 fold and 26.83 fold, 
respectively. The combination of three mutations causes a bigger opening than R2C2, 
possibly facilitating even better substrate access.
R2A2 contains F119Y, F l961 and L273V mutations. The kcat towards MPO, 
EPS, EPO and ECO has increased 1.56, 1.82, 30.33 and 9.33 folds, respectively. The
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catalytic efficiencies of EPS, EPO and ECO have increased 9.35, 34.53 and 6.91 folds, 
respectively.
It is worth noting that for all three variants, the stacking of single mutations with 
modest improvement towards EPO (1.56-4.2 fold) can result in much better 
improvement against EPO (17.12-40.61 fold). Figure 5.28 shows the change in the 
substrate-binding pocket caused by the mutations and Table 5.14 summarises the 
kinetic parameters for R2C2, R2D4 and R2A2.
Figure 5.28: The active site pocket of (a) WT MPH, (b) R2C2, (c) R2D4 and (d) R2A2.
The shape of the active site cavity entrance is altered by mutations in R2C2, R2D4 and R2A2 as 
compared to WT MPH. The residues at positions 119, 196 and 273 are coloured red to highlight the 
changes. The grey surfaces represent the solvent excluded surfaces of WT MPH in (a), R2C2 in (b), 
R2D4 in (c) and R2A2 in (d) respectively. The grey sphere represents Zn metal and the wheat sphere 
represents the Cd metal. The mutations were modelled with SWISS-MODEL using subunit B of WT 
MPH as template.
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Table 5.14: Kinetic parameters for R2C2, R2D4 and R2A2 on various OPs.
The relative kca„ Km and kcJ K m were obtained by dividing the values obtained for R2C2, R2D4 and 
R2A2 with that o f  WT MPH for each o f the substrate. The relative kca„ Km and kca/K m are colour-coded 
for easy reference. Green: increase in value, pink: decrease in value.
Variant Substrate k ca ,  (S‘‘)
Relative
k c a t
K-n, (pM)
Relative
K m
k c a / K m
(s’1 mM'1)
Relative
k cJ K m
R2C2 MPS 1.0 ± 0.03 0.04 7.9 ± 1.2 0.29 126.6 0.13
MPO 3.2 ± 0.40 0.71 139.2 ± 28.6 1.93 23.0 0.37
R2D4
EPS
EPO
MCO
ECO
MPS
MPO
EPS
EPO
MCO
ECO
ND
3.3
9.8
4.2
1.8
4.4 
ND 
13.6
10.4
10.2
4.2
7.6
1.6
ND
0.64
2.61
0.93
ND
104.4
175.3
289.7
ND
17.12
0.54
15.09
0.15
1.07
ND
40.61
0.56
26.83
R2A2 MPS
MPO
EPS
EPO
MCO
ECO
2.3
7.0
2.0 
9.1 
3.9 
2.8
0.30
0.60
0.02
0.30
0.10
0.10
0.08
1.56
1.82
30.33 
0.57
9.33
27.8
187.5
2.1
43.2
70.6
21.1
7.4
28.2
0.3
4.1
3.3
4.3
1.02
2.60
0.19
0.88
3.30
1.35
82.7 
37.3 
952.4 
210.6 
55.2
132.7
0.08
0.60
9.35
34.53
0.17
6.91
5.7.3.4. R2D2 and R2F3
R2D2 and R2F3 both contain Fl 19Y and L258H mutations. R2F3 contains an 
extra mutation of Fl 961.
R2D2 seemed to be a decent all-rounder with kca, improvements for all 
substrates except MPS. The kca, for MPO, EPO, MCO and ECO have improved 5.47, 
2.09, 37.33, 17.07 and 105.33 folds, respectively. While the kcat for MPS has 
decreased, the overall catalytic efficiency is similar to WT MPH due to decreased Km. 
The catalytic efficiencies for MPO, EPO, MCO and ECO have increased 8.87, 50.03, 
5.45 and 44.36 folds, respectively. The catalytic efficiency of EPS remained similar to 
WT due to an increase in Km despite the improvement in kca,. Of the six substrates 
examined, five of the catalytic efficiencies obtained were at least 1 x 105 s 'M '1 and two 
out of the five catalytic efficiencies were at least 1 x 106 s 'M '1. These are significant 
improvements from WT MPH that has only one substrate where its catalytic efficiency 
is 1 x 106 s 'M '1. The R2D2 reaction progression curve shows a stark difference 
between WT MPH and the variant. At higher substrate concentrations, R2D2 reaches 
stable catalytic rate slower than WT MPH. (Figure 5.29). As the substrate
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concentration increases, R2D2 requires longer time to reach stable catalytic rate 
(Figure 5.29b). WT MPH does not display such behaviour (Figure 5.29a).
This behaviour was observed for MPO and EPO. R2D2 did not show such 
behaviour against MPS and EPS, probably due to lower substrate concentrations used to 
determine the kinetic parameters against those substrates. Higher MPS and EPS 
concentrations would result in the substrates precipitating out of solution due to their 
hydrophobic nature. R2D2 exhibited such behaviour to a lesser degree against MCO 
and ECO when very high concentration was used (379.8 pM). The behaviour was only 
observed in R2D2 (F119Y, L258H) and was not observed in F119Y mutant, L258H 
mutant and R2F3 (F119Y, F l961, L258H). A similar characteristic was observed in 
yeast pyruvate decarboxylase, albeit for different reasons. Pyruvate decarboxylase has 
allosteric properties as part of its regulatory mechanism.20 This creates a pyruvate 
concentration threshold such that the catalytic rate is low if the substrate concentration 
falls below the threshold. Stevenson et al., in their protein evolution work, found a 
mutant that abolishes such allosteric property. They attributed the observation to 
reduced sensitivity to phosphate and the ease of substrate activation due to the 
mutations.21 What we found in R2D2 is the opposite of what Stevenson et al. observed. 
The reason for R2D2 displaying such character is still unclear at this point and requires 
further investigation.
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Reaction time (mins)
Reaction time (mins)
Figure 5.29: The reaction progression curve for (a) WT MPH and (b) R2D2 with MPO at pH 7.6 
and 30°C.
The concentrations of MPO used were 60.4 pM (o), 119.6 pM (□) and 189.9 pM (O)- The regression 
line represents the stable-state reaction.
R2F3 contains F119Y, F l961 and L258H mutations. R2F3 is the best mutant 
against EPO selected from the evolution. R2F3 showed 73.33-fold kca, improvement 
and 97.47-fold catalytic efficiency improvement against EPO. The kcat/Km for R2F3 was 
5.94 x l O V V . u p  from 6.1 x 103 s^M '1 for WT MPH. R2F3 also showed 119.33- 
fold kca, improvement and 83.99-fold catalytic efficiency improvement against ECO, 
thus making R2F3 efficient at hydrolysing diethyl substituted oxon substrates. The 
improvement against EPO was consistent with other variants that carry the L258H 
mutation. L258H is the best beneficial single mutation found against EPO and almost
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all variants carrying the L258H mutation showed large improvement in EPO- 
hydrolysing activity. R2F3 also displayed slightly improved catalytic efficiencies 
against MPO and MCO at 1.76 and 1.27 folds, respectively.
Figure 5.30 shows the difference in substrate binding pockets in R2D2 and 
R2F3 with WT MPH. Table 5.15 summarizes the kinetic parameters of R2D2 and 
R2F3 against various OPs.
a)
Figure 5.30: The substrate-binding pocket comparison between (a) WT MPH, (b) R2D2 and (c) 
R2F3.
The shape of the active site cavity is altered by mutations in R2D2 and R2F3. The residues at positions 
119, 196 and 258 are coloured to highlight the changes.The grey surface represents the solvent excluded 
surface for WT MPH in (a), R2D2 in (b) and R2F3 in (c), respectively. The grey sphere represents Zn 
metal and the wheat sphere represents the Cd metal. The mutations were modelled with SWISS-MODEL 
using subunit B of WT MPH as template.
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Table 5.15: Kinetic parameters for R2D2 and R2F3 on various OPs
The relative kcah Km and kca/K m were obtained by dividing the values obtained for R2D2 and R2F3 with 
that of WT MPH for each of the substrate. The relative kcal, Km and kca/K m are colour-coded for easy 
reference. Green: increase in value, pink: decrease in value_______________________________________
Variant Substrate kca, (s'1)
Relative
at
(HM) Relative
Km
kca/Km
(s'1 mM'1)
Relative
kca/Km
R2D2 MPS 13.9 ± 0.40 0.51 10.1 ± 1.2 0.37 1376.2 1.37
MPO 24.6 ± 1.30 5.47 44.5 ± 7.5 0.62 552.8 8.87
EPS 2.3 ± 0.20 2.09 25.4 ± 6.9 2.35 90.6 0.89
EPO 11.2 ± 0.30 37.33 36.7 ± 3.0 0.75 305.2 50.03
MCO 117.8 ± 6.60 17.07 67.0 ± 11.4 3.13 1758.2 5.45
ECO 31.6 ± 1.30 105.33 37.1 ± 5.9 2.38 851.8 44.36
R2F3 MPS 1.5 ± 0.10 0.05 50.4 ± 3.4 1.85 29.8 0.03
MPO 6.3 ± 0.40 1.40 57.6 ± 8.9 0.80 109.4 1.76
EPS ND ND ND ND ND ND
EPO 22.0 ± 2.00 73.33 37.0 ± 10.5 0.76 594.6 97.47
MCO 42.4 ± 2.90 6.14 103.9 ± 18.1 4.86 408.1 1.27
ECO 35.8 ± 0.50 119.33 22.2 ± 1.6 1.42 1612.6 83.99
5.8. Mechanistic implications of mutations to residues 
surrounding the active site
The site saturation mutagenesis study highlights the “plasticity” of MPH active 
site. In this study, nine active site lining residues were probed for flexibility in altering 
substrate specificity, as well as an attempt to understand the substrate binding mode of 
the enzyme. Of the nine residues, four residues demonstrated flexibility to different 
degrees when altered for improved activity against ethyl paraxon. While some residues 
such as R72, FI 19 and W179 seemed intolerant to mutations (Figures 5.9b, c and e), 
the deterioration in activity might stem from structural, substrate-binding or catalytic 
reasons. It is also worth noting that while FI 19 was intolerant to most mutations 
introduced by the NDT codon randomisation, Fl 19Y was found to improve the kca, for 
most substrate tested, albeit with an increase in the Km for all substrates tested (Table 
5.8). This could be due to the structural similarities of phenylalanine and tyrosine, 
which led us to believe that the aromatic ring is essential in substrate binding.
While there are two phenylalanine residues in MPH active site, we believe FI 19 
is the more essential phenylalanine residue based on three observations -  the activity 
distributions of FI 19 and FI96 mutant libraries, the number of improved variants 
selected from FI 19 and FI96 libraries and the kinetic parameters of the improved 
mutants on various substrates when compared to wild type. As mentioned in section 
5.5.3, FI 19 and FI96 exhibited different mutational tolerance based on the activity
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distribution plots of the mutant libraries for the two sites on EPO hydrolysing 
capability. From the plots (Figures 5.9c and f), 48% of FI96 mutants retain less than 
50% relative activity, compared to 73% of FI 19 mutants retaining the same amount of 
activity. Amino acid changes at FI96 are more tolerant compared to FI 19. Of the 
improved mutants selected from FI 19 and FI96 libraries, Fl 19Y is the only improved 
mutant found from the FI 19 library whereas F196Y, F196L and FI961 were found from 
the FI96 library. These suggest there are no other alternative residues at position 119 
and aromatic residue at this position is necessary for activity. In contrast, F196L and 
FI961 are hydrophobic alkyl residues suggesting leucine and isoleucine can alternative 
residues at this position. When analysing the kinetic parameters of WT MPH, Fl 19Y, 
F196Y, F196L and F l961 on various OP substrates, it was observed that the substrate 
profiles of F119Y and F196Y are largely similar to WT MPH with only minor 
differences. On the other hand, F l961 and F196L showed decrease in catalytic 
efficiencies against most substrates with the exception of EPO, the screening substrate. 
It is worth stressing here that EPO was a poor substrate for MPH and the catalytic 
efficiencies of F l961 and F196L against EPO were still lower than that for MPS despite 
the improvement. However, this seems to suggest that while FI96 is important for the 
high catalytic efficiency in hydrolysing MPS, its role is not as important in hydrolysing 
bulkier substrates such as EPO and ECO. This could be due to steric hindrance of the 
phenylalanine when larger substrates are involved and mutations to leucine and 
isoleucine enlarge the substrate pocket to accommodate the substrate.
The possible roles of PI 50 and W179 were discussed in Section 5.5.4 and were 
attributed to structural roles in the enzyme. As discussed in the previous section, L273 
is believed to be one of the residues to shape the active site pocket. The two mutations, 
L273I and L273V were found to enhance the catalytic efficiencies of oxon substrates, 
suggesting that the oxygen/sulphur group of the substrate is positioned nearby. The role 
of L258 is unclear but it is of great interest due to its flexibility and the catalytic 
efficiency enhancement seen from mutations at this site. Oxon substrates seem to 
benefit the most from polar mutations to this site, suggesting the oxygen/sulphur group 
of the substrate is also nearby.
During the course of the structural comparisons described in the previous 
section, it became apparent that there are structural differences in the active sites of the 
two subunits of MPH. While the overall superimposition of the two MPH subunits gave
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good agreement -  RMSD of 0.5322 for 288 residues, there were some conformational 
differences in some substrate binding residues (Figure 5.31). Analysis of the by residue 
Ca RMSD of the superimposed MPH subunits showed good agreement, with the 
exception of some regions in the enzyme showing a difference of more than one 
angstrom. These regions correspond to flexible regions in the protein, as indicated by 
their high B-factor values (Figure 5.32). The B-factors were extracted from the MPH 
PDB structure using StrucTools (http://helixweb.nih.gov/structbio/). In Figure 5.32, the 
side chain B-factors of some amino acid reduce to zero due to the absence of side chain 
(e.g. glycine).
0 50 100 150 200 250 300
Residue number (Ca)
Figure 5.31: (a) The metal centre superimposition of different MPH subunits, (b) the 
superimpostion of active site lining residues and (c) the by-residue Ca RMSD plot of the different 
MPH subunits.
Subunit A of MPH is coloured grey, subunit B is coloured wheat, the Zn metals are coloured grey, Cd 
metal is coloured wheat and water molecules are coloured red.
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Figure 5.32: The average B-factor for different subunits of MPH.
(a) shows the average B factor for subunit A and (b) shows the average B factor for subunit B. In both 
plots, the B-factor of the main chain is coloured red, while the B-factor of the side chains is coloured 
blue.
The B-factor values and the Ca RMSD of active site lining residues for both 
subunits A and B are summarised in Table 5.16. The big difference in Cot RMSD 
values observed between the two subunits in W179 and FI96 is probably due to the two 
residues being located near a highly flexible loop (residue 177 to residue 197). R72, 
FI 19 and L273 residues are located at slightly flexible regions on the enzyme. It is 
worth noting that the Ca RMSD values for R72 and FI 19 were not large despite having 
different conformations. While the exact reason for the flexibility of those residues is 
not known, the different conformations of some residues, particularly R72, FI 19, FI96 
and L273, result in different active site conformations between the two MPH subunits 
(Figure 5.33). This difference might have mechanistic repercussion, since different 
active site conformations will result in different hypotheses for substrate binding.
Table 5.16: The average B-factor values and Ca RMSD of MPH subunit
The B-factor values were extracted from MPH PDB structure (PDB ID: 1P9E) and the B-factor values 
for the overall structures were obtained by calculating the average Ca B-factor of the respective subunits. 
The numbers in bracket for overall structure Ca B-factor represent the standard deviation of the data set. 
Residues Chain A B-Factor Chain B B-Factor Ca RMSD (A)
Side Chain Main Chain Side Chain Main Chain
L67 35.21 36.09 24.28 27.27 0.31
P68 38.47 38.87 29.03 30.94 0.31
R72 44.78 35.28 49.15 40.89 0.45
FI 19 35.35 32.95 36.88 34.27 0.34
P150 27.08 26.54 25.99 25.11 0.45
W179 34.15 35.1 34.21 37.39 0.43
FI 96 48.04 43.32 42.02 41.17 0.72
F258 25.51 25.19 27.98 26.58 0.34
F273 35.09 34.7 39.35 37.03 0.71
Structure average 30.14(8.74) 29.89 (8.90) 0.53
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a) b)
Figure 5.33: The different active site conformations of the two MPH monomeric subunits.
(a) shows the active site lining residues for subunit A and (b) shows the active site lining residues for 
subunit B. In both figures, the grey surface represents the solvent excluded surface of the active site.
Computer simulation of substrate docking was carried out with SwissDock-2 23 
and Auto Dock Vina24. During the course of the study on both subunits of MPH 
structure, it was concluded that the active site conformation observed in subunit B will 
allow substrate binding while access to the A subunit was restricted, suggesting that the 
conformation observed in subunit A obstructs the substrate from entering the active site. 
Methyl parathion was successfully docked into the subunit B of MPH with SwissDock 
and Autodock Vina, and a potential substrate-binding model from each method was 
shortlisted (Figure 5.34). The terminally bound water in the active site was removed 
from the structure before virtual docking experiments were performed to prevent it from 
obstructing the docking procedure.
The two models selected are similar to each other, with some minor differences. 
The two models were selected based on the current understanding of MPH catalytic 
mechanism, that was derived from how substrate docked into OPDA (PDB ID: 2R1N)2' 
(Figure 5.35), as well as observations obtained from the mutagenesis studies of the 
active site lining residues. In both models, the sulphur group of the substrate is located 
near the ß-metal, L273 and L258, displacing the ß-metal terminally bound water. This 
is consistent with the proposed catalytic mechanism for MPH and OPH.3 26 The p- 
nitrophenolate ring of the substrate is located near FI 19, where Jt-stacking is possible 
with the more essential phenylalanine residue. Active site close-up of substrate docking 
models obtained from Swiss-Dock and AutoDock Vina, as well as OPDA with a slow
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substrate, are given in Figure 5.36 to show the interaction between the substrate and the 
metal centre.
a) b)
Figure 5.34: The substrate-binding models of MPS obtained from virtual docking with SwissDock 
and AutoDock Vina.
(a) and (b) show the MPS substrate-binding model of MPH subunit B obtained from virtual docking with 
SwissDock, while (c) and (d) show the model obtained from virtual docking with AutoDock Vina, (a) 
and (c) show the position of the active site lining residues and the substrate while (b) and (d) show the 
same structure with solvent excluded surface displayed to show how the substrate sits in the active site 
pocket. The numbers and the dashed lines indicate the distances of the phosphate centre and the sulphur 
group from the bridging water and ß-metal respectively. The red sphere represents the bridging water; 
grey sphere represents the Zn metal and yellow sphere represents the Cd metal.
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a) b)
Figure 5.35: The substrate-binding of diethyl 4-methyoxyphenyl phosphate in OPDA.
(a) and (b) show how diethyl 4-methoxyphenyl phosphate sits in the active site o f OPDA. (a) show the 
position o f the active site lining residues and the substrate, while (b) shows the same structure with 
solvent excluded surface displayed to show how the substrate sits in the active site pocket. The number 
and the dashed lines indicate the distances o f the phosphate centre and the phosphoryl oxygen from the 
bridging water and ß-metal, respectively. The orange sphere represents Fe2+; the pink sphere represents 
Mn2+ and the red sphere represents the bridging water.
C)
Figure 5.36: Active site close up of (a) MPS docked MPH simulated by Swiss-Dock, (b) MPS 
docked MPH simulated by AutoDock Vina and (c) OPDA soaked with diethyl 4-methyoxyphenyl 
phosphate.
The substrates in (a) and (b) are MPS while the substrate in (c) is diethyl methoxyphenyl phosphate. The 
red spheres represent the bridging hydroxides in all three structures; the grey spheres represent Zn2+ ions, 
the wheat spheres represent Cd2 ions, the orange sphere represents Fe2' ion and the pink sphere 
represents Mn2+ ion. The numbers and dashed lines indicate the distances o f the substrate to the metal 
centre.
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5.9. Summary
This chapter describes the site saturation mutagenesis on MPH active site lining 
residues and subsequently the directed evolution of MPH for improved EPO hydrolysis. 
To my best knowledge, the work described in this chapter is the most extensive 
substrate profile characterisation on MPH to date. Single site mutants Fl 19Y, F196Y, 
F1961, F196L, L258S, L258N, L258I, L258H, L273I and L273V were the improved 
variants found in EPO hydrolysis. The substrate profiles of these mutants were 
characterised with various OP substrates in an attempt to understand the roles of these 
residues in substrate interaction. All of the selected single site mutants have modest 
improvements on EPO hydrolysis. Interestingly, unexpected but admirable 
improvements were seen for L258 mutants on hydrolysis of non-selected substrates 
(MCO and ECO). By coupling the kinetics data and the mutant activity distribution of 
single site libraries, insights into the possible roles of some residues were suggested. 
Two rounds of directed evolution aimed to further enhance EPO hydrolysing efficiency 
were conducted with DNA shuffling, and numerous multiple site mutants with better 
EPO activity were obtained. Among the multiple site mutants characterised, four 
interesting multiple site mutants will be singled out for special mention. R1A6 (Fl 19Y, 
L258S) was found to be a TCPy leaving group substrate specialist, with 46 and 267 
folds catalytic efficiency improvement on MPO and EPO. R2F3 (F119Y, FI961, 
L258H) was found to be a diethyl substituted oxon specialist, with 97 and 84 folds 
catalytic efficiency improvement on EPO and ECO. R2D4 (Fl 19Y, F l961, L273I) is an 
example of moderately beneficial mutations stack, which had significant improvement 
on a selected substrate. This mutant had 41-fold catalytic efficiency improvement 
towards EPO. The final interesting mutant is R2D2 (Fl 19Y, L258H), a generalist. Five 
of the six substrates characterised see improvement in overall catalytic efficiencies. The 
substrate specificity of R2D2 is vastly broadened compared to WT MPH, as five of the 
substrates show catalytic efficiencies of at least IO V m 1. The results we observe here 
highlight the “plasticity” of MPH active site -  a few amino acid changes in the active 
site pocket result in drastic changes in OP specificity. Therefore, it is no surprise that 
various MPH variants with high sequence identity have been isolated from different 
microorganisms. Based on the current understanding of MPH mechanism, as well as the 
data we obtained in this study, potential substrate binding models obtained from Swiss- 
Dock and AutoDock Vina were selected.
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6. Future directions
6.1. MPH proteolytic degradation
A protocol that allowed rapid purification of MPH was developed so that 
proteolytic degradation can be minimised. While it was a viable protocol to produce 
MPH for the purpose of characterisation, a more direct solution to address the problem 
is required, if MPH is to be used for bioremediation and medicinal applications. Site 
directed mutagenesis on the predicted cleavage site was performed but it was not 
effective in eliminating the degradation. As discussed previously in Chapter 3, there is 
a possibility that the mutation was not performed on the key residues for protease 
recognition. One possible approach is to perform site directed mutagenesis on multiple 
sites around the proteolytic cleavage region to eliminate the protease recognition site. 
However, since autoproteolysis was ruled out as the source of degradation, identifying a 
suitable protease inhibitor for use during cell lysis and protein purification might be 
another possible solution. Serine inhibitors, such as PMSF and AEBSF, were not 
effective in stopping the degradation, indicating that the protease responsible was not a 
serine protease.
Since the enzyme purified with immobilised-metal affinity chromatography 
(IMAC) using Ni2 charged column gave good purity, the possibility of using this 
purification protocol in the future should be explored. However, efforts should be made 
to investigate the effects of his-tag on the dimeric assembly, as well as the metal content 
of MPH before employing IMAC for routine MPH purification. An ubiquitinase 
cleavable His-Tag construct, such as pHUE1 vector can be considered to facilitate the 
fusion tag removal. By removing the His-Tag after purification, unwanted fusion tag 
associated effects can be eliminated.
6.2. Directed evolution of MPH for enhanced thermal stability
Ideas to improve the thermostability evolution were given in section 4.4.5 and 
will not be discussed in this section. As mentioned earlier, stability is a desired trait for 
any enzyme that is to be used for practical applications. While the work done in 
evolving MPH to be more thermostable has met with little success, it gave some
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indications on the effects of Zn: on the protein stability. At this point, little is known 
about the metal binding properties of MPH or how different metals affect the stability. 
Miss Nur Hafizah Azizan is investigating this front by performing site directed 
mutagenesis on primary and secondary shells metal-binding ligands, and investigate the 
associated changes in metal binding affinity. Rapid activity independent stability assay, 
such as Hot-CoFi2 agar screening method, developed by Asial and co-workers should 
be employed to directly probe the thermostability changes during library screen. This 
method will also eliminate the laborious nature of the thermostability screening 
employed in this work.
6.3. Altering the substrate specificity of methyl parathion 
hydrolase
Mutants with moderate improvement in ethyl paraoxon (EPO) activity have 
been isolated from site saturation mutagenesis of the active site lining residues. Some of 
these mutants exhibited altered substrate specificity compared to the wild type variant. 
Shuffling of these mutations produced multiple site mutants that gave respectable 
improvements in EPO activity and unexpectedly, improvements in MCO and ECO 
activities. The evolution of MPH should continue to isolate MPH variants with 
quadruple mutations. The 10 single site mutants isolated consist of mutations from 
FI 19, F196, L258 and L273. The multiple site mutants isolated after two rounds of 
StEP shuffling consist of predominantly double-site and triple-site mutants. We expect 
that the quadruple mutants isolated from further shuffling will give further enhancement 
to what we already achieved in this work.
The anomalous reaction progression for R2D2 at high substrate concentrations 
should be further investigated to identify the underlying reason. R2D2 is an interesting 
“generalist” mutant that can hydrolyse many OPs efficiently and therefore should be 
further studied. Other characteristics, such as metal content and thermostability of the 
isolated mutants, should also be studied to ensure that the activity enhancement does 
not come at the cost of stability.
Crystal structures of some interesting mutants should be obtained to better 
understand the structural changes introduced by the mutations. The possible effects of 
various mutations discussed in this work were based on modelled structure produced
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with SWISS-MODEL. While the trend of altered substrate specificity for some 
mutations are clear, e.g., L258S and L258N shifted the specificity towards chlorpyrifos 
based OPs, it was not immediately clear how those mutations resulted in such changes. 
Obtaining the crystal structures of some mutants will give some insights as to how these 
mutations change the active site pocket of MPH and result in altered substrate 
specificity. Co-crystallisation of MPH with a slow substrate or substrate mimic should 
also be attempted to verify' the substrate-binding models obtained with Swiss-Dock and 
AutoDock Vina. One potential slow substrate that can be used for such study is 
coumaphos oxon. MPH has very low activity against coumaphos oxon. The different 
conformations observed in R72 and FI 19 between the monomeric subunits of published 
MPH structure should be further investigated to ensure that the difference observed was 
not due to crystallisation artefact. It is important to obtain such information since the 
difference in conformation will result in different active site shapes, and thus the 
substrate-binding model and mechanism.
From a practical application point of view, the substrate profiles of some 
mutants isolated in this work are broad and efficient enough for bioremediation 
purposes. The substrate profile can be further enhanced for bioremediation by 
formulating mixtures of MPH mutants with different substrate profiles, or mixtures of 
MPH and OPDA.
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Appendix A: Recipes
Bromophenol Blue Loading Dye (for DNA agarose electrophoresis)
The solution contained 30% (v/v) glycerol and 0.25% bromophenol blue in dH20.
LB (Lysogeny Broth)
Dissolve 10 g of tryptone (Difco), 5 g of Bacto yeast extract (Difco) and 10g ofNaCl in 
1000 mL of water and sterilise by autoclaving. Add 15 g/L of agar prior to autoclaving 
to make LB agar plates. Add antibiotics to final concentrations of 100 pg/mL for 
ampicilin (Amresco) and 50 pg/mL for kanamycin (AG Scientific) as require once the 
media had cooled to approximately 60°C.
Organophosphate Substrate Stock
18.99 mM of methyl parathion, methyl paraoxon, ethyl parathion, ethyl paraoxon, 
methyl chlropyrifos oxon or ethyl chlorpyrifos oxon was prepared by dissolving or 
diluting the organophosphates in 100% methanol.
SB Buffer (for DNA agarose electrophoresis)
20x stock solution was prepared by dissolving 8 g of NaOH in 0.9 L of dH20  and 
adjusting the pH to 8.0 with boric acid and making the volume of 1 L with dH20.
SDS Running Buffer (for SDS-PAGE)
lOx stock solution was prepared by dissolving 144 g glycine, 30 g Tris base and 10 g 
SDS in 1 L of dH20.
SDS-PAGE Stock Sample Buffer
The solution was prepared by mixing 120 pL 0.1% (w/v) bromophenol blue, 1.12 mL 
80% (v/v) glycerol, 800 pL of 2 M Tris buffer at pH 6.8, 2 mL of 10% (w/v) SDS and 
0.31 g of dithiothreitol. dH20  was added to a final volume of 10 mL. 10 pL of ß- 
mercapoethanol was added to every 190 pL of stock sample buffer immediately before 
use to obtain SDS-reducing sample buffer.
YENB (Yeast Extract Nutrient Broth)
Dissolve 7.5 g Bacto yeast extract (Difco) and 8 g Bacto Nutrient Broth (Difco) in 1000 
mL water and sterilise with autoclaving.
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Appendix B: Suppliers of Equipments, Consumables and Chemicals
Equipment and Consumable Suppliers
E q u ip m e n ts  an d  c o n su m a b le s M a n u fa c tu r e r s  a n d  su p p lie r s
5 415  M ic ro c e n tr ifu g e E p p e n d o r f
5 8 0 4  C e n tr ifu g e E p p e n d o r f
A K T A  F P L C  S y s tem G .E . H e a lth c a re
A m ic o n  U l t r a -15 C e n tr ifu g a l F ilte r  U n it M illip o re
A S B 2 7 0 B T  A u to c la v e A ste ll S c ie n tif ic
C l 0 0 0  T h erm a l C y c le r B io -R ad
C 0 8 0 0 0  C ell D e n sity  M e te r W P A  B io w a v e
F re n c h  P re ssu re  C e ll P re ss S L M  In s tru c m e n ts
G e n e A m p  P C R  S y s tem  9 7 0 0 A p p lie d  B io sy s te m s
H isT ra p  FF  C o lu m n G .E . H e a lth c a re
H iT ra p  D E A E  FF C o lu m n G .E . H e a lth c a re
H iT ra p  D e sa ltin g  C o lu m n G .E . H e a lth c a re
H iT ra p  SP  FF  C o lu m n G .E . H e a lth c a re
I-C y c le r B io -R ad
M ic ro P u lse r  E le c tro p o ra to r B io -R ad
M J M in i P e rso n a l T h e rm a l C y c le r B io -R ad
N a n o D ro p ®  N D -1 0 0 0  S p e c tro p h o to m e te r N a n o D ro p
O rio n  R O S S  C o m b in a tio n  pH  E le c tro d e O rio n  P a c if ic  P ty  L td
Q  S e p h a ro se  A ffin ity  C o lu m n A m e rsh a m  B io sc ie n c e s
Q IA p re p  S p in  M in ip re p  k it Q ia g e n
Q IA q u ic k  P C R  P u rif ic a tio n  K it Q ia g e n
R 2 0 A 2  a n d  R 9 A  R o to rs  fo r  V X 2 2 G H itach i
R o to rf ix  32  C e n tr ifu g e H e ttic h
S E 2 5 0  M ig h ty  S m all II M in i V e rtic a l E le c tro p h o re s is  U n it H o e fe r
S p e c tra M a x ®  M 2 /M 2 e  M ic ro p la te  R e a d e r M o le c u la r  D e v ic e s
S u p e rd e x  2 0 0  S iz e  E x c lu s io n  C o lu m n A m e rsh a m  B io sc ie n c e s
U V  tra n s il lu m in a to r  31 2  nm  w ith  U V Ite c  c a m e ra H a n im a x  S ta te sm a n
V a rian  C ary  U V /V is  S p e c tro p h o to m e te r V a rian
V eriti 9 6 -W ell T h e rm a l C y c le r A p p lie d  B io sy s te m s
V X 2 2 G  H igh  S p e e d  C e n tr ifu g e V W R
W id e  M in i S u b  C e ll E le c tro p h o re s is  T an k B io -R ad
W iz a rd ®  SV  G el a n d  P C R  C le a n -U p  S y stem P ro m e g a
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Chemical Suppliers
Chemcals
1 kb DNA Marker
1,10-phenanthroline
2-methyl-2,4-pentanediol
2- propanol
2.6- pyridine dicarboxylate
3- methyl-1-butanol
3.5.6- trichloro-2-pyridinol
4- (2-Aminoethyl) Benzenesulfonyl Fluoride 
4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid 
8-hydroxyquionoline-5-sulfonic acid
Acetone
Acetonitrile
Acryl/Bis 37.5:1, 40% (w/v)
Agar
Agarose
Ammonium Persulfate
Ampicilin
Asel and Buffer
BigDye® Terminator and Buffer 
BioTaq™ Polymerase 
bis-p-(nitrophenyl) Phosphate 
Bromophenol Blue
BugBuster® Protein Extraction Reagent
Calf Intestinal Alkaline Phosphatase and Buffer
Chelex
Dimethyl Sulfoxide
Dithiothreitol
dNTPs
Dpnl and Buffer
Dual Color Precision Plus Protein Standards
£coRI and Buffer
EDTA
Ethanol
Ethidium Bromide 
Ethyl acetate 
Ethyl Chlorpyrifos Oxon 
Ethyl Parathion 
Ethyl Paraxon 
Ethylene Glycol
Gel Filtration Markers Kit 12,000 - 200,000 Da
Glycerol
Glycine
HC1
HN03
Imidazole
Manufacturers and suppliers
New England Biolabs 
Sigma Corporation 
Sigma Corporation 
Merck
Sigma Corporation
Sigma Corporation
Sigma Corporation
Sigma Corporation
Amresco
Sigma
Merck
Sigma Corporation
Amresco
Difco
Sigma Corporation 
Sigma Corporation 
Amresco
New England Bioiabs
Biomolecular Resource Facility, JCSMR
Bioline
Sigma Corporation 
Sigma Corporation 
Novagen
New England Biolabs 
Bio-Rad
Sigma Corporation 
Sigma Corporation 
Roche
New England Biolabs 
Bio-Rad
New England Biolabs 
Ajax Chemicals 
Merck
Sigma Corporation 
Merck
Chemservice
Chemservice
Sigma
Fluka
Sigma Corporation
Merck
Amresco
Ajax Chemicals
Merck
Sigma Corporation
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Isopropyl ß-D-1 -thiogalactopyranoside
k 2h p o 4
Kanamycin
KH2P04
Low Range SDS-PAGE Marker
Methanol
Methoxy Ethanol
Methyl Chlorpyrifos Oxon
Methyl Paraoxon
Methyl Parathion
MgCl2
MnCl2
N,N,N',N\-Tetramethylethylenediamine
NaCl
NaOH
Native Pfu / ’olymerase and Buffer
NdeI and Buffer
Nutrient Broth
p-nitrophenol
/Miitrophenyl Acetate
p-nitrophenyl Phophate
Petroleum jelly
Phenylmethylsulfonyl fluoride 
Phusion Polymerase 
Piperazine
Polyethylene Glycol 8000 
Propylene Glycol 
Pst\ and Buffer 
RedSafe™ DNA Stain 
rLysozyme™
Sodium Acetate
Sodium Dodecyl Sulfate
T4 DNA Ligase
Taq Polymerase
tert-butanol
Tris Base
Tryptone
Tween 20
Yeast Extract
ß-mercaptoethanol
Astral
Ajax Chemicals 
AG Scientific Inc 
Ajax Chemicals 
Bio-Rad 
Merck
Ajax Chemicals 
Chemservice 
Sigma Corporation 
Chemservice 
Sigma Corporation 
Ajax Chemicals 
Sigma Corporation 
Chem Supply 
Ajax Chemicals
Thermo Scientific; Agilent Technologies
New England Biolabs
Difco
Sigma Corporation 
Sigma Corporation 
Sigma Corporation 
Shell
Sigma Corporation
Finnzyme; New England Biolabs
Sigma Corporation
Fluka
Fluka
New England Biolabs
Chembio
Novagen
ICN Biomedical
Amresco
Thermo Scientific; Fermentas; New England Biolabs 
Roche
Sigma Corporation
Amresco
Difco
Sigma Corporation 
Difco
Sigma Corporation
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Appendix C: Oligonucleotide Primers
All oligos were supplied by GeneWorks or Integrated DNA Technologies
Name________________
(4)pCY76F
F S S M F l a n k M  1 T As e
F-M1T-pJ WL1030flank- 
Ase
F-MPH-NDTSSM-F119
F-MPH-NDTSSM-
L67P68R72
F-MPH-NDTSSM-P150 
F-MPH-SSM-R72 
F-MPH-SSM-W179 
F-SDM-M1T-F54A
Description_______________________________
Forward sequencing primer for pCY76 and 
pJWL1030
Forward flanking primer for MPH without signal
in pETMCSI and pCY76. Contains Asel site
Forward flanking primer for MPH without signal
in pJWL1030. Contains AseI site
Forward site saturation mutagenesis primer with
NDT randomisation at FI 19
Forward site saturation mutagenesis primer with
NDT randomisation at sites L67, P68 and R72 for
MPH
Forward site saturation mutagenesis primer with
NDT randomisation at P I50
Forward site saturation mutagenesis primer with
NNK randomisation at R72
Forward site saturation mutagenesis primer with
NNK randomisation at W 179
Forward site directed mutagenesis primer at F88
FSac2Sp2
pCY76R(M13)
pET3
Forward flanking primer for MPH without signal 
in pET47b. Contains SacII site 
Reverse sequencing primer for pCY76 and 
pJWL1030
Forward sequencing primer for pETMCSI
pET4 Reverse sequencing primer for pETMCSI
R S S M F l a n k M  1 T E c o
R-M lT-pJWL 103011 ank- 
Pst
R-MPH-NDTSSM-F196 
R-MPH-NDTSSM-L258 
R-MPH-NDTSSM-L273 
R-SDM-M1T-F54A
Reverse flanking primer for MPH without signal
in pETMCSI and pCY76. Contains £coRI site
Reverse flanking primer for MPH without signal
in pJWL1030. Contains Pst] site
Reverse site saturation mutagenesis primer with
NDT randomisation at F 196
Reverse site saturation mutagenesis primer with
NDT randomisation at L258
Reverse site saturation mutagenesis primer with
NDT randomisation at L273
Reverse site directed mutagenesis primer at F88
RSacSp Reverse flanking primer for MPH without signal
in pET47b. Contains Sac\ site
T7Fwd Forward sequencing primer for pET47b
T7Rev Reverse sequencing primer for pET47b
Sequence (5’-3')_______________
GCC GGC GAT ATC GGA 
TCCG
GCT TCT ATT AAT GGC AGC 
ACC GCA GGT T 
GAT ATA ATT AAT GGC 
AGC ACC GCA GGT T 
TGC AGC AGG TCT GND 
TGG TCC GAC ACT 
ACC GTT GCA NDT NDT 
GTT GAT AAA NDT CTG 
AAT CAG
ACC CAT ATG CAT NDT 
GAT CAT GTT GGT 
CCG GTT GAT AAA NNK 
CTG AAT CAG CCT 
GAA GCA GAT TTT NNK 
CTG AGC CAG ACC 
CTG GCA AAA AGC GCA 
CAG AAA GCA CC 
ACC ATC ACT CCG CGG CTG 
CAG CAC CGC AGG TT 
GTA AAA CGA CGG CCA 
GTG
CGA CTC ACT ATA GGG
AGA CCA CAA C
CCT TTC GGG CTT TGT TAG
CAG
TGC CAT GAA TTC TTA TTA
TTT CGG ATT CAC
AAG CTT CTG CAG TTA TTA
TTT CGG ATT CAC
GCA CCT TTA AAA HNG
CCT TTG CTT TC
AAC GGC TGC AAC AHN
AAT CAG ATC ACC
GCT ATC GCT ATC AHN CTG
GGT GGT AAC
GGT GCT TTC TGT GCG CTT
TTT GCC AG
ATT TAA GCG AGC TCT TAT 
TTC GGA TTC ACA ACG C 
TAA TAC GAC TCA CTA TAG 
GG
GCT AGT TAT TGC TCA GCG 
G
*Bolded nucleotides are the sites subjected to mutagenesis. 
♦Restriction sites are underlined
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Appendix D: Organophosphates Described in This Thesis
Methyl parathion (MPS) Methyl paraoxon (MPO) Ethyl paraoxon (EPO)
Methyl chlorpyrifos oxon (MCO) Ethyl chlorpynfos oxon (ECO) Diisopropyl fluorophosphale bis-(p-nitrophenyl) phosphate (bpNPP)
p-nitrophenyl diphenylphosphatc (pNPDPP)
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Appendix E: MPH Homologues Sequence Alignments
Closely related MPH homologues
OCHMPH
M6MPH
WBC3MPH
YC1MPH
FDS1MPH
BCMPH
MPLKNRLLARLSCVAAWAATAAVAPLTLVSTAHAAAPQVRTSAPGYYRMLLGDFEITAL 60 
MPLKNRLLARLSCVAAWAATAAVAPLTLVSTAHAAAPQVRTSAPGYYRMLLGDFEITAL 60 
MPLKNRLLARLSCVAAWAATAAVAPLTLVSTAHAAAPQVRTSAPGYYRMLLGDFEITAL 60 
MPLKNRLLARLSCVAAWAATAAVAPLTLVSTAHAAAPQVRTSAPGYYRMLLGDFEITAL 60 
MPLKNRLLARLSCVAAWAATAAVAPLTLVSTAHAAAPQVRTSAPGYYRMLLGDFEITAL 6 0 
MPLKNRLLARLSCVAAWAATAAVAPLTLVSTAHAAAPQVRTSAPGYYRMLLGDFEITAL 60
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ I * *
OCHMPH
M6MPH
WBC3MPH
YC1MPH
FDS1MPH
BCMPH
SDGTVALPVDKRLNQPAPKTQSALAKYFQKAPLETSVTGYLVNTGSKLVLVDTGAAGLFG 120 
SDGTVALPVDKRLNQPAPKTQSALAKSFQKAPLETSVTGYLVNTGSKLVLVDTGAAGLFG 120 
SDGTVALPVDKRLNQPAPKTQSALAKSFQKAPLETSVTGYLVNTGSKLVLVDTGAAGLFG 120 
SDGTVALPVDKRLNQPAPKTQSALAKSFQKAPLETSVTGYLVNTGSKLVLVDTGAAGLFG 120 
SDGTVALPVDKRLNQPAPKTQSALAKSFQKAPLETSVTGYLVNTGSKLVLVDTGAAGLFG 120 
SDGTVALPVDKRLNQPAPKTQSALAKSFQKAPLETSVTGYLVNTGSKLVLVDTGAAGLFG 120 
************************** *********************************
OCHMPH
M6MPH
WBC3MPH
YC1MPH
FDS1MPH
BCMPH
PTLGRLAANLKAAGYQPEQVDEIYITHMHPDHVGGLMVGEQLAFPNAWRADQKEADFWL 180 
PTLGRLAANLKAAGYQPEQVDEIYITHMHPDHVGGLMVGEQLAFPNAWRADQKEADFWL 180 
PTLGRLAANLKAAGYQPEQVDEIYITHMHPDHVGGLMVGEQLAFPNAWRADQKEADFWL 180 
PTLGRLAANLKAAGYQPEQVDEIYITHMHPDHVGGLMVGEQLAFPNAWRADQKEADFWL 180 
PTLGRLAANLKAAGYQPEQVDEIYITHMHPDHVGGLMVGEQLAFPNAWRADQKEADFWL 180 
PTLGRLAANLKAAGYQPEQVDEIYITHMHPDHVGGLMAGEQLAFPNAWRADQKEADFWL 180
OCHMPH
M6MPH
WBC3MPH
YC1MPH
FDS1MPH
BCMPH
SQTNLDKAPDD-SKGFFKGAMASLNPYVKAGKFKPFSGNTDLVPGIKALASHGHTAGHTT 239 
SQTNLDKAPDDESKGFFKGAMASLNPYVKAGKFKPFSGNTDLVPGIKALASHGHTPGHTT 24 0 
SQTNLDKAPDDESKGFFKGAMASLNPYVKAGKFKPFSGNTDLVPGIKALASHGHTPGHTT 240 
SQTNLDKAPDDESKGFFKGAMASLNPYVKAGKFKPFSGNTDLVPGIKALASHGHTPGHTT 24 0 
SQTNLDKAPDDESKGFFKGAMASLNPYVKAGKFKPFSGNTDLVPGIKALASHGHTPGHTT 240 
SQTNLDKAPDDESKGFFKGAMASLNPYVKAGKFKPFSGNTDLVPGIKALASHGHTPGHTT 24 0
OCHMPH
M6MPH
WBC3MPH
YC1MPH
FDS1MPH
BCMPH
YWESQGQKLALLGDLILVAAVQFDDPSVTNQLDSDSKSAAVERKKAFADAAKGGYLIAA 299 
YWESQGQKLALL.GDLILV AAVQFDDPSVTNQ1.DIDGKSAAVERKKAFADAAKGGYLIAA 300 
YWESQGQKLALLGDLILVAAVQFDDPSVTTQLDSDSKSVAVERKKAFADAAKGGYLIAA 300 
YWESQGQKLALLGDLILVAAVQFDDPSVTTQLDSDSKSVAVERKKAFADAAKGGYLIAA 300 
YWESQGQKLALLGDLILVAAVQLDDPSVTIQLDSDSKSAAVERKKAFADAAKGGYLIAA 300 
YWESQGQKLALLGDLILVAAVQFDDPSVTIQLDSDSKSAAVERKKAFADAAKGGYLIAA 300 
****************************** *** *,**.********************
OCHMPH
M6MPH
WBC3MPH
YC1MPH
FDS1MPH
BCMPH
AHLSFPGI GH IRAEGKGYRFVPVNY SWNPK 330 
SHLPFPGIGHIRAEGKGYRFVPVNYSWNPK 331 
SHLSFPGIGHIRAEGKGYRFVPVNYSWNPK 331 
SHLSFPGIGH IRAEGKGYRFVPVNY SWNPK 331 
THLSFPGIGHIRAEGKGYRFVPVNYSWNPK 331 
THLSFPGIGHIRAEGKGYRFVPVNYSWNPK 331
Legend:
OCHMPH -  Ochrobactrum sp. M231 
M6MPH -  Plesiomonas sp. M6 
WBC3MPH -  Pseudomonas sp. WBC-3 
YC1MPH -  Stenotrophomonas sp. YC-1 
FDS1MPH -  Bulkhoderia sp. FDS-1 
BCMPH -  Bulkhoderia cepacia
Residues in blue are the metal-binding ligands and residues that are different from WBC3-MPH are 
coloured red.
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Alignment between WBC3MPH and OPHC2
WBC3MPH
0PHC2
MPLKNRLLARLSCVAAWAATAAVAPLTLVSTAHAAAPQVRTSAPGYYRMLLGDFEITAL 60 
--- MRLF---SLSTA---LSSAMIALVSLPLQAAAPAQQKTQVPGYYRMALGDFEVTAL 50
22*2 *• 2 ** * j*##★★★★★★
WBC3MPH
0PHC2
SDGTVALPVDKRLNQPAPKTQSALAKSFQ— KAPLETSVTGYLVNTGSKLVLVDTGAAGL 118 
YDGYVDLPASLLKGIDDKDLQSLLARMFVASEKGVQTAVNAYLINTGDNLVLIDTGAAQC 110
★ ★ * *  -k ' ' # ★★ * • ! !*!*» ,**•***, •**★•★★***
WBC3MPH
0PHC2
FGPTLGRLAANLKAAGYQPEQVDEIYITHMHPDHVGGLMVG-EQLAFPNAWRADQKEAD 177 
FGPTLGWQTNLKASGYQPEQVDTVLLTHLHPDHACGLVNADGSPAYPNATVEVPQAEAE 170
****** • ************** • •**•**★* ^ ** • ^  ^ *j***#*f # * ** •
WBC3MPH
0PHC2
FWLSQTNLDKAPDDESKGFFKGAMASLNPYVKAGKFKPFSGNTDLVPGIKALASHGHTPG 237 
FWLDEATMAKAPEG-MQGMFKMAQQAVAPYAKMNKLKPYKTEGELLPGVSLVASPGHTPG 229 
★★★ •• • •*•** ★ •• ★★ ★ ★★★★★
WBC3MPH
0PHC2
HTTYWESQGQKLALLGDLILVAAVQFDDPSVTTQLDSDSKSVAVERKKAFADAAKGGYL 297 
HTSYLFKSGGQSLLVWGDILLNHAVQFAKPEWFEFDVDSDQARQSRQRILAEAATDKLW 289 
★★•★• ★★ * • **••* ★★★★ ★ ★ •*•**
WBC3MPH
0PHC2
IAASHLSFPGIGHIRAEGKGYRFVPVNYSWNPK- 331 
VAGAHLPFPGLGHVRKEAQGYAWVPVEFSPIRSDR 324 
2 * • 2 * * ******** * # •** •***• •* • 4
Legend:
WBC3MPH -  Pseudomonas sp. WBC-3 
0PHC2 -  Pseudomonas pseudoalcaligenes
Residues in blue are the metal-binding ligands
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Appendix F: Full List of Mutants from Chapter 4
The full list of all mutations present in mutant mpd genes generated during the 
process of directed evolution described in Chapter 4 are presented across the following 
pages. The asterisk (*) on Round 1 mutants indicates the mutants contain only silent 
mutations.
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34
WT S 
Round 1 
1D4 
1G6 
2B3 
3A2*
3B5
3B10
3C2
3D2
3E2
3G2*
3H4*
4A6 
4C6 
5A7 
5B8 
5F11 
Round 2 
1 A3 
1A7 
1B3 
1D2
1 E8 
1F8 
1G5 
1H11 
2A7 
2B8 
2C4 
2D4 
2D8 
2D9
2 E ll 
2G9 
2H5 
2H8 
3A5 
3A8 
3B4 
3B8 
3C6 
3C10
3 E9 
3F2 
3G5 
3H4 
4A7 
4A8 
4C9 
4D8 
4E3
4 E8 
4F3 
4F11 
4G5 
4G10 
4H5 
4H9 
5A8 
5B6 
5B8 
5C2
5 E2 
5F6 
5F10 
5G6 
6C3 
6D6 
6E4 
6E7 
6F10 
6G5 
6H5 
7B5 
7B9 
7C8 
7D11
50 90 107 109 113 116 128 162 164 191 202 209 211 212 226 237 256
M K K V T  A L L F D A K G K  I G L
Q
A
K
A
V
N
G
S
V
Q
Q
E
E Q
Q
A
Q
Q
Q
Q
A
R
Q
Q
G
S
Q
Q
N
A
P
Q
Q
Q
Q
Q
Q
G
E
E
N
Q
Q
Q
S
Q
s
R Q
R Q
S
Q
Q
Q
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264 265 266 268 275 278 281 282 285 293
WT F I) D S S K A V K K 
Round 1 
1D4
1G6 E A
2B3
3A2*
3B5
3B10
3C2
3D2 E
3E2
3G2*
3H4*
4A6
4C6
5A7
5B8
5F11____________________________________________________________
Round 2 
1 A3 
1A7 
1B3 
1D2
1 E8 
1F8 
1G5 
1H11 
2A7 
2B8 
2C4 
2D4 
2D8
2D9 N
2 E ll 
2G9 
2H5 
2H8 
3A5 
3A8 
3B4 
3B8 
3C6 
3C10 
3E9 
3F2 
3G5
3H4 L
4A7
4A8
4C9
4D8
4E3
4E8
4F3
4F11
4G5
4G10
4H5
4H9
5A8
5B6 E
5B8
5C2
5E2
5F6
5F10
5G6
6C3
6D6
6E4
6E7
6F10
6G5
6H5
7B5
7B9 N
7C8
7D11
300 307 313 315 316 318 320
A A A G K Y F
D
D
H
D
E
Y
D
E
E
G
D
E
E
E
E
D
E
D
D
E
D
E
E
E
E
D
E
E
E
D
E
D
D
D
E
E
D
E
E
E
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WT
90
K
107
K
109
V
113
T
116
A
128
L
162
L
164
F
191
D
202
A
209
K
211
G
Round 3 
1A2 
1 A4 
1A10 
1B2 
1B8 
1D10 
1 E2 
1 E3 
1F8 
1G4 
1G6 
1G7 
1H5 
2A6 
2A7 
2B4 
2B11 
2C11 
2D6 
2D10 
2E6 
2F6 
2F7 
2H3 
3A4 
3C6 
3D5 
3E8 
3G10 
3H8 
3H9 
4C2 
4C7 
4D9 
4 E3 
4 E5 
4G8 
4H11 
5A9 
5B4
Round 4 
1 A4 
1D5
I E6 
5H6 
6A10 
6B3 
6C11 
8A6 
8C8 
8H6 
9B8
II A3 
10H2 
10G8 
13D4 
13D11 
13G6 
13G9 
14A7 
14H9
15 E2 
15F3 
15H5 
17F11
16 A4 
20A6 
16H7 
17E10 
20H9
212 226 237 256
K I G L
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
<3
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
R
Q
Q
Q
Q
Q
Q
Q
D Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
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264 265 266 268 275 278 281 282 285 293 300 307 313 315 316 318 320
WT F D D S  S K A V K K A A A G K Y F  
Round 3 
1A2 
1 A4 
1A10 
1B2 
1B8 
1D10 
1 E2 
1 E3 
1F8 
1G4 
1G6 
1G7 
1H5 
2A6 
2A7 
2B4 
2B11 
2C11 
2D6 
2D10 
2E6 
2F6 
2F7 
2H3
3 A4 L
3C6 
3D5 
3E8 
3G10 
3H8 
3H9 
4C2 
4C7 
4D9 
4E3 
4E5 
4G8 
4H11 
5A9 
5B4
Round 4
1 A4 E
1D5 G E
1 E6 V E
5H6 E
6A10 G E
6B3 E
6C11 E
8A6 E
8C8 E
8H6 E
9B8 1 E
11 A3 E
10H2 E
10G8 E
13D4 E
13D11 E
13G6 T E
13G9 N E
14A7 E
14H9 G E
15 E2 E
15F3 T E
15H5 E
17F11 V E
16 A4 E
20A6 E
16H7 N E
17E10 G E
20H9 E
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Appendix G: Kinetics Overview for MPH Variants from Chapter 5
Kinetics parameters for the hydrolysis of various OP various IMPH variants.
The relative kca„ Km and kcJ K m values are colour-coded for easy reference. Green: Increase in value;
Pink: Decrease in value; ND: Not determined.
Substrate Variant KaA s'1)
Relative
kc a l
Km ((xM) Relative
Km
kca/Km 
(s'1 mM1)
Relative
kca|/Km
MPS WT 27.5 ± 1.800 1.00 27.3 ± 6.0 1.00 1007.3 1.00
F119Y 28.8 ± 0.300 1.05 29.8 ± 1.0 1.09 966.4 0.96
F196L 1.5 ± 0.060 0.05 45.6 ± 4.5 1.67 32.9 0.03
Fl 961 1.7 ± 0.050 0.06 12.9 ± 1.7 0.47 131.8 0.13
F196Y 34.5 ± 0.700 1.25 37.8 ± 2.2 1.38 912.7 0.91
L258S 1.2 ± 0.050 0.04 25.8 ± 3.7 0.95 46.5 0.05
L258I 14.1 ± 0.500 0.51 5.2 ± 0.9 0.19 2711.5 2.69
L258H 1.7 ± 0.070 0.06 16.9 ± 2.7 0.62 100.6 0.10
L258N 3.5 ± 0.300 0.13 48.2 ± 10.0 1.77 72.6 0.07
L273I 3.0 ± 0.100 0.11 12.8 ± 1.8 0.47 234.4 0.23
L273V 7.7 ± 0.050 0.28 8.9 ± 0.3 0.33 865.2 0.86 1
MPO WT 4.5 ± 0.300 1.00 72.2 ± 10.2 1.00 62.3 TOO
F119Y 8.6 ± 1.500 1.91 241.9 ± 65.3 3.35 35.6 0.57
F196L 1.1 ± 0.100 0.24 297.9 ± 53.1 4.13 3.7 0.06
Fl 961 1.3 ± 0.100 0.29 286.8 ± 45.6 3.97 4.5 0.07
F196Y 6.6 ± 0.600 1.47 208.8 ± 30.9 2.89 31.6 0.51
L258S 6.4 ± 1.000 1.42 187.7 ± 47.3 2.60 34.1 0.55
L2581 8.7 ± 0.200 1.93 57.9 ± 2.8 0.80 150.3 2.41
L258H 3.0 ± 0.200 0.67 27.4 ± 5.9 0.38 109.5 1.76
L258N 15.2 ± 0.900 3.38 195.6 ± 20.0 2.71 77.7 1.25
L273I 16.4 ± 0.700 3.64 116.5 ± 10.5 1.61 140.8 2.26
L273V 18.7 ± 3.000 4.16 108.1 ± 35.3 1.50 173.0 2.78
EPS WT 1.1 ± 0.004 1.00 10.8 ± 1.4 1.00 101.9 1.00
F119Y 3.6 ± 0.200 3.27 14.8 ± 2.2 1.37 243.2
o i s  1F196L 0.6 ± 0.020 0.55 21.2 ± 2.7 1.96 28.3
Fl 961 1.9 ± 0.100 1.73 12.9 ± 1.8 1.19 147.3 1.45
F196Y 1.8 ± 0.040 1.64 16.1 ± 0.8 1.49 111.8 1.10
L258S ND
(464
ND ND ND ND
L258I 0.7 ± 0.010 4.0 ± 0.5 175.0 1.72
L258H ND ND ND ND ND ND
L258N 0.1 ± 0.010 0.09 18.8 ± 3.7 1.74 5.3 0.05
L273I 0.2 ± 0.003 0.18 5.5 ± 0.4 0.51 36.4 0.36
L273V 0.3 ± 0.030 0.27 10.3 ± 4.0 0 95 29.1 0.29 ■
EPO WT 0.3 ± 0.010 1.00 49.0 ± 5.5 1.00 6.1 1.00
F119Y 0.8 ± 0.100 2.67 84.3 ± 21.1 1.72 9.5 1.56
F196L 0.7 ± 0.030 2.33 96.3 ± 9.5 1.97 7.3 1.19
Fl 961 1.2 ± 0.100 4.00 109.1 ± 9.8 2.23 11.0 1.80
F196Y 0.7 ± 0.070 2.33 86.7 ± 18.8 1.77 8.1 1.32
L258S 0.5 ± 0.003 1.67 62.4 ± 9.0 1.27 8.0 1.31
L258I 0.5 ± 0.010 1.67 18.6 ± 1.9 0.38 26.9 4.41
L258H 0.8 ± 0.040 2.67 18.6 ± 3.9 0.38 43.0 7.05
L258N 1.7 ± 0.040 5.67 102.0 ± 5.6 2.08 16.7 2.73
L273I 0.7 ± 0.030 2.33 46.7 ± 6.1 0.95 15.0 2.46
L273V 0.7 ± 0.010 2.33 27.3 ± 2.5 0.56 25.6 4.20
MCO WT 6.9 ± 0.100 1.00 21.4 ± 1.6 1.00 322.4 1.00
F119Y 3.3 ± 0.040 0.48 51.5 ± 1.7 2.41 64.1 0.20
F196L 0.5 ± 0.010 0.07 48.3 ± 4.0 2.26 10.4 0.03
Fl 961 1.5 ± 0.040 0.22 57.9 ± 4.1 2.71 25.9 0.08
F196Y 9.5 ± 0.400 1.38 72.5 ± 7.8 3.39 131.0 0.41
L258S 76.1 ± 2.700 11.03 31.5 ± 4.0 1.47 2415.9 7.49
L258I 7.0 ± 0.200 1.01 42.9 ± 4.2 2.00 163.2 0.51
L258H 23.1 ± 0.200 3.35 64.5 ± 1.6 3.01 358.1 1.11
L258N 133.1 ± 2.400 19.29 35.6 ± 2.2 1.66 3738.8 11.60
L273I 13.6 ± 0.200 1.97 31.7 ± 2.0 1.48 429.0 1.33
L273V 17.4 ± 0.500 2.52 23.4 ± 2.9 1.09 743.6 2.31
ECO WT 0.3 ± 0.010 1.00 15.6 ± 2.5 1.00 19.2 1.00
F119Y 0.3 ± 0.002
m & m
23.1 ± 0.9 1.48 13.0 0.68
F196L 0.2 ± 0.010 37.8 ± 4.4 2.42 5.3 0.28
Fl 961 0.6 ± 0.004 2.00 33.7 ± 0.9 2.16 17.8 0.93
F196Y 0.5 ± 0.010 1.67 31.7 ± 2.6 2.03 15.8 0 82
L258S 9.7 ± 0.200 32.33 10.1 ± 1.5 0.65 960.4 50.02
L258I 0.4 ± 0.004 1.33 12.7 ± 0.7 0.81 31.5 1.64
L258H 1.6 ± 0.010 5.33 11.8 ± 0.5 0.76 135.6 7.06
L258N 27.4 ± 0.600 91.33 24.3 ± 2.2 1.56 1127.6 58.73
L273I 0.5 ± 0.020 1.67 18.5 ± 3.3 1.19 27.0 1.41
L273V 0.3 ± 0.006 1.00 8.5 ± 1.3 0.54 35.3 1.84
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Kinetic parameters for the hydrolysis of various OP by multi-site MPH variants.
The relative kca„ Km and kca/K m values are color-coded for easy reference. Green: Increase in value; Pink:
Decrease in value; ND: Not determined.
Substrate Variant kca, (s'1)
Relative
kcat
Km (mM) RelativeKm
kca/Km 
(s'1 mM'1)
Relative
kca/f^ m
MPS WT 27.5 ± 1.80 1.00 27.3 ± 6.0 1.00 1007.3 1.00
R1A6 6.3 ± 0.20 0.23 22.5 ± 2.2 0.82 280.0 0.28
R1B6 0.3 ± 0.01 0.01 19.1 ± 1.5 0.70 15.7 0.02
R2B2 0.7 ± 0.01 0.03 16.1 ± 0.8 0.59 43.5 0.04
R2C2 1.0 ± 0.03 0.04 7.9 ± 1.2 0.29 126.6 0.13
R2D2 13.9 ± 0.40 0.51 10.1 ± 1.2 0.37 1376.2 1.37
R2A2 2.3 ± 0.30 0.08 27.8 ± 7.4 1.02 82.7 0.08 1
R2F3 1.5 ± 0.10 0.05 50.4 ± 3.4 1.85 29.8 0.03
R2D4 1.8 ± 0.10 0.07 12.0 ± 2.1 0.44 150.0 0 15 8
MPO WT 4.5 ± 0.30 1.00 72.2 ± 10.2 1.00 62.3 1.00
R1A6 30.7 ± 5.50 6.82 231.4 ± 65.2 3.20 132.7 2.13
R1B6 2.6 ± 0.40 0.58 213.3 ± 51.1 2.95 12.2 0.20
R2B2 19.4 ± 1.60 4.31 321.0 ± 39.1 4.45 60.4 0.97
R2C2 3.2 ± 0.40 0.71 139.2 ± 28.6 1.93 23.0 0.37 ■
R2D2 24.6 ± 1.30 5.47 44.5 ± 7.5 0.62 552.8 8.87
R2A2 7.0 ± 0.60 1.56 187.5 ± 28.2 2.60 37.3 0.60 8
R2F3 6.3 ± 0.40 1.40 57.6 ± 8.9 0.80 109.4 1.76
R2D4 4.4 ± 0.50 0.98 66.0 ± 15.2 0.91 66.7 1.07
EPS WT 1.1 ± 0.00 1.00 10.8 ± 1.4 1.00 101.9 1.Q0
R1A6 1.6 ± 0.10 1.45 34.5 ± 4.5 3.19 46.4 0.46
R1B6 0.3 ± 0.01 0.27 11.5 ± 0.7 1.06 26.1 0.26 ■
R2B2 ND ND ND ND ND ND
R2C2 ND ND ND ND ND ND
R2D2 2.3 ± 0.20 2.09 25.4 ± 6.9 2.35 90.6 0.89 8
R2A2 2.0 ± 0.02 1.82 2.1 ± 0.3 0.19 952.4 9.35
R2F3 ND ND ND ND ND ND
R2D4 ND ND ND ND ND ND
EPO WT 0.3 ± 0.01 1.00 49.0 ± 5.5 1,00 6.1 1.00
R1A6 4.4 ± 0.10 14.67 46.6 ± 2.6 0.95 94.4 15.48
R1B6 7.4 ± 0.20 24.67 202.2 ± 10.5 4.13 36.6 6.00
R2B2 14.5 ± 0.80 48.33 68.4 ± 8.9 1.40 212.0 34.75
R2C2 3.3 ± 0.10 11.00 31.6 ± 4.2 0.64 104.4 17.12
R2D2 11.2 ± 0.30 37.33 36.7 ± 3.0 0.75 305.2 50.03
R2A2 9.1 ± 0.30 30.33 43.2 ± 4.1 0.88 210.6 34.53
R2F3 22.0 ± 2.00 73.33 37.0 ± 10.5 0 76 594.6 97.47
R2D4 13.6 ± 0.90 45.33 54.9 ± 9.3 1.12 247.7 40.61
MCO WT 6.9 ± 0.10 1.00 21.4 ± 1.6 TOO 322.4 1.00
R1A6 249.1 ± 10.30 36.10 16.8 ± 4.1 0.79 14827.4 45.99
R1B6 144.2 ± 8.47 20.90 135.3 ± 18.5 6.32 1065.8 3.31
R2B2 60.2 ± 1.70 8.72 70.4 ± 5.9 3.29 855.1 2.65
R2C2 9.8 ± 0.40 1.42 55.9 ± 7.6 2.61 175.3 0.54
R2D2 117.8 ± 6.60 17.07 67.0 ± 11.4 3.13 1758.2 5.45
R2A2 3.9 ± 0.10 0.57 70.6 ± 3.3 3.30 55.2 0.17
R2F3 42.4 ± 2.90 6.14 103.9 ± 18.1 4.86 408.1 1.27
R2D4 10.4 ± 0.10 1.51 57.1 ± 1.7 2.67 182.1 0.56
ECO WT 0.3 ± 0.01 1.00 15.6 ± 2.5 1.00 19.2 1.00
R1A6 91.3 ± 5.20 304.33 17.8 ± 5.1 1.14 5129.2 267.15
R1B6 109.7 ± 6.10 365.67 49.9 ± 8.0 3.20 2198.4 114.50
R2B2 30.3 ± 0.90 101.00 12.6 ± 2.8 0.81 2404.8 125.25
R2C2 4.2 ± 0.10 14.00 14.5 ± 1.6 0.93 289.7 15.09
R2D2 31.6 ± 1.30 105.33 37.1 ± 5.9 2.38 851.8 44.36
R2A2 2.8 ± 0.10 9.33 21.1 ± 4.3 1.35 132.7 6.91
R2F3 35.8 ± 0.50 119.33 22.2 ± 1.6 1.42 1612.6 83.99
R2D4 10.2 ± 0.10 34.00 19.8 ± 1.5 1.27 515.2 26.83
Variants Mutations
R1A6 F119Y, L258S
R1B6 F1961, L258N
R2B2 Fl961, L258H
R2C2 Fl961, L2731
R2D2 F119Y, L258H
R2A2 Fl 19Y, Fl961, L273V
R2F3 F119Y, F196Y, L258H
R2D4 F119Y, F196I, L2731
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Appendix H: Oversampling Formula used in CASTer
Oversampling required was calculated using CASTer 2.0, a handy worksheet written by 
Reetz, (http://www.kofo.mpg.de/en/research/organic-synthesis) .The algorithm used in 
CASTer is approximated by Poisson distribution, described by Equation E.l and was 
discussed by Patrick et al.1:
P(r)
r!
(E.l)
Where P(r) is the probability any one variant, v, occurs exactly r times in the library, 
and p is the mean number of occurrence v, in the library, assuming all possible variants 
are equally probable. The mean, p, can also be rewritten as p = L/V where L is the 
library size and V is the total number of possible sequence variants. The probability of 
all variants occurring at least once would be 1- P(0). \-P(0) can be defined as F, the 
fraction of completeness of the library. Equation E.l can be transformed into
1 - P{0) = l - e  v
L
F = 1 - e  v
— = - l n ( l - F )
V
L = -V ln(l -  F)
(E.2)
The relationship between the sampling factor, L/V, and library coverage can be 
estimated from Equation E.2 and is shown in Figure E.l. Due to the exponential 
nature of the relationship, library coverage beyond 95% requires exhaustive screening 
efforts. To achieve 95% library coverage, the sampling factor is about three, which 
means three fold excess of transformants needs to be screened.
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Figure E.l: Correlation between library coverage and oversampling of enzyme variants for a given 
codon randomization calculated based on Equation E.l.
Sampling factor, L/V, represents the number of folds of excess to screen in order to achieve a certain 
percentage of coverage.
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